Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002079)

(Analysis AN003391)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12
DG 39:2; [M+NH4]+; DG(18:2/21:0/0:0)	ME479312	0.04	8.28	0.06	0.15	0.10	2.67	0.12	0.10	0.10	0.10	0.10	0.17
PE 31:0; [M+H]+; GPEtn(5:0/26:0)	ME480024	0.11	7.17	0.32	0.18	0.21	2.38	0.32	0.26	0.20	0.26	0.35	0.23
PE 40:6; [M+H]+; GPEtn(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480150	0.13	6.69	0.30	0.56	0.20	1.79	0.12	0.34	0.17	1.09	0.15	0.47
CE(17:0); [M+NH4]+; 17:0 Cholesteryl ester	ME479233	0.46	1.97	0.32	0.25	6.06	0.63	0.26	0.16	0.37	0.73	0.22	0.58
PC 40:1; [M+H]+; GPCho(17:1(9Z)/23:0)	ME479781	0.23	0.56	0.63	0.55	1.73	1.08	2.52	2.31	1.25	0.39	0.38	0.36
PC 40:1; [M+H]+; GPCho(18:1(13Z)/22:0)	ME479784	0.87	0.60	0.45	0.40	1.56	0.62	2.39	2.36	1.46	0.40	0.36	0.54
lysoPC 20:0; [M+H]+; PC(20:0/0:0)	ME479359	0.54	0.31	3.87	0.31	1.55	0.26	1.65	0.86	0.74	0.13	1.41	0.38
DG 31:1; [M+NH4]+; DG(13:0/18:1/0:0)	ME479246	0.66	0.46	3.42	0.39	1.25	0.33	1.54	0.81	0.95	0.24	1.54	0.40
lysoPC 22:5; [M+H]+; PC(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)	ME479367	0.60	0.61	3.06	0.50	1.30	0.42	1.43	0.98	0.85	0.25	1.37	0.64
PC 28:2; [M+H]+; GPCho(8:0/20:2(11Z,14Z))	ME479500	0.47	0.59	3.14	0.78	1.60	0.88	0.72	0.80	0.91	0.47	0.96	0.69
SM 32:1; [M]+; SM(d14:0/18:1(9Z))	ME480221	0.62	0.23	3.52	1.02	0.94	0.84	0.79	1.24	0.70	0.19	1.17	0.73
DG 40:10; [M+Li]+; DG(18:4/22:6/0:0)	ME479317	1.14	0.45	0.64	0.94	2.02	0.85	1.97	0.44	0.70	0.28	2.17	0.41
TG 56:6; [M+NH4]+; TG(17:1/17:2/22:3)	ME480641	0.59	0.96	0.80	1.65	0.87	1.33	0.61	0.71	0.75	1.66	0.70	1.35
TG 55:0; [M+NH4]+; TG(17:0/19:0/19:0)	ME480513	0.52	0.64	0.85	1.84	0.83	1.69	0.28	0.73	0.69	1.69	0.68	1.55
TG 56:7; [M+NH4]+; TG(17:0/17:2/22:5)	ME480656	0.52	0.64	0.86	1.85	0.83	1.69	0.28	0.73	0.69	1.69	0.68	1.55
TG 55:1; [M+NH4]+; TG(16:0/18:1/21:0)	ME480517	0.46	0.40	0.85	2.12	0.83	1.69	0.25	0.80	0.63	1.63	0.67	1.67
TG 55:1; [M+NH4]+; TG(16:1/18:0/21:0)	ME480518	0.44	0.31	1.00	2.13	0.91	1.66	0.25	0.93	0.64	1.39	0.67	1.67
TG 52:5; [M+NH4]+; TG(16:0/16:1/20:4)	ME480390	0.45	0.86	0.95	1.51	1.08	1.51	0.25	1.51	0.60	1.36	0.63	1.30
TG 56:6; [M+NH4]+; TG(16:1/18:1/22:4)	ME480640	0.55	0.65	1.00	1.75	1.00	1.48	0.44	1.28	0.75	1.17	0.73	1.20
TG 56:7; [M+NH4]+; TG(16:0/18:2/22:5)	ME480652	0.33	0.33	0.96	2.02	0.70	1.86	0.13	1.52	0.57	1.66	0.42	1.50
TG 56:7; [M+NH4]+; TG(18:1/18:2/20:4)	ME480658	0.37	0.31	1.15	1.78	0.81	1.72	0.38	1.73	0.59	1.26	0.53	1.37
PC 43:0; [M+H]+; GPCho(20:0/23:0)	ME479919	0.24	0.62	1.51	2.41	0.46	2.07	0.26	1.10	0.25	1.77	0.32	0.98
PC 48:6; [M+Na]+; GPCho(22:4(7Z,10Z,13Z,16Z)/26:2(5E,9Z))	ME479956	0.19	0.34	1.04	3.61	0.63	2.00	0.09	0.87	0.32	0.92	0.34	1.64
PC 50:4; [M+H]+; GPCho(24:4(5Z,8Z,11Z,14Z)/26:0)	ME479957	0.32	0.20	0.73	2.93	0.83	1.64	0.39	1.66	0.58	0.70	0.53	1.49
TG 55:3; [M+NH4]+; TG(18:1/18:2/19:0)	ME480542	0.21	0.31	1.26	2.61	0.66	1.97	0.10	1.65	0.36	1.18	0.39	1.31
TG 55:2; [M+NH4]+; TG(16:1/18:1/21:0)	ME480528	0.29	0.31	1.07	2.57	0.82	1.80	0.16	1.34	0.51	1.13	0.47	1.51
TG 55:2; [M+NH4]+; TG(17:1/18:1/20:0)	ME480530	0.29	0.36	1.01	2.64	0.78	1.85	0.15	1.24	0.49	1.23	0.46	1.49
PC 45:1; [M+H]+; GPCho(20:1(11E)/25:0)	ME479947	0.26	0.84	0.64	3.22	0.23	1.59	0.34	0.68	0.33	2.02	0.58	1.26
PC 46:6; [M+H]+; GPCho(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)	ME479952	0.29	1.69	0.34	2.22	0.52	1.82	0.15	0.48	0.32	2.65	0.38	1.16
TG 56:8; [M+NH4]+; TG(18:1/18:3/20:4)	ME480667	0.54	1.19	0.41	2.19	0.45	1.91	0.23	0.54	0.56	2.55	0.55	0.87
PC 44:6; [M+H]+; GPCho(18:4(6Z,9Z,12Z,15Z)/26:2(5E,9Z))	ME479941	0.34	1.09	0.81	2.23	0.50	1.90	0.36	0.80	0.37	2.32	0.34	0.93
PC 46:5; [M+H]+; GPCho(22:1(13Z)/24:4(5Z,8Z,11Z,14Z))	ME479949	0.33	1.30	0.59	2.16	0.54	1.93	0.09	0.77	0.35	2.33	0.30	1.31
PC 40:2; [M+H]+; GPCho(18:2(2E,4E)/22:0)	ME479791	0.24	1.89	1.26	1.82	0.48	1.63	0.17	1.13	0.28	1.86	0.29	0.95
PC 40:2; [M+H]+; GPCho(23:0/17:2(9Z,12Z))	ME479793	0.23	1.72	1.40	1.75	0.51	1.73	0.18	1.20	0.31	1.72	0.25	1.00
TG 55:8; [M+Li]+; TG(17:0/18:3/20:5)	ME480568	0.38	1.45	0.78	2.02	0.66	1.47	0.14	1.04	0.50	1.90	0.69	0.96
TG 56:4; [M+Na]+; TG(18:1/18:3/20:0)	ME480612	0.34	1.34	0.73	2.29	0.64	1.67	0.16	1.02	0.55	1.70	0.51	1.06
DG 37:2; [M+NH4]+; DG(18:2/19:0/0:0)	ME479283	1.03	1.96	0.54	1.91	0.36	1.17	1.23	0.82	0.52	0.57	0.80	1.09
lysoPC 26:1; [M+H]+; PC(26:1(5Z)/0:0)	ME479373	1.55	1.03	0.41	2.04	0.37	1.67	0.50	1.50	0.45	0.82	0.75	0.91
PE 38:6; [M+H]+; GPEtn(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480125	0.22	2.12	1.24	1.12	1.09	2.61	0.42	0.89	0.37	0.60	0.42	0.88
TG 56:4; [M+Na]+; TG(16:0/20:1/20:3)	ME480609	0.17	1.71	1.13	1.60	0.35	1.40	0.16	2.20	0.28	1.74	0.62	0.64
TG 56:4; [M+Na]+; TG(18:1/18:2/20:1)	ME480611	0.21	1.82	0.76	1.78	0.45	1.57	0.15	1.62	0.27	2.03	0.55	0.78
PC 43:2; [M+H]+; GPCho(21:0/22:2(13Z,16Z))	ME479928	0.22	2.15	0.69	1.72	0.67	1.37	0.38	1.59	0.39	1.39	0.57	0.84
TG 54:1; [M+Na]+; TG(16:0/18:1/20:0)	ME480449	0.56	1.74	0.82	1.45	0.83	1.08	0.14	1.66	0.41	1.45	1.09	0.77
TG 56:5; [M+Li]+; TG(18:0/18:1/20:4)	ME480620	0.48	1.88	0.59	1.30	0.56	1.34	0.35	1.66	0.45	1.41	1.10	0.87
MGDG 42:5; [M+Na]+; MGDG(20:1(11E)/22:4(7Z,10Z,13Z,16Z))	ME479395	0.22	2.13	0.69	1.09	0.66	2.07	0.23	1.66	0.35	1.49	0.37	1.03
TG 53:2; [M+NH4]+; TG(17:0/18:0/18:2)	ME480418	0.23	1.61	1.34	1.46	0.62	2.37	0.22	1.59	0.33	1.08	0.47	0.67
PC 43:2; [M+H]+; GPCho(17:0/26:2(5E,9Z))	ME479925	0.24	1.86	0.85	1.50	0.64	2.04	0.30	1.64	0.39	1.21	0.67	0.66
TG 55:0; [M+Li]+; TG(16:0/19:0/20:0)	ME480507	0.30	1.52	1.01	1.46	0.51	1.94	0.15	1.58	0.36	1.43	1.02	0.72
TG 55:3; [M+NH4]+; TG(17:0/18:2/20:1)	ME480539	0.38	1.36	1.00	1.26	0.77	1.64	0.34	1.65	0.41	1.01	1.22	0.96
TG 53:2; [M+NH4]+; TG(16:1/18:1/19:0)	ME480416	0.47	1.40	0.59	1.60	0.94	1.93	0.31	1.19	0.28	1.38	0.96	0.96
TG 53:2; [M+NH4]+; TG(17:0/18:1/18:1)	ME480419	0.31	1.46	0.56	1.71	0.67	1.96	0.36	1.46	0.46	1.11	1.11	0.84
TG 54:0; [M+Na]+; TG(16:0/16:0/22:0)	ME480444	0.25	1.96	0.80	2.06	0.69	1.80	0.22	1.00	0.23	0.95	1.35	0.70
TG 53:1; [M+NH4]+; TG(17:0/17:1/19:0)	ME480412	0.28	1.48	0.83	2.00	0.68	2.33	0.39	1.11	0.40	1.10	0.62	0.77
TG 56:7; [M+Li]+; TG(18:0/18:3/20:4)	ME480648	0.55	1.50	0.70	2.25	0.80	1.86	0.40	0.91	0.73	0.82	0.76	0.73
TG 53:5; [M+NH4]+; TG(17:1/18:1/18:3)	ME480431	0.46	2.25	0.67	1.60	0.48	1.89	0.89	0.93	0.62	0.87	0.40	0.93
TG 53:3; [M+NH4]+; TG(17:1/18:1/18:1)	ME480424	0.26	2.35	0.44	1.83	0.53	2.36	0.25	1.06	0.39	1.47	0.46	0.61
MGDG 44:5; [M+Na]+; MGDG(20:1(11E)/24:4(5Z,8Z,11Z,14Z))	ME479397	0.18	2.41	0.75	2.34	0.49	1.82	0.22	1.24	0.29	0.96	0.92	0.37
TG 53:2; [M+NH4]+; TG(17:0/17:2/19:0)	ME480417	0.31	2.53	0.71	1.84	0.49	1.94	0.15	1.26	0.35	1.02	0.55	0.85
TG 55:5; [M+NH4]+; TG(17:0/18:2/20:3)	ME480554	0.26	2.23	0.98	1.91	0.42	1.88	0.23	1.28	0.40	1.40	0.63	0.39
TG 53:4; [M+NH4]+; TG(17:0/18:1/18:3)	ME480428	0.35	2.65	1.13	1.62	0.80	1.48	0.61	1.19	0.41	0.69	0.63	0.44
TG 53:4; [M+NH4]+; TG(17:0/18:2/18:2)	ME480429	0.50	2.69	1.12	1.68	0.63	1.48	0.42	1.19	0.50	0.72	0.64	0.44
TG 55:4; [M+NH4]+; TG(17:0/18:1/20:3)	ME480547	0.27	2.39	1.27	1.74	0.61	1.74	0.19	1.40	0.29	0.98	0.54	0.58
TG 55:4; [M+NH4]+; TG(18:2/18:2/19:0)	ME480550	0.21	1.86	1.41	1.86	0.58	1.77	0.28	1.63	0.24	0.92	0.49	0.75
TG 56:2; [M+Na]+; TG(16:0/18:2/22:0)	ME480585	0.18	0.54	0.92	2.02	0.57	3.00	0.17	1.95	0.23	0.93	0.46	1.02
TG 55:6; [M+NH4]+; TG(17:0/18:2/20:4)	ME480560	0.25	1.06	1.12	2.86	0.47	1.70	0.26	1.19	0.24	1.06	0.99	0.81
TG 55:7; [M+NH4]+; TG(17:1/18:2/20:4)	ME480566	0.47	1.51	0.63	2.90	0.59	1.54	0.44	1.62	0.43	0.63	0.67	0.57
TG 55:6; [M+NH4]+; TG(16:0/17:0/22:6)	ME480558	0.10	1.60	0.77	2.47	0.62	1.91	0.16	2.03	0.27	0.61	1.03	0.42
TG 52:0; [M+Na]+; TG(16:0/16:0/20:0)	ME480362	0.41	1.82	0.85	2.02	0.57	2.10	0.32	1.73	0.27	0.88	0.44	0.59
TG 53:3; [M+NH4]+; TG(16:1/18:2/19:0)	ME480422	0.35	1.62	0.71	1.98	0.65	2.14	0.22	1.83	0.27	0.82	0.70	0.71
TG 56:1; [M+Na]+; TG(16:0/18:1/22:0)	ME480576	0.27	1.22	0.51	2.59	0.84	2.13	0.20	1.73	0.27	0.94	0.33	0.98
TG 56:2; [M+Na]+; TG(16:1/18:1/22:0)	ME480586	0.31	0.94	0.85	2.42	0.39	2.37	0.25	1.78	0.38	1.14	0.40	0.76
TG 56:3; [M+Na]+; TG(16:0/18:1/22:2)	ME480594	0.25	0.82	1.07	2.72	0.51	2.51	0.20	1.68	0.41	0.93	0.52	0.38
PE 33:0; [M+H]+; GPEtn(8:0/25:0)	ME480038	0.74	0.37	1.11	0.47	1.14	3.01	0.95	1.03	1.03	0.35	1.24	0.55
PE 33:0; [M+H]+; GPEtn(9:0/24:0)	ME480039	0.94	0.42	1.44	0.52	0.80	2.51	1.25	1.25	0.93	0.54	0.86	0.55
TG 51:2; [M+NH4]+; TG(16:0/17:0/18:2)	ME480333	0.39	0.83	3.01	2.01	0.43	1.08	0.30	1.47	0.37	0.77	0.63	0.70
TG 51:2; [M+NH4]+; TG(16:0/17:1/18:1)	ME480334	0.32	0.28	3.27	2.41	0.51	1.12	0.23	1.74	0.32	0.76	0.41	0.62
DG 32:3; [M+NH4]+; DG(14:0/18:3/0:0)	ME479249	0.50	0.59	2.08	1.47	0.98	0.69	0.38	1.30	1.15	1.52	0.60	0.72
TG 54:9; [M+Na]+; TG(16:1/18:3/20:5)	ME480505	0.60	0.57	1.35	1.86	0.75	0.94	0.53	1.28	0.74	1.82	0.69	0.87
PE 28:1; [M+H]+; GPEtn(6:0/22:1(13Z))	ME480016	0.33	1.40	2.17	1.78	0.60	0.79	0.40	1.02	0.82	1.32	1.01	0.36
PC 43:1; [M+H]+; GPCho(17:0/26:1(5Z))	ME479921	0.51	1.31	1.27	2.58	0.51	1.00	0.56	0.75	0.63	1.05	0.74	1.11
TG 53:4; [M+NH4]+; TG(17:1/18:1/18:2)	ME480430	0.47	1.45	2.13	2.25	0.56	0.63	0.48	0.90	0.66	1.07	0.37	1.03
TG 54:3; [M+NH4]+; TG(16:0/18:0/20:3)	ME480466	0.82	0.62	1.01	1.38	0.99	0.86	0.93	2.10	0.98	0.42	1.22	0.67
TG 54:3; [M+NH4]+; TG(16:0/18:3/20:0)	ME480469	0.84	0.62	0.98	1.34	0.99	0.94	0.94	2.22	0.79	0.42	1.24	0.68
PC 34:1; [M+Na]+; GPCho(16:0/18:1(11E))	ME479579	0.76	0.35	2.05	0.61	1.34	0.49	0.97	1.93	1.30	0.34	1.04	0.81
PE 39:4; [M+H]+; GPEtn(19:0/20:4(5E,8E,11E,14E))	ME480135	0.76	0.35	2.05	0.61	1.34	0.48	0.97	1.93	1.30	0.34	1.04	0.81
TG 53:1; [M+Na]+; TG(17:0/18:0/18:1)	ME480409	0.68	0.31	2.08	0.98	1.25	0.84	0.43	1.97	0.84	0.57	1.28	0.76
TG 54:0; [M+Li]+; TG(16:0/18:0/20:0)	ME480442	0.42	0.38	2.09	1.08	1.15	1.00	0.46	2.20	0.70	0.48	1.33	0.73
TG 54:0; [M+Li]+; TG(16:0/19:0/19:0)	ME480443	0.50	0.33	2.25	1.04	1.28	0.76	0.41	2.17	0.80	0.36	1.34	0.77
TG 56:7; [M+NH4]+; TG(16:0/18:1/22:6)	ME480651	0.50	0.67	1.56	1.24	0.80	1.19	0.47	2.29	0.69	1.03	0.58	0.99
TG 54:5; [M+NH4]+; TG(16:0/18:2/20:3)	ME480482	0.42	0.58	1.64	1.10	0.96	1.13	0.49	2.41	0.61	0.85	0.85	0.96
TG 54:5; [M+NH4]+; TG(16:1/18:1/20:3)	ME480483	0.39	0.60	1.68	1.09	0.97	1.15	0.49	2.44	0.58	0.85	0.79	0.97
TG 53:0; [M+NH4]+; TG(16:0/18:0/19:0)	ME480405	0.38	0.37	1.90	1.12	1.19	1.07	0.32	2.11	0.83	0.52	1.10	1.09
TG 55:8; [M+Li]+; TG(17:1/18:3/20:4)	ME480569	0.42	0.28	1.87	1.24	1.08	1.11	0.32	2.25	0.71	0.70	0.97	1.03
TG 55:8; [M+Li]+; TG(17:2/18:2/20:4)	ME480570	0.37	0.25	1.88	1.28	1.05	1.14	0.27	2.40	0.64	0.72	0.98	1.04
TG 51:1; [M+Na]+; TG(16:0/17:0/18:1)	ME480329	0.40	0.39	1.74	1.34	1.34	1.14	0.25	2.21	0.51	0.77	0.68	1.24
TG 51:1; [M+Na]+; TG(16:0/17:1/18:0)	ME480330	0.39	0.37	1.82	1.32	1.29	1.12	0.26	2.22	0.52	0.78	0.69	1.21
TG 52:1; [M+Li]+; TG(17:0/17:1/18:0)	ME480367	0.34	0.43	1.79	1.50	1.05	1.23	0.22	2.47	0.49	0.77	0.61	1.10
TG 53:2; [M+Na]+; TG(17:0/18:1/18:1)	ME480414	0.32	0.35	1.73	1.50	0.94	1.27	0.17	2.51	0.55	0.79	0.88	1.00
TG 55:7; [M+Li]+; TG(17:0/18:3/20:4)	ME480563	0.42	0.75	1.67	1.24	1.04	1.23	0.27	1.87	0.64	0.60	1.32	0.96
PC 40:0; [M+H]+; GPCho(21:0/19:0)	ME479770	0.39	0.94	1.47	1.19	1.03	1.54	0.26	1.78	0.73	0.95	0.61	1.12
TG 55:2; [M+NH4]+; TG(17:0/18:2/20:0)	ME480529	0.34	0.69	1.47	1.33	0.96	1.47	0.27	2.03	0.61	0.68	0.92	1.22
TG 55:0; [M+NH4]+; TG(18:0/18:0/19:0)	ME480514	0.77	0.41	1.63	1.34	0.68	0.70	0.77	1.84	0.69	0.73	1.07	1.36
TG 55:2; [M+Na]+; TG(18:1/18:1/19:0)	ME480526	0.80	0.28	1.74	1.89	1.10	0.74	0.59	1.55	0.81	0.61	0.91	0.96
TG 56:1; [M+Li]+; TG(17:0/18:1/21:0)	ME480572	0.56	0.34	1.79	1.96	1.12	0.77	0.61	1.58	0.83	0.48	0.93	1.01
TG 57:1; [M+NH4]+; TG(16:0/20:1/21:0)	ME480679	0.56	0.23	2.41	1.54	1.11	0.74	0.60	1.31	0.79	0.59	0.85	1.27
TG 57:0; [M+NH4]+; TG(16:0/19:0/22:0)	ME480678	0.52	0.21	2.24	1.35	1.15	1.02	0.77	1.52	0.81	0.65	0.71	1.05
TG 57:1; [M+NH4]+; TG(18:1/19:0/20:0)	ME480681	0.54	0.20	2.33	1.41	1.31	0.87	0.57	1.57	0.79	0.51	0.77	1.14
TG 57:2; [M+NH4]+; TG(16:0/19:0/22:2)	ME480683	0.48	0.17	2.35	1.22	1.27	0.96	0.48	1.59	0.87	0.51	1.02	1.09
PA 50:0; [M+Na2-H]+; GPA(24:0/26:0)	ME479422	0.34	0.18	2.21	1.41	1.14	1.09	0.37	1.84	0.78	0.52	0.94	1.18
TG 57:1; [M+NH4]+; TG(17:0/18:1/22:0)	ME480680	0.54	0.30	1.99	1.46	1.16	0.90	0.58	1.57	0.80	0.50	0.95	1.25
TG 57:2; [M+NH4]+; TG(17:0/18:2/22:0)	ME480686	0.44	0.18	1.99	1.44	1.23	0.85	0.48	1.88	0.78	0.59	0.98	1.17
TG 57:2; [M+NH4]+; TG(16:0/20:2/21:0)	ME480684	0.48	0.16	2.17	1.60	1.31	0.73	0.48	1.70	0.75	0.53	0.91	1.19
TG 57:2; [M+NH4]+; TG(17:0/18:1/22:1)	ME480685	0.47	0.15	2.13	1.57	1.28	0.88	0.47	1.66	0.83	0.52	0.88	1.16
TG 55:3; [M+Na]+; TG(18:1/18:2/19:0)	ME480535	0.61	0.31	1.95	1.35	0.74	1.10	0.63	1.67	1.19	0.67	0.82	0.96
TG 55:1; [M+NH4]+; TG(17:0/18:1/20:0)	ME480520	0.57	0.34	1.74	1.11	1.23	1.17	0.66	1.75	0.78	0.64	0.83	1.18
TG 51:0; [M+Na]+; TG(16:0/17:0/18:0)	ME480325	0.66	0.40	1.61	1.02	1.26	1.00	0.51	2.11	0.90	0.66	0.91	0.97
TG 53:0; [M+NH4]+; TG(16:0/17:0/20:0)	ME480404	0.52	0.55	1.41	1.02	1.15	1.09	0.48	1.98	0.94	0.70	1.08	1.07
TG 56:4; [M+Na]+; TG(18:1/18:1/20:2)	ME480610	0.66	0.50	1.49	1.20	1.16	1.00	0.60	1.85	1.00	0.66	0.92	0.95
TG 56:1; [M+Li]+; TG(18:1/19:0/19:0)	ME480574	0.78	0.32	1.67	1.47	1.07	0.99	0.57	1.53	1.01	0.58	1.07	0.94
TG 55:2; [M+Na]+; TG(17:0/18:1/20:1)	ME480524	0.54	0.22	1.62	1.25	1.11	0.78	0.81	1.58	0.98	0.52	1.23	1.37
TG 55:0; [M+NH4]+; TG(17:0/18:0/20:0)	ME480512	0.56	0.25	1.61	1.39	1.20	0.84	0.94	1.78	0.85	0.56	0.91	1.10
TG 55:0; [M+NH4]+; TG(16:0/18:0/21:0)	ME480510	0.57	0.23	1.73	1.32	1.26	0.83	0.85	1.76	0.84	0.55	0.99	1.08
TG 55:2; [M+Na]+; TG(18:0/18:2/19:0)	ME480525	0.59	0.33	1.80	1.26	1.16	0.83	0.86	1.73	0.83	0.54	1.01	1.05
TG 56:8; [M+NH4]+; TG(18:0/18:3/20:5)	ME480665	0.47	0.19	1.69	1.75	1.19	1.17	0.38	1.39	0.85	0.74	0.87	1.30
TG 55:1; [M+NH4]+; TG(17:0/17:1/21:0)	ME480519	0.49	0.24	1.72	1.60	1.21	1.14	0.40	1.45	0.88	0.71	0.89	1.27
TG 56:2; [M+Li]+; TG(18:2/19:0/19:0)	ME480583	0.48	0.24	1.71	1.64	1.20	1.15	0.40	1.43	0.87	0.72	0.89	1.27
TG 56:7; [M+NH4]+; TG(17:2/19:0/20:5)	ME480657	0.48	0.24	1.71	1.64	1.20	1.15	0.40	1.43	0.87	0.72	0.89	1.27
TG 55:1; [M+NH4]+; TG(18:0/18:1/19:0)	ME480521	0.49	0.19	1.81	1.46	1.25	1.13	0.41	1.55	0.84	0.65	0.90	1.31
TG 55:3; [M+Na]+; TG(17:1/18:1/20:1)	ME480534	0.55	0.24	1.86	1.30	1.28	1.15	0.47	1.51	0.82	0.70	0.82	1.31
PA 52:1; [M+Na2-H]+; GPA(26:0/26:1(5Z))	ME479424	0.52	0.33	1.71	1.32	1.33	1.13	0.47	1.36	0.86	0.94	0.74	1.30
TG 56:6; [M+NH4]+; TG(16:0/18:1/22:5)	ME480637	0.65	0.25	1.60	1.42	1.17	1.07	0.47	1.51	0.93	0.89	0.87	1.18
TG 56:6; [M+NH4]+; TG(16:0/18:2/22:4)	ME480638	0.65	0.33	1.46	1.26	1.27	1.11	0.45	1.48	0.96	0.87	0.93	1.22
TG 56:6; [M+NH4]+; TG(18:2/18:2/20:2)	ME480644	0.65	0.33	1.46	1.25	1.28	1.12	0.45	1.48	0.95	0.87	0.93	1.22
DG 38:7; [M+NH4]+; DG(18:2/20:5/0:0)	ME479310	0.57	0.33	1.35	1.44	1.51	1.09	0.49	1.70	0.82	1.01	0.70	0.99
TG 55:0; [M+NH4]+; TG(16:0/19:0/20:0)	ME480511	0.50	0.27	1.38	1.72	1.07	0.97	0.79	1.76	0.77	0.63	0.89	1.25
TG 56:6; [M+NH4]+; TG(18:1/18:1/20:4)	ME480643	0.47	0.33	1.40	1.55	1.15	1.13	0.53	1.92	0.76	0.77	0.80	1.19
TG 56:7; [M+NH4]+; TG(18:2/18:2/20:3)	ME480659	0.36	0.34	1.43	1.62	0.95	1.52	0.26	2.36	0.55	0.80	0.52	1.29
TG 56:3; [M+Li]+; TG(18:1/18:2/20:0)	ME480593	0.28	0.18	1.53	1.99	1.01	1.55	0.20	1.84	0.57	0.73	0.55	1.55
TG 57:10; [M+Li]+; TG(17:1/20:4/20:5)	ME480682	0.34	0.21	1.65	1.72	1.05	1.49	0.24	1.97	0.56	0.64	0.64	1.50
TG 55:2; [M+NH4]+; TG(16:0/18:2/21:0)	ME480527	0.33	0.39	1.75	1.65	1.07	1.33	0.22	2.03	0.61	0.67	0.64	1.30
TG 55:2; [M+NH4]+; TG(18:0/18:2/19:0)	ME480531	0.32	0.25	1.79	1.74	1.10	1.33	0.22	2.06	0.60	0.67	0.64	1.29
TG 55:3; [M+NH4]+; TG(17:0/18:1/20:2)	ME480538	0.18	0.21	1.77	2.36	0.78	1.57	0.11	2.20	0.40	0.78	0.44	1.20
TG 56:4; [M+Li]+; TG(17:0/19:0/20:4)	ME480605	0.19	0.26	1.84	2.35	0.73	1.60	0.11	2.19	0.36	0.70	0.45	1.21
TG 51:0; [M+NH4]+; TG(16:0/16:0/19:0)	ME480326	0.20	0.46	1.83	1.96	0.72	1.60	0.12	2.13	0.32	1.15	0.41	1.10
TG 53:1; [M+NH4]+; TG(16:0/18:1/19:0)	ME480411	0.17	0.41	1.46	2.33	0.73	1.68	0.11	1.97	0.36	1.07	0.59	1.12
PA 50:1; [M+Na2-H]+; GPA(24:0/26:1(5Z))	ME479423	0.23	0.20	2.30	2.10	0.86	1.35	0.17	1.99	0.49	0.53	0.66	1.14
TG 55:3; [M+NH4]+; TG(17:1/18:2/20:0)	ME480540	0.19	0.67	1.80	1.92	0.84	1.46	0.17	2.15	0.42	0.64	0.60	1.16
TG 53:0; [M+NH4]+; TG(17:0/17:0/19:0)	ME480406	0.20	0.23	2.04	1.92	0.83	1.37	0.15	2.45	0.36	0.71	0.67	1.06
TG 53:1; [M+NH4]+; TG(16:0/17:1/20:0)	ME480410	0.23	0.29	2.04	1.78	0.86	1.28	0.17	2.52	0.39	0.69	0.71	1.02
TG 54:3; [M+Li]+; TG(17:1/18:2/19:0)	ME480462	0.34	0.46	2.13	1.89	0.67	1.48	0.25	2.35	0.31	0.73	0.43	0.95
TG 54:3; [M+Li]+; TG(18:0/18:1/18:2)	ME480463	0.32	0.40	2.12	1.94	0.69	1.48	0.23	2.43	0.28	0.71	0.45	0.95
TG 52:1; [M+Li]+; TG(16:0/17:1/19:0)	ME480365	0.20	0.33	2.33	1.77	0.75	1.43	0.14	2.47	0.34	0.80	0.44	1.00
TG 52:1; [M+Li]+; TG(16:1/17:0/19:0)	ME480366	0.18	0.34	2.17	1.79	0.82	1.40	0.12	2.50	0.33	0.90	0.44	1.02
TG 54:4; [M+Na]+; TG(18:0/18:2/18:2)	ME480473	0.66	0.54	1.55	2.28	0.56	1.41	0.45	1.34	0.79	0.95	0.73	0.74
PC 40:2; [M+Na]+; GPCho(17:2(9Z,12Z)/23:0)	ME479794	0.30	0.42	2.14	2.35	0.49	1.54	0.34	1.61	0.31	1.20	0.37	0.93
TG 51:1; [M+NH4]+; TG(16:0/16:1/19:0)	ME480331	0.31	0.48	2.00	2.31	0.47	1.59	0.42	1.49	0.33	1.30	0.41	0.90
PC 46:5; [M+Na]+; GPCho(20:3(5Z,8Z,11Z)/26:2(5E,9Z))	ME479950	0.20	0.17	1.93	2.71	0.81	1.48	0.13	1.65	0.47	0.70	0.51	1.26
PC 47:2; [M+H]+; GPCho(21:0/26:2(5E,9Z))	ME479953	0.28	0.61	2.11	2.57	0.68	1.82	0.25	1.37	0.40	0.54	0.47	0.90
TG 55:4; [M+NH4]+; TG(17:0/18:2/20:2)	ME480548	0.18	0.56	2.20	2.55	0.69	1.46	0.16	1.64	0.31	0.78	0.42	1.05
TG 56:3; [M+Na]+; TG(16:0/18:2/22:1)	ME480595	0.28	0.31	1.46	2.66	0.45	2.15	0.25	2.30	0.25	0.69	0.63	0.56
TG 56:3; [M+Na]+; TG(18:1/18:2/20:0)	ME480599	0.34	0.36	1.40	2.70	0.49	2.33	0.22	1.99	0.27	0.65	0.77	0.48
TG 56:4; [M+Na]+; TG(16:0/18:0/22:4)	ME480606	0.24	0.69	1.04	2.37	0.61	1.65	0.22	2.77	0.31	0.77	0.79	0.54
TG 56:4; [M+Na]+; TG(16:0/18:2/22:2)	ME480608	0.26	0.62	1.59	2.31	0.61	1.32	0.22	2.28	0.38	0.78	1.07	0.56
TG 54:3; [M+Na]+; TG(16:0/18:0/20:3)	ME480464	0.37	0.67	1.54	2.04	0.49	1.43	0.27	2.58	0.32	0.91	0.78	0.59
TG 54:2; [M+Na]+; TG(16:0/18:2/20:0)	ME480454	0.36	0.75	1.31	2.01	0.57	1.70	0.33	2.42	0.37	0.71	0.94	0.53
TG 54:2; [M+Na]+; TG(16:0/18:1/20:1)	ME480453	0.36	0.89	1.41	1.90	0.46	1.74	0.32	2.36	0.35	0.81	0.84	0.57
TG 56:8; [M+Li]+; TG(18:0/18:3/20:5)	ME480660	0.35	0.96	1.40	1.87	0.45	1.72	0.32	2.33	0.36	0.83	0.82	0.60
TG 56:4; [M+Na]+; TG(16:0/18:1/22:3)	ME480607	0.21	0.58	1.91	1.88	1.06	1.83	0.19	2.30	0.35	0.50	0.71	0.48
TG 56:4; [M+Na]+; TG(18:2/18:2/20:0)	ME480613	0.19	0.61	2.05	1.70	0.47	1.46	0.19	2.77	0.29	0.62	1.14	0.50
TG 55:6; [M+NH4]+; TG(17:1/18:2/20:3)	ME480562	0.30	1.45	1.29	1.89	0.63	1.27	0.27	1.92	0.36	0.93	1.12	0.57
TG 56:7; [M+Li]+; TG(16:0/18:3/22:4)	ME480646	0.23	1.09	1.04	1.77	0.79	1.97	0.27	1.90	0.36	0.92	1.04	0.61
TG 55:7; [M+NH4]+; TG(17:0/18:2/20:5)	ME480565	0.29	0.88	0.90	1.98	0.67	1.99	0.34	1.86	0.45	1.11	0.86	0.68
TG 55:7; [M+NH4]+; TG(16:0/17:1/22:6)	ME480564	0.25	0.81	0.87	1.89	0.76	1.99	0.36	2.12	0.41	1.11	0.78	0.66
TG 55:7; [M+NH4]+; TG(17:2/18:2/20:3)	ME480567	0.26	0.78	0.85	1.90	0.81	2.15	0.36	2.08	0.38	1.02	0.76	0.66
TG 51:2; [M+Na]+; TG(17:0/17:1/17:1)	ME480332	0.28	1.05	1.15	1.97	0.80	1.63	0.16	1.83	0.41	1.21	0.45	1.06
TG 53:0; [M+NH4]+; TG(16:0/16:0/21:0)	ME480403	0.22	0.74	1.39	1.98	0.75	1.66	0.13	1.86	0.46	1.06	0.78	0.97
lysoPC 22:0; [M+H]+; PC(22:0/0:0)	ME479363	1.70	0.29	1.80	1.64	1.16	0.49	1.78	0.73	0.34	0.54	0.68	0.84
N-(docosanoyl)-sphinganine; [M+H]+; Cer(d18:0/22:0)	ME479406	1.78	0.72	1.28	0.77	1.51	0.62	2.24	0.73	0.49	0.65	0.58	0.65
PC 26:1; [M+Na]+; GPCho(2:0/24:1(15Z))	ME479466	1.91	0.51	1.64	0.52	1.23	0.81	1.92	1.15	0.73	0.39	0.68	0.53
DG 42:9; [M+NH4]+; DG(20:4/22:5/0:0)	ME479342	2.24	1.01	0.97	0.91	0.41	0.84	0.73	0.68	1.78	0.51	1.06	0.88
PC 24:0; [M+Na]+; GPCho(21:0/3:0)	ME479445	1.21	1.24	0.70	1.36	0.93	1.06	0.46	0.93	2.31	0.43	0.61	0.77
SM 39:2; [M]+; SM(d15:1(4E)/24:1(15Z))	ME480235	0.41	1.23	0.79	0.80	0.91	1.35	1.25	1.14	1.94	0.51	1.10	0.56
PE 36:2; [M+H]+; GPEtn(16:1(7Z)/20:1(11E))	ME480082	0.45	1.06	0.72	1.88	1.86	0.73	0.40	0.97	1.34	1.00	0.97	0.61
TG 55:6; [M+NH4]+; TG(17:1/18:1/20:4)	ME480561	1.05	0.28	1.55	0.49	2.07	0.55	1.68	1.03	1.13	0.29	1.12	0.75
PC 40:0; [M+Na]+; GPCho(17:0/23:0)	ME479774	0.49	0.40	1.00	1.44	2.01	0.86	1.07	1.21	0.99	0.62	1.12	0.79
PC 44:5; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/26:2(5Z,9E))	ME479936	0.69	0.34	1.05	1.04	3.03	0.86	0.99	0.91	1.25	0.44	0.84	0.56
PC 31:2; [M+H]+; GPCho(11:0/20:2(11Z,14Z))	ME479543	0.58	1.41	2.52	1.04	0.90	0.56	0.63	0.56	0.66	1.07	0.88	1.20
PE 32:3; [M+H]+; GPEtn(14:0/18:3(6Z,9Z,12Z))	ME480030	0.85	1.58	1.96	0.68	0.70	1.05	0.72	0.42	1.07	0.27	1.50	1.21
MGDG 20:3; [M+NH4]+; MGDG(2:0/18:3(6Z,9Z,12Z))	ME479381	0.61	1.37	1.77	1.11	0.70	0.70	0.93	0.62	1.23	0.73	1.01	1.21
PE 40:7; [M+H]+; GPEtn(18:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480154	0.68	1.57	1.63	1.14	0.58	0.52	1.12	0.55	1.43	0.85	0.74	1.20
PC 42:8; [M+Na]+; GPCho(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479910	1.42	1.19	0.75	0.88	0.82	0.73	1.41	0.39	1.28	1.05	1.34	0.75
TG 52:2; [M+Na]+; TG(16:0/18:0/18:2)	ME480370	1.86	1.25	0.48	0.58	0.88	0.58	1.49	0.29	1.52	0.87	1.51	0.69
PC 37:0; [M+H]+; GPCho(13:0/24:0)	ME479651	1.39	1.07	1.21	1.14	0.38	0.77	1.36	0.61	0.99	1.31	0.54	1.22
TG 53:7; [M+NH4]+; TG(17:2/18:2/18:3)	ME480440	0.94	0.99	0.99	1.09	0.97	0.46	1.52	0.98	1.02	1.54	0.65	0.86
TG 53:8; [M+NH4]+; TG(17:2/18:3/18:3)	ME480441	1.44	1.01	1.06	1.05	1.25	0.55	1.02	0.65	1.32	1.29	0.81	0.55
PC 31:6; [M+Na]+; GPCho(9:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479552	0.37	0.55	2.46	0.73	1.87	0.65	0.66	1.07	0.84	0.34	1.78	0.67
PC 42:4; [M+H]+; GPCho(18:4(6Z,9Z,12Z,15Z)/24:0)	ME479876	0.53	0.45	2.58	0.76	2.53	0.61	0.58	0.99	0.94	0.42	1.07	0.54
PC 29:2; [M+H]+; GPCho(17:2(9Z,12Z)/12:0)	ME479508	0.44	0.27	2.00	1.26	1.18	1.54	0.67	0.70	1.38	0.25	1.86	0.46
SM 42:0; [M+Na]+; SM(d16:0/26:0)	ME480246	0.80	0.49	2.20	1.31	0.61	0.79	1.30	1.32	0.78	0.71	0.90	0.77
TG 55:5; [M+NH4]+; TG(17:1/18:1/20:3)	ME480555	0.50	0.50	1.85	1.06	1.05	0.66	1.31	1.43	1.13	0.57	0.88	1.06
PE 24:0; [M+H]+; GPEtn(7:0/17:0)	ME479996	0.65	0.19	2.32	1.27	1.15	0.66	1.67	1.18	0.98	0.24	0.98	0.71
PC 28:1; [M+H]+; GPCho(8:0/20:1(11Z))	ME479495	0.79	0.23	2.73	1.22	1.42	0.75	1.02	1.24	0.74	0.18	1.10	0.59
PC 16:0; [M+Na]+; GPCho(3:0/13:0)	ME479426	0.91	0.39	2.47	1.56	0.96	0.87	0.98	1.05	0.70	0.29	0.96	0.87
TG 50:1; [M+Li]+; TG(16:0/16:1/18:0)	ME480301	0.83	0.34	2.40	1.39	1.12	0.68	1.03	1.37	0.81	0.54	0.85	0.64
PC 27:1; [M+H]+; GPCho(5:0/22:1(13Z))	ME479480	0.45	0.19	2.87	0.80	1.55	0.91	0.84	0.85	1.27	0.19	1.40	0.67
PC 26:5; [M+Na]+; GPCho(6:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME479473	0.54	0.19	2.77	0.86	1.40	0.67	1.01	0.97	1.13	0.18	1.50	0.78
PC 27:1; [M+H]+; GPCho(9:0/18:1(11E))	ME479483	0.44	0.18	2.82	1.01	1.58	0.69	1.00	0.83	1.11	0.19	1.43	0.72
PC 27:1; [M+H]+; GPCho(3:0/24:1(15Z))	ME479479	0.63	0.22	2.60	0.99	1.17	0.82	0.97	0.87	1.38	0.22	1.43	0.69
PC 26:5; [M+Na]+; GPCho(4:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME479471	0.60	0.21	2.36	1.33	1.29	0.88	0.98	0.95	1.03	0.20	1.50	0.65
PC 27:1; [M+H]+; GPCho(13:0/14:1(9Z))	ME479478	0.62	0.21	2.39	1.30	1.31	0.87	0.97	0.97	1.12	0.21	1.44	0.60
PC 27:1; [M+H]+; GPCho(7:0/20:1(11E))	ME479481	0.62	0.21	2.39	1.30	1.31	0.87	0.97	0.97	1.12	0.21	1.44	0.60
PC 25:0; [M+Na]+; GPCho(11:0/14:0)	ME479449	0.67	0.27	2.07	0.98	1.49	0.91	1.18	0.94	1.23	0.30	1.38	0.59
PC 25:0; [M+Na]+; GPCho(4:0/21:0)	ME479451	0.53	0.25	2.01	1.09	1.54	1.03	1.11	0.92	1.20	0.30	1.28	0.75
PC 30:1; [M+H]+; GPCho(4:0/26:1(5Z))	ME479525	0.87	0.40	2.14	0.97	1.36	0.93	0.98	1.10	1.12	0.22	1.35	0.56
PC 30:4; [M+H]+; GPCho(12:0/18:4(6Z,9Z,12Z,15Z))	ME479532	0.82	0.43	2.16	1.04	1.44	0.68	0.93	0.81	1.18	0.40	1.35	0.76
PC 39:7; [M+H]+; GPCho(17:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479767	0.86	0.55	2.03	0.94	1.43	0.81	1.09	0.81	0.98	0.27	1.54	0.69
DG 33:2; [M+NH4]+; DG(15:0/18:2/0:0)	ME479251	0.47	0.51	2.64	0.61	1.67	0.44	1.82	0.83	0.80	0.39	1.42	0.42
PE 24:0; [M+H]+; GPEtn(2:0/22:0)	ME479992	0.57	0.42	2.20	0.98	1.95	0.55	1.49	0.86	0.93	0.32	1.31	0.44
PE 23:0; [M+H]+; GPEtn(19:0/4:0)	ME479991	0.76	0.25	2.15	0.90	1.51	0.69	1.27	0.80	0.90	0.20	1.98	0.58
DG 38:7; [M+NH4]+; DG(16:1/22:6/0:0)	ME479309	0.82	0.31	2.61	0.79	1.41	0.46	1.64	0.92	0.99	0.24	1.24	0.56
lysoPC 24:1; [M+H]+; PC(24:1(15Z)/0:0)	ME479369	0.89	0.37	2.43	0.67	1.25	0.37	1.60	0.89	1.10	0.45	1.42	0.56
PC 25:1; [M+Na]+; GPCho(7:0/18:1(11E))	ME479453	0.70	0.34	2.71	0.89	1.14	0.53	1.24	1.05	1.00	0.35	1.41	0.63
PC 40:8; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME479828	0.88	0.32	2.38	0.82	1.05	0.46	1.33	1.19	1.05	0.43	1.30	0.79
DG 33:2; [M+NH4]+; DG(16:1/17:1/0:0)	ME479252	0.63	0.59	2.24	0.39	1.49	0.43	1.66	0.95	1.00	0.43	1.75	0.43
DG 39:7; [M+NH4]+; DG(17:1/22:6/0:0)	ME479315	0.67	0.50	2.20	0.45	1.38	0.61	1.38	1.12	1.02	0.53	1.47	0.66
PC 27:1; [M+H]+; GPCho(7:0/20:1(13E))	ME479482	0.59	0.21	2.31	0.73	1.68	0.84	1.14	0.98	1.17	0.20	1.65	0.48
DG 35:4; [M+NH4]+; DG(17:1/18:3/0:0)	ME479266	0.78	0.30	2.36	0.73	1.45	0.53	1.23	0.97	1.19	0.45	1.51	0.50
DG 38:7; [M+Li]+; DG(16:1/22:6/0:0)	ME479308	0.57	0.35	2.26	0.64	1.38	0.47	1.24	1.13	1.45	0.34	1.69	0.48
lysoPC 22:2; [M+H]+; PC(22:2(13Z,16Z)/0:0)	ME479365	0.66	1.01	2.35	0.49	1.12	0.59	1.57	0.60	0.93	0.54	1.68	0.47
PC 31:4; [M+Na]+; GPCho(9:0/22:4(7Z,10Z,13Z,16Z))	ME479549	1.20	0.63	2.12	0.50	1.28	0.62	0.95	0.64	1.09	0.63	1.74	0.60
PE 24:1; [M+H]+; GPEtn(6:0/18:1(11E))	ME480000	1.24	0.90	2.77	0.71	1.05	0.50	1.04	0.72	0.96	0.35	0.99	0.78
PC 28:1; [M+Na]+; GPCho(12:0/16:1(7Z))	ME479496	1.10	0.61	2.26	0.88	0.58	0.88	0.70	0.86	1.18	0.66	1.22	1.07
PC 29:1; [M+H]+; GPCho(14:1(9Z)/15:0)	ME479504	0.86	0.77	2.47	0.77	1.07	0.91	0.51	0.72	1.39	0.80	1.01	0.74
PC 24:0; [M+Na]+; GPCho(6:0/18:0)	ME479447	0.74	1.36	1.98	0.85	1.38	0.53	0.64	1.15	0.79	0.47	1.15	0.97
PE 35:3; [M+H]+; GPEtn(17:1(9Z)/18:2(2E,4E))	ME480072	0.64	1.20	1.54	0.78	1.66	0.71	0.53	1.32	0.94	0.68	1.25	0.75
PC 44:5; [M+H]+; GPCho(22:4(7Z,10Z,13Z,16Z)/22:1(13Z))	ME479940	0.82	1.07	2.34	0.87	1.36	0.54	1.16	0.73	1.02	0.55	0.96	0.58
PE 33:2; [M+H]+; GPEtn(16:1(7Z)/17:1(9Z))	ME480046	0.95	1.48	2.18	0.76	1.44	0.55	0.94	0.93	1.00	0.41	0.91	0.47
PE 38:1; [M+H]+; GPEtn(16:1(7Z)/22:0)	ME480109	0.66	0.82	2.09	0.94	1.63	0.62	0.97	0.99	0.70	0.66	1.02	0.89
TG 50:3; [M+Na]+; TG(16:0/16:1/18:2)	ME480313	0.52	0.72	1.78	1.01	1.46	0.69	1.18	1.02	1.06	0.54	1.14	0.88
PC 25:1; [M+Na]+; GPCho(9:0/16:1(7Z))	ME479454	0.59	0.62	2.39	0.72	1.22	0.61	1.12	0.93	1.23	0.45	1.28	0.84
PE 30:3; [M+H]+; GPEtn(10:0/20:3(5Z,8Z,11Z))	ME480023	0.55	1.00	2.00	0.78	1.19	0.61	1.34	0.92	1.25	0.50	1.26	0.61
plasmenyl-PE 36:2; [M+H]+; PE(P-16:0/20:2(11Z,14Z))	ME480198	0.66	0.47	2.27	0.90	1.64	0.51	0.93	1.25	1.57	0.36	0.98	0.47
SM 33:1; [M+Na]+; SM(d15:0/18:1(9Z))	ME480225	0.64	0.59	2.24	0.82	1.77	0.84	0.55	0.92	1.43	0.61	1.09	0.50
DG 42:9; [M+NH4]+; DG(20:3/22:6/0:0)	ME479341	0.92	0.34	1.81	0.83	1.76	0.73	0.99	0.96	1.20	0.69	1.25	0.52
MGDG 6:0; [M+NH4-CO]+; MGDG(2:0/4:0)	ME479401	0.99	0.25	1.99	0.91	1.44	0.56	0.78	1.15	1.19	0.74	1.39	0.61
PC 40:0; [M+Na]+; GPCho(19:0/21:0)	ME479775	1.02	0.54	1.64	1.05	1.58	0.85	0.77	0.90	0.77	0.53	1.62	0.74
PE 36:6; [M+H]+; GPEtn(18:2(2E,4E)/18:4(6Z,9Z,12Z,15Z))	ME480094	0.93	0.47	1.99	1.43	1.53	0.69	0.67	0.90	0.95	0.44	1.40	0.59
MGDG 27:0; [M+Na]+; MGDG(11:0/16:0)	ME479388	0.63	0.34	2.05	1.23	1.25	0.83	0.26	1.31	0.93	1.00	1.17	1.01
CE(19:0); [M+NH4]+; 19:0 Cholesteryl ester	ME479238	0.84	0.31	2.05	1.13	1.55	0.85	0.63	1.41	1.02	0.63	0.93	0.66
DG 39:1; [M+NH4]+; DG(18:1/21:0/0:0)	ME479311	0.63	0.22	2.42	1.16	1.41	0.71	0.37	1.49	1.04	0.58	1.01	0.95
PC 27:0; [M+Na]+; GPCho(9:0/18:0)	ME479474	0.73	0.50	2.08	1.38	1.52	0.89	0.52	0.84	1.18	0.76	0.67	0.93
PC 24:0; [M+Na]+; GPCho(3:0/21:0)	ME479446	0.52	0.33	2.31	1.40	1.41	0.89	0.53	1.14	0.92	0.53	1.43	0.60
SM 32:0; [M]+; SM(d14:0/18:0)	ME480220	0.61	0.66	1.89	1.10	1.36	0.88	0.67	1.16	1.33	0.54	1.08	0.72
PC 39:5; [M+Na]+; GPCho(22:4(7Z,10Z,13Z,16Z)/17:1(9Z))	ME479762	0.48	0.49	2.07	1.77	1.22	0.96	0.68	1.02	1.15	0.54	0.97	0.65
PC 38:7; [M+Na]+; GPCho(16:1(7Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479721	0.56	0.55	2.14	1.44	1.37	0.88	0.74	1.11	0.96	0.52	1.09	0.64
PC 27:3; [M+Na]+; GPCho(7:0/20:3(5Z,8Z,11Z))	ME479486	0.56	0.52	2.10	1.41	1.41	0.96	0.66	0.94	1.21	0.46	1.11	0.66
PC 29:6; [M+H]+; GPCho(7:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479514	0.52	0.45	1.89	1.37	1.33	1.00	0.76	0.97	1.34	0.46	1.23	0.68
PC 26:1; [M+Na]+; GPCho(10:0/16:1(7Z))	ME479465	0.68	0.91	2.13	1.07	1.19	1.41	0.61	0.76	1.05	0.48	0.89	0.81
PC 28:6; [M+Na]+; GPCho(6:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479503	0.62	0.94	1.96	1.08	1.26	1.56	0.57	0.73	1.37	0.48	0.75	0.69
PC 28:2; [M+H]+; GPCho(6:0/22:2(13Z,16Z))	ME479499	0.51	0.76	1.87	1.26	0.97	1.50	0.59	0.99	0.95	0.59	1.15	0.85
PE 35:4; [M+H]+; GPEtn(15:0/20:4(5E,8E,11E,14E))	ME480074	0.53	0.85	1.91	1.19	1.02	1.05	0.67	1.20	1.11	0.66	0.89	0.91
PE 39:7; [M+H]+; GPEtn(17:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480139	0.53	0.92	1.92	1.09	0.84	1.04	0.58	1.47	0.93	0.76	1.08	0.84
PE 34:3; [M+H]+; GPEtn(16:0/18:3(6Z,9Z,12Z))	ME480055	0.45	0.55	2.31	1.15	0.83	0.78	1.17	0.62	1.46	0.62	1.36	0.70
PC 28:0; [M+H]+; GPCho(5:0/23:0)	ME479491	0.59	1.05	1.59	0.98	1.15	0.97	1.02	0.73	1.68	0.60	1.12	0.52
PC 27:5; [M+Na]+; GPCho(5:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME479488	0.67	0.60	1.62	1.05	1.15	0.70	1.06	0.94	1.78	0.64	0.98	0.81
PC 40:3; [M+H]+; GPCho(18:2(2E,4E)/22:1(13Z))	ME479798	0.79	0.42	1.48	1.06	1.19	0.95	1.26	0.89	1.58	0.66	0.98	0.74
PC 42:4; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/24:1(15Z))	ME479875	0.76	0.62	1.80	1.24	1.01	1.04	0.72	0.61	1.54	0.54	1.16	0.96
PE 24:0; [M+H]+; GPEtn(4:0/20:0)	ME479993	0.63	0.50	1.65	1.16	1.22	1.15	0.85	0.69	1.56	0.58	1.41	0.59
PE 24:0; [M+H]+; GPEtn(5:0/19:0)	ME479994	0.69	0.39	1.68	1.28	1.23	1.03	0.84	0.85	1.39	0.45	1.46	0.71
PE 33:1; [M+H]+; GPEtn(15:0/18:1(11Z))	ME480041	0.79	0.57	1.95	0.64	1.27	0.92	0.90	1.06	1.68	0.50	1.18	0.52
PC 24:0; [M+H]+; GPCho(9:0/15:0)	ME479443	0.76	0.52	2.06	0.88	1.07	1.28	0.80	0.85	1.40	0.45	1.19	0.75
SM 38:5; [M]+; SM(d14:1(4E)/24:4(5Z,8Z,11Z,14Z))	ME480232	0.56	0.75	2.19	0.92	1.11	1.08	0.66	0.68	1.69	0.37	1.29	0.71
PC 35:0; [M+H]+; GPCho(26:0/9:0)	ME479605	0.82	0.89	1.00	1.74	1.02	0.74	0.64	1.00	0.64	0.56	1.24	1.72
TG 56:4; [M+NH4]+; TG(16:0/18:2/22:2)	ME480616	0.87	0.70	1.13	2.15	1.04	1.15	0.81	0.89	0.87	0.50	0.91	0.97
TG 56:9; [M+Li]+; TG(18:1/18:3/20:5)	ME480670	0.67	0.87	1.01	2.08	1.00	1.37	1.04	0.67	0.88	0.91	0.61	0.90
TG 56:1; [M+Li]+; TG(18:0/18:1/20:0)	ME480573	0.53	0.38	1.22	1.85	0.95	1.19	0.75	1.30	0.71	0.84	0.85	1.42
TG 56:4; [M+NH4]+; TG(16:0/18:0/22:4)	ME480614	1.06	0.42	1.18	1.90	0.75	0.84	1.00	1.30	0.80	0.68	0.83	1.24
TG 56:4; [M+NH4]+; TG(16:0/18:1/22:3)	ME480615	1.07	0.44	1.20	1.88	0.76	1.05	1.03	1.33	0.85	0.70	0.83	0.88
CE(18:0); [M+NH4]+; 18:0 Cholesteryl ester	ME479234	0.31	0.80	2.02	1.37	0.58	1.69	0.57	0.95	1.01	0.15	1.37	1.81
PC 41:1; [M+H]+; GPCho(17:0/24:1(15Z))	ME479838	0.76	0.60	1.32	1.58	0.89	0.80	0.49	0.74	1.70	1.01	0.77	1.34
PC 43:1; [M+H]+; GPCho(18:1(11E)/25:0)	ME479922	0.74	0.29	1.76	1.40	1.09	1.13	0.67	0.90	0.95	0.51	0.93	1.63
PC 42:6; [M+Na]+; GPCho(20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z))	ME479898	0.84	0.48	1.82	1.46	0.98	0.83	0.36	0.74	1.15	0.56	1.20	1.58
PC 44:9; [M+H]+; GPCho(24:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))	ME479945	0.84	0.37	2.00	1.38	1.04	0.76	0.40	0.80	1.16	0.47	1.21	1.58
PC 42:5; [M+Na]+; GPCho(20:5(5Z,8Z,11Z,14Z,17Z)/22:0)	ME479895	0.81	0.54	1.68	1.43	0.87	1.03	0.48	0.82	1.05	0.58	1.15	1.55
PC 43:2; [M+H]+; GPCho(17:1(9Z)/26:1(5Z))	ME479926	0.84	0.66	1.59	1.55	0.90	0.86	0.32	0.71	1.12	0.67	1.15	1.64
PC 30:3; [M+H]+; GPCho(10:0/20:3(5Z,8Z,11Z))	ME479528	0.45	0.64	1.36	1.28	0.61	1.11	0.60	1.02	1.42	0.92	1.33	1.27
PC 30:3; [M+H]+; GPCho(12:0/18:3(6Z,9Z,12Z))	ME479529	0.45	0.64	1.36	1.28	0.61	1.11	0.60	1.02	1.42	0.92	1.33	1.27
PC 26:0; [M+Na]+; GPCho(6:0/20:0)	ME479461	0.67	1.09	1.51	1.33	0.65	0.94	0.34	0.99	1.17	0.56	1.25	1.51
PC 26:0; [M+Na]+; GPCho(8:0/18:0)	ME479462	0.69	0.90	1.59	1.30	0.78	1.01	0.35	1.02	1.24	0.42	1.22	1.48
PC 30:3; [M+Na]+; GPCho(12:0/18:3(9Z,12Z,15Z))	ME479531	0.47	1.18	1.23	0.90	1.13	0.77	0.97	0.83	1.13	0.60	2.28	0.51
PC 29:1; [M+H]+; GPCho(5:0/24:1(15Z))	ME479505	1.09	0.94	1.25	0.67	0.84	0.87	0.84	0.74	1.40	0.62	2.05	0.70
PC 42:5; [M+H]+; GPCho(18:4(6Z,9Z,12Z,15Z)/24:1(15Z))	ME479885	0.77	1.12	1.66	0.68	0.85	0.74	0.81	0.83	1.20	0.74	1.85	0.74
PC 26:1; [M+H]+; GPCho(9:0/17:1(9Z))	ME479464	1.19	1.18	0.74	0.70	0.59	0.76	1.19	1.21	0.99	0.87	1.65	0.94
PC 42:7; [M+Na]+; GPCho(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME479906	1.18	1.44	1.00	0.70	0.55	0.53	0.75	0.96	1.01	1.10	1.95	0.83
PC 32:0; [M+Na]+; GPCho(10:0/22:0)	ME479554	1.02	1.30	1.40	0.85	0.77	0.91	0.59	0.76	0.97	1.18	1.72	0.53
PE 26:4; [M+H]+; GPEtn(4:0/22:4(7Z,10Z,13Z,16Z))	ME480008	0.87	1.59	0.86	0.98	0.73	0.96	0.76	0.70	0.70	1.37	1.60	0.86
DG 36:6; [M+NH4]+; DG(14:0/22:6/0:0)	ME479281	0.98	0.93	1.86	0.42	0.91	0.58	1.18	1.08	1.39	0.52	1.38	0.77
MGDG 25:1; [M+NH4-CO]+; MGDG(10:0/15:1(9Z))	ME479385	1.19	0.58	1.81	0.82	0.80	0.64	1.04	1.18	1.46	0.62	1.02	0.83
DG 40:5; [M+NH4]+; DG(18:0/22:5/0:0)	ME479323	1.63	0.78	1.62	0.83	0.59	0.49	1.53	1.13	1.09	0.33	1.09	0.88
PE 32:0; [M+H]+; GPEtn(9:0/23:0)	ME480028	1.73	0.64	1.55	0.64	0.69	0.90	1.05	1.28	1.14	0.44	1.18	0.76
DG 35:5; [M+NH4]+; DG(17:2/18:3/0:0)	ME479268	0.74	0.42	1.55	0.61	1.15	0.80	1.84	1.55	0.69	0.40	1.22	1.02
MGDG 22:2; [M+NH4]+; MGDG(2:0/20:2(11Z,14Z))	ME479382	0.88	0.72	1.63	0.79	0.58	1.21	1.54	0.88	1.21	0.72	1.05	0.77
PC 39:1; [M+H]+; GPCho(22:0/17:1(9Z))	ME479733	1.06	0.73	1.36	0.97	0.82	0.86	1.79	1.31	0.82	0.67	0.81	0.81
PE 42:1; [M+H]+; GPEtn(18:1(11E)/24:0)	ME480160	1.04	0.73	1.12	0.96	0.81	1.22	1.73	1.29	0.81	0.67	0.81	0.81
PC 29:6; [M+Na]+; GPCho(7:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479515	1.27	1.10	0.77	1.55	1.46	0.80	1.34	0.70	1.08	0.36	1.06	0.51
N-(15Z-tetracosenoyl)-sphinganine; [M+H]+; Cer(d18:0/24:1(15Z))	ME479403	1.81	0.76	1.32	1.19	1.28	0.83	1.32	0.89	0.68	0.65	0.75	0.52
SM 21:0; [M]+; SM(d19:0/2:0)	ME480217	1.30	0.79	1.12	0.97	1.30	0.70	1.74	1.04	0.96	0.65	0.44	1.00
PC 38:0; [M+H]+; GPCho(18:0/20:0)	ME479689	1.34	0.82	1.02	0.98	1.06	0.77	1.19	1.02	0.91	0.69	0.92	1.29
PC 43:0; [M+H]+; GPCho(24:0/19:0)	ME479920	1.44	0.71	1.17	0.95	1.22	0.71	1.40	0.65	1.08	0.68	0.92	1.07
PC 41:2; [M+H]+; GPCho(18:2(2E,4E)/23:0)	ME479844	1.05	0.44	0.98	0.71	0.97	0.48	0.84	1.57	1.22	0.76	1.79	1.20
PC 42:9; [M+H]+; GPCho(20:4(5E,8E,11E,14E)/22:5(7Z,10Z,13Z,16Z,19Z))	ME479913	1.17	0.32	0.91	0.95	1.05	0.65	0.80	1.20	1.27	0.47	1.42	1.80
PC 41:2; [M+H]+; GPCho(20:2(11Z,14Z)/21:0)	ME479846	1.20	0.33	0.96	1.02	1.10	0.48	0.85	1.24	1.32	0.49	1.11	1.87
PC 41:2; [M+H]+; GPCho(24:0/17:2(9Z,12Z))	ME479847	1.19	0.33	0.95	0.99	1.08	0.66	0.83	1.23	1.30	0.48	1.10	1.85
PC 48:4; [M+Na]+; GPCho(24:0/24:4(5Z,8Z,11Z,14Z))	ME479955	1.13	0.62	1.23	0.87	0.71	0.61	0.95	1.47	1.24	0.94	0.85	1.39
PE 39:4; [M+H]+; GPEtn(17:2(9Z,12Z)/22:2(13Z,16Z))	ME480134	1.32	0.54	0.80	0.94	0.88	0.98	0.83	1.20	1.30	1.10	0.82	1.28
PC 41:2; [M+H]+; GPCho(17:1(9Z)/24:1(15Z))	ME479842	1.63	0.64	1.01	0.81	1.12	0.62	0.98	1.23	1.44	0.50	1.00	1.00
PC 42:9; [M+H]+; GPCho(20:4(5E,8E,11E,14E)/22:5(4Z,7Z,10Z,13Z,16Z))	ME479912	1.18	0.45	0.96	1.03	1.05	0.58	0.65	1.44	1.35	0.82	1.16	1.32
PC 38:2; [M+H]+; GPCho(12:0/26:2(5E,9Z))	ME479702	1.09	0.54	1.07	1.11	0.90	0.70	0.98	1.19	1.64	0.55	1.17	1.07
PC 41:2; [M+H]+; GPCho(17:2(9Z,12Z)/24:0)	ME479843	1.18	0.52	0.80	1.14	0.98	0.68	0.71	1.14	1.71	0.73	1.11	1.30
PC 35:1; [M+Na]+; GPCho(9:0/26:1(5Z))	ME479611	0.74	1.07	0.73	1.04	0.73	1.17	0.62	0.80	1.66	0.78	1.40	1.26
PC 35:5; [M+Na]+; GPCho(15:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME479623	0.90	0.88	0.78	1.05	0.80	1.35	0.94	0.78	1.27	0.57	1.40	1.27
PC 34:1; [M+H]+; GPCho(12:0/22:1(13Z))	ME479577	1.01	0.69	0.97	1.18	0.91	0.88	0.51	0.67	1.52	0.96	1.36	1.35
PE 38:8; [M+H]+; GPEtn(18:4(6Z,9Z,12Z,15Z)/20:4(5E,8E,11E,14E))	ME480129	0.91	0.80	0.78	1.24	0.95	0.87	0.49	0.64	1.49	1.26	1.29	1.29
PE 36:6; [M+H]+; GPEtn(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480091	0.89	0.81	0.96	1.20	1.02	0.84	0.64	0.75	1.29	1.20	1.21	1.21
PE 36:6; [M+H]+; GPEtn(16:1(7Z)/20:5(5Z,8Z,11Z,14Z,17Z))	ME480093	0.90	0.73	0.96	1.21	1.02	0.84	0.64	0.76	1.30	1.21	1.21	1.21
PC 38:1; [M+Na]+; GPCho(16:1(7Z)/22:0)	ME479698	0.90	0.69	1.39	1.08	0.92	0.75	0.96	0.90	1.44	0.66	1.04	1.28
PC 38:1; [M+Na]+; GPCho(23:0/15:1(9Z))	ME479700	1.06	0.85	1.15	0.99	1.01	0.96	0.57	0.77	1.53	0.78	1.06	1.27
PC 39:1; [M+Na]+; GPCho(15:0/24:1(15Z))	ME479734	1.25	0.59	1.04	1.18	0.85	1.11	0.57	1.14	1.37	0.51	1.56	0.83
PC 41:2; [M+H]+; GPCho(15:0/26:2(5E,9Z))	ME479841	1.30	0.98	0.91	1.17	0.74	0.80	0.50	0.99	1.37	0.66	1.39	1.18
PC 38:3; [M+Na]+; GPCho(18:0/20:3(5Z,8Z,11Z))	ME479710	1.46	0.63	1.18	1.54	0.98	0.82	0.77	0.93	1.00	0.72	1.12	0.86
SM 43:2; [M]+; SM(d17:1(4E)/26:1(17Z))	ME480254	1.28	0.52	0.98	1.24	1.12	0.84	0.84	1.10	1.24	0.67	1.13	1.02
PC 41:3; [M+H]+; GPCho(17:2(9Z,12Z)/24:1(15Z))	ME479849	1.65	0.34	0.68	0.98	1.12	0.90	0.68	0.79	1.22	0.66	1.51	1.47
PC 41:3; [M+H]+; GPCho(23:0/18:3(6Z,9Z,12Z))	ME479850	1.45	0.35	0.85	1.09	1.25	0.82	0.96	0.84	1.15	0.49	1.46	1.28
PC 39:2; [M+H]+; GPCho(24:1(15Z)/15:1(9Z))	ME479742	1.14	0.33	1.01	1.04	1.22	0.85	0.75	1.04	1.27	0.52	1.49	1.33
PC 40:0; [M+H]+; GPCho(18:0/22:0)	ME479769	1.24	0.34	1.20	0.96	1.23	0.93	0.85	1.19	1.16	0.46	1.34	1.09
PC 43:5; [M+H]+; GPCho(21:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME479930	1.43	0.63	0.83	1.13	1.11	0.79	0.67	0.86	1.25	0.69	1.45	1.16
PE 40:9; [M+H]+; GPEtn(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME480156	1.31	0.55	1.06	0.97	1.00	0.82	0.77	0.78	1.40	0.71	1.60	1.03
PE 42:2; [M+H]+; GPEtn(18:1(11E)/24:1(15Z))	ME480161	1.05	0.54	1.05	1.14	1.05	0.98	0.72	0.93	1.47	0.59	1.30	1.18
PE 42:2; [M+H]+; GPEtn(18:2(2E,4E)/24:0)	ME480162	1.06	0.54	1.05	1.17	1.06	0.98	0.71	0.86	1.47	0.66	1.26	1.18
PE 36:6; [M+H]+; GPEtn(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME480092	0.96	0.55	1.22	1.08	1.14	0.82	0.73	0.79	1.25	0.91	1.42	1.11
PE 37:1; [M+H]+; GPEtn(16:1(7Z)/21:0)	ME480100	1.16	0.51	1.10	1.16	1.09	0.84	0.66	0.65	1.41	0.84	1.45	1.13
PC 36:4; [M+H]+; GPCho(12:0/24:4(5Z,8Z,11Z,14Z))	ME479633	0.95	0.66	0.72	1.31	1.16	1.01	0.77	1.08	1.18	0.76	1.07	1.32
PE 31:0; [M+H]+; GPEtn(6:0/25:0)	ME480025	0.77	0.66	0.94	1.45	1.08	1.01	0.70	1.05	1.15	0.67	1.14	1.39
PC 39:1; [M+Na]+; GPCho(19:0/20:1(11Z))	ME479739	1.06	0.54	0.62	1.17	1.15	0.94	0.74	0.92	1.41	0.79	1.39	1.28
PC 39:1; [M+Na]+; GPCho(15:1(9Z)/24:0)	ME479735	1.10	0.48	0.74	1.04	1.24	0.89	0.93	0.74	1.28	0.78	1.38	1.41
PC 41:4; [M+H]+; GPCho(18:4(6Z,9Z,12Z,15Z)/23:0)	ME479856	1.04	0.58	0.69	1.12	1.20	0.87	0.84	0.68	1.31	0.85	1.24	1.58
PC 26:0; [M+Na]+; GPCho(3:0/23:0)	ME479460	1.30	0.74	1.41	1.14	1.13	1.01	1.30	0.87	1.40	0.38	0.97	0.35
DG 35:1; [M+NH4]+; DG(17:0/18:1/0:0)	ME479261	1.14	1.14	1.60	1.13	0.75	1.09	0.75	0.77	1.15	0.85	0.80	0.83
PC 27:1; [M+H]+; GPCho(12:0/15:1(9Z))	ME479477	1.21	0.99	1.84	1.02	1.00	0.96	0.93	0.69	1.39	0.52	0.76	0.70
PC 34:0; [M+H]+; GPCho(16:0/18:0)	ME479576	1.05	0.95	1.60	1.10	0.48	1.68	0.66	1.13	0.88	0.65	1.10	0.71
PC 42:5; [M+H]+; GPCho(20:1(11E)/22:4(7Z,10Z,13Z,16Z))	ME479886	1.43	0.65	1.31	0.88	0.99	1.51	0.74	0.74	1.17	0.52	1.24	0.81
PA 23:0; [M+Na2-H]+; GPA(7:0/16:0)	ME479412	1.04	0.20	1.54	0.94	1.41	0.91	1.18	1.18	1.20	0.32	1.20	0.87
PC 40:0; [M+H]+; GPCho(22:0/18:0)	ME479771	1.07	0.28	1.35	1.04	1.40	0.91	1.12	1.14	1.12	0.33	1.23	1.01
PC 26:2; [M+H]+; GPCho(6:0/20:2(11Z,14Z))	ME479470	0.87	0.37	1.49	0.96	1.39	0.95	1.28	1.10	1.14	0.43	1.32	0.71
PC 28:3; [M+H]+; GPCho(8:0/20:3(5Z,8Z,11Z))	ME479502	0.90	0.40	1.44	1.05	1.33	1.05	1.06	1.16	0.88	0.54	1.37	0.80
PC 42:8; [M+H]+; GPCho(18:4(6Z,9Z,12Z,15Z)/24:4(5Z,8Z,11Z,14Z))	ME479907	0.95	0.37	1.30	1.10	1.50	0.89	1.04	1.30	1.26	0.55	1.08	0.65
PE 44:1; [M+H]+; GPEtn(22:0/22:1(13Z))	ME480171	1.02	0.39	1.41	1.13	1.44	0.93	1.06	1.19	1.27	0.54	1.07	0.55
PE 36:0; [M+H]+; GPEtn(18:0/18:0)	ME480076	0.86	0.35	1.53	1.15	1.23	0.98	1.14	1.12	1.14	0.70	1.18	0.61
plasmenyl-PE 38:6; [M+H]+; PE(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480207	0.80	0.28	1.70	1.10	1.22	0.99	1.19	1.18	1.11	0.64	1.23	0.56
PC 38:9; [M+Na]+; GPCho(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))	ME479723	0.92	0.58	1.57	1.17	1.33	0.96	1.10	1.14	0.90	0.59	1.01	0.71
SM 34:2; [M+Na]+; SM(d16:1(4E)/18:1(9Z))	ME480228	0.91	0.48	1.57	1.11	1.14	1.09	1.02	1.16	1.08	0.70	0.96	0.76
lysoPC 25:0; [M+H]+; PC(25:0/0:0)	ME479371	0.71	0.34	1.62	1.23	1.51	1.33	0.84	1.18	1.01	0.32	1.19	0.72
PC 29:2; [M+Na]+; GPCho(11:0/18:2(2E,4E))	ME479510	0.60	0.61	1.72	0.80	1.51	1.09	1.13	1.23	0.92	0.43	1.42	0.54
PC 42:4; [M+H]+; GPCho(20:4(5Z,8Z,11Z,14Z)/22:0)	ME479878	0.94	0.62	1.82	0.91	1.40	1.05	0.93	1.19	1.01	0.52	1.03	0.59
PC 26:1; [M+Na]+; GPCho(6:0/20:1(11E))	ME479467	1.03	0.48	1.51	0.74	1.07	0.95	1.01	1.65	1.16	0.57	1.28	0.55
TG 52:4; [M+NH4]+; TG(16:0/18:2/18:2)	ME480387	0.90	0.42	1.43	0.88	1.16	0.86	1.29	1.54	0.74	0.69	1.24	0.85
TG 54:3; [M+NH4]+; TG(16:0/18:1/20:2)	ME480467	0.94	0.57	1.10	1.08	1.11	0.97	1.15	1.78	0.88	0.49	1.31	0.61
TG 54:3; [M+NH4]+; TG(18:0/18:1/18:2)	ME480472	0.96	0.40	1.27	1.09	1.15	0.85	1.14	1.64	0.93	0.58	1.37	0.63
PC 39:6; [M+H]+; GPCho(17:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME479764	1.11	0.36	1.54	0.92	1.35	1.07	0.71	1.32	0.90	0.51	1.20	1.00
DG 38:3; [M+NH4]+; DG(18:1/20:2/0:0)	ME479297	1.06	0.46	1.49	0.63	1.39	0.81	0.84	1.43	1.21	0.62	1.06	1.01
PC 39:1; [M+H]+; GPCho(17:0/22:1(13Z))	ME479731	1.05	0.30	1.45	0.79	1.29	0.72	0.91	1.35	1.11	0.49	1.46	1.08
N-(eicosanoyl)-sphing-4-enine; [M+H]+; Cer(d18:1(4E)/20:0)	ME479407	1.11	0.44	1.39	0.88	1.47	0.86	1.09	1.35	0.97	0.70	1.04	0.69
TG 56:6; [M+Li]+; TG(18:0/18:3/20:3)	ME480633	0.98	0.40	1.46	0.93	1.41	0.91	0.94	1.55	0.88	0.65	1.00	0.87
TG 56:2; [M+NH4]+; TG(16:0/20:1/20:1)	ME480589	1.05	0.34	1.64	0.68	1.41	0.98	0.93	1.66	0.93	0.68	1.00	0.70
TG 56:2; [M+NH4]+; TG(18:0/18:2/20:0)	ME480591	0.91	0.59	1.61	0.66	1.33	0.89	0.93	1.65	0.99	0.74	0.94	0.75
TG 56:5; [M+Na]+; TG(18:0/18:2/20:3)	ME480622	0.77	0.59	1.59	0.73	1.30	0.93	0.75	1.74	0.99	0.84	0.97	0.80
TG 56:5; [M+Na]+; TG(18:1/18:1/20:3)	ME480623	0.72	0.42	1.43	0.73	1.25	1.03	1.00	1.89	0.96	0.68	1.04	0.85
TG 56:2; [M+NH4]+; TG(17:0/18:2/21:0)	ME480590	0.93	0.61	1.32	0.69	1.49	0.89	0.99	1.77	0.90	0.69	0.97	0.73
TG 56:2; [M+NH4]+; TG(18:2/19:0/19:0)	ME480592	0.93	0.61	1.32	0.69	1.42	0.90	1.00	1.78	0.91	0.69	0.98	0.76
TG 54:5; [M+NH4]+; TG(18:1/18:2/18:2)	ME480485	0.89	0.29	1.81	0.93	1.37	0.87	0.86	1.48	1.00	0.52	1.10	0.89
TG 57:0; [M+Li]+; TG(16:0/19:0/22:0)	ME480676	0.84	0.38	1.74	1.05	1.24	0.67	0.95	1.81	0.97	0.49	1.14	0.72
TG 53:1; [M+Na]+; TG(16:0/18:1/19:0)	ME480408	0.60	0.37	1.87	1.01	1.23	0.85	0.96	1.63	0.99	0.47	1.22	0.81
TG 56:1; [M+Na]+; TG(16:0/18:0/22:1)	ME480575	0.74	0.41	1.82	0.84	1.23	0.77	0.83	1.74	0.97	0.61	1.23	0.81
PC 39:0; [M+H]+; GPCho(23:0/16:0)	ME479726	0.88	0.31	1.68	0.93	1.32	0.90	1.14	1.41	0.89	0.37	1.27	0.87
PC 39:0; [M+H]+; GPCho(14:0/25:0)	ME479724	0.88	0.39	1.68	0.85	1.28	0.88	1.16	1.49	0.91	0.35	1.14	1.00
PC 40:7; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))	ME479826	1.01	0.38	1.68	0.86	1.27	0.85	1.27	1.48	0.90	0.36	1.10	0.85
PC 39:0; [M+H]+; GPCho(24:0/15:0)	ME479727	1.16	0.47	1.72	1.04	1.34	0.69	1.23	1.42	0.85	0.40	0.99	0.69
PC 40:1; [M+H]+; GPCho(18:1(11E)/22:0)	ME479783	1.12	0.37	1.65	1.11	1.23	0.90	1.05	1.50	0.70	0.55	1.02	0.80
PE 35:2; [M+H]+; GPEtn(17:1(9Z)/18:1(11E))	ME480070	1.09	0.52	1.62	1.02	1.10	0.99	1.06	1.28	0.89	0.49	1.14	0.81
PC 30:0; [M+Na]+; GPCho(6:0/24:0)	ME479521	0.88	0.58	0.99	1.02	0.87	1.38	0.86	1.45	1.02	0.57	1.34	1.03
PC 40:3; [M+H]+; GPCho(20:0/20:3(5Z,8Z,11Z))	ME479799	1.07	0.66	1.26	0.91	0.68	1.02	0.89	1.43	1.02	0.71	1.34	1.00
PC 29:3; [M+H]+; GPCho(11:0/18:3(6Z,9Z,12Z))	ME479513	1.10	1.00	1.29	0.82	1.06	1.00	0.47	1.59	0.83	0.85	1.27	0.73
MGDG 46:6; [M+Na]+; MGDG(22:2(13Z,16Z)/24:4(5Z,8Z,11Z,14Z))	ME479399	0.70	0.55	1.66	1.03	1.27	0.81	0.71	1.41	1.02	0.70	1.40	0.75
DG 36:4; [M+NH4]+; DG(18:2/18:2/0:0)	ME479279	0.86	0.37	1.52	1.17	1.14	1.06	0.35	1.50	0.95	0.88	1.29	0.91
TG 55:6; [M+Li]+; TG(16:1/19:0/20:5)	ME480557	0.75	0.50	1.43	1.00	1.14	1.11	0.60	1.50	0.99	0.79	1.26	0.93
TG 54:4; [M+NH4]+; TG(16:0/18:1/20:3)	ME480474	0.79	0.55	1.61	0.92	1.07	1.06	0.62	1.62	0.94	0.67	1.32	0.84
TG 54:4; [M+NH4]+; TG(18:0/18:1/18:3)	ME480479	0.76	0.50	1.62	0.94	1.06	1.04	0.59	1.54	0.98	0.79	1.32	0.85
PC 28:2; [M+H]+; GPCho(2:0/26:2(5E,9Z))	ME479498	0.90	0.95	2.01	0.82	0.86	0.84	0.83	0.96	1.13	0.78	1.36	0.56
plasmenyl-PE 36:5; [M+H]+; PE(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME480201	0.73	0.96	1.93	0.71	1.09	1.05	0.53	0.96	1.08	0.54	1.65	0.77
PC 26:1; [M+Na]+; GPCho(8:0/18:1(11E))	ME479468	0.74	0.49	1.99	1.06	1.25	0.99	0.75	1.02	1.01	0.56	1.25	0.89
PC 40:5; [M+H]+; GPCho(18:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME479816	0.88	0.44	1.97	1.04	1.02	0.76	0.64	1.13	1.18	0.67	1.31	0.96
PC 40:5; [M+H]+; GPCho(20:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME479820	0.94	0.41	1.89	1.05	1.01	0.93	0.58	1.16	1.19	0.61	1.27	0.95
PC 40:5; [M+H]+; GPCho(20:1(11E)/20:4(5E,8E,11E,14E))	ME479821	0.97	0.40	2.00	1.04	1.05	0.85	0.60	1.13	1.18	0.59	1.24	0.95
PA 16:0; [M+Na2-H]+; GPA(6:0/10:0)	ME479411	0.94	0.51	1.62	0.79	1.30	1.03	0.63	0.77	1.26	0.82	1.29	1.04
PC 28:2; [M+H]+; GPCho(14:1(9Z)/14:1(9Z))	ME479497	0.89	0.43	1.54	0.96	1.23	0.88	0.90	0.95	1.28	0.44	1.53	0.97
PE 37:0; [M+H]+; GPEtn(12:0/25:0)	ME480095	1.04	0.39	1.54	0.99	1.14	0.78	0.71	1.02	1.26	0.75	1.30	1.08
PE 37:0; [M+H]+; GPEtn(16:0/21:0)	ME480097	1.04	0.42	1.45	1.00	1.18	0.79	0.71	1.04	1.26	0.74	1.29	1.07
PE 37:0; [M+H]+; GPEtn(18:0/19:0)	ME480098	1.04	0.42	1.45	1.00	1.18	0.79	0.71	1.03	1.26	0.74	1.30	1.07
PE 37:0; [M+H]+; GPEtn(15:0/22:0)	ME480096	0.75	0.37	1.55	0.89	1.27	0.80	0.80	1.21	1.29	0.64	1.40	1.02
PE 37:0; [M+H]+; GPEtn(19:0/18:0)	ME480099	0.86	0.37	1.45	0.81	1.33	0.85	0.85	1.15	1.26	0.66	1.35	1.06
PC 32:2; [M+Na]+; GPCho(15:1(9Z)/17:1(9Z))	ME479562	0.82	0.44	1.78	0.76	1.25	0.68	0.72	1.16	1.50	0.54	1.54	0.82
PC 34:6; [M+Na]+; GPCho(12:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479600	0.80	0.61	1.54	0.86	1.45	0.65	0.61	1.14	1.45	0.77	1.21	0.92
DG 42:5; [M+NH4]+; DG(20:0/22:5/0:0)	ME479336	0.87	0.77	1.77	0.93	1.14	0.73	1.31	0.83	1.22	0.75	1.28	0.41
PC 31:2; [M+H]+; GPCho(14:1(9Z)/17:1(9Z))	ME479545	0.81	0.51	1.80	0.94	1.14	0.68	1.25	1.02	1.28	0.65	1.40	0.50
PC 40:7; [M+H]+; GPCho(18:2(2E,4E)/22:5(7Z,10Z,13Z,16Z,19Z))	ME479825	0.87	0.69	1.77	0.69	1.07	0.98	1.13	0.93	1.23	0.80	1.42	0.43
PE 33:1; [M+H]+; GPEtn(16:0/17:1(9Z))	ME480042	0.78	0.75	1.82	0.71	1.24	0.90	1.09	1.18	1.17	0.57	1.24	0.54
PC 41:5; [M+H]+; GPCho(17:1(9Z)/24:4(5Z,8Z,11Z,14Z))	ME479858	0.97	0.78	1.98	0.78	1.30	0.80	1.09	0.66	1.20	0.55	1.23	0.65
DG 41:5; [M+Li]+; DG(19:0/22:5/0:0)	ME479328	0.84	0.70	1.94	1.04	1.17	0.88	1.12	0.80	1.02	0.64	1.09	0.76
PE 24:0; [M+H]+; GPEtn(8:0/16:0)	ME479997	0.82	0.62	1.80	1.06	1.27	1.04	0.86	0.77	1.20	0.62	1.23	0.69
DG 37:3; [M+NH4]+; DG(17:0/20:3/0:0)	ME479284	1.01	0.76	1.76	1.03	1.17	0.91	0.99	0.83	1.25	0.37	1.43	0.47
PC 26:5; [M+Na]+; GPCho(4:0/22:5(7Z,10Z,13Z,16Z,19Z))	ME479472	0.90	0.68	1.61	1.12	1.31	1.04	0.88	0.90	0.96	0.57	1.39	0.62
PE 27:1; [M+H]+; GPEtn(7:0/20:1(11E))	ME480010	1.15	0.82	1.56	1.08	1.12	0.97	0.91	0.81	0.93	0.54	1.37	0.74
PC 34:2; [M+H]+; GPCho(16:0/18:2(9E,10E))	ME479581	0.71	0.70	1.65	1.14	0.88	0.79	0.74	1.36	0.93	0.89	1.17	1.03
PE 37:2; [M+H]+; GPEtn(17:2(9Z,12Z)/20:0)	ME480102	0.71	0.70	1.65	1.14	0.88	0.79	0.74	1.36	0.93	0.89	1.17	1.03
PC 36:6; [M+Na]+; GPCho(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))	ME479647	0.87	0.72	1.71	0.98	1.00	0.79	1.03	1.03	0.94	0.96	1.09	0.88
SM 41:1; [M]+; SM(d15:0/26:1(17Z))	ME480240	0.87	0.69	1.74	0.97	1.01	0.79	1.04	1.03	0.94	0.93	1.10	0.88
PC 38:1; [M+Na]+; GPCho(24:1(15Z)/14:0)	ME479701	0.91	0.55	1.81	1.28	1.04	0.92	0.85	1.00	0.90	0.84	1.00	0.89
PC 40:4; [M+H]+; GPCho(20:0/20:4(5E,8E,11E,14E))	ME479807	1.01	0.66	1.51	1.21	1.02	0.92	0.88	0.99	0.99	0.97	0.99	0.85
PE 34:2; [M+H]+; GPEtn(16:0/18:2(2E,4E))	ME480053	0.97	0.79	1.37	0.94	1.06	0.78	1.05	0.89	1.27	0.89	1.42	0.58
SM 34:0; [M]+; SM(d14:0/20:0)	ME480226	0.75	0.83	1.48	0.83	1.00	0.88	1.10	0.83	1.46	0.68	1.34	0.83
PC 17:0; [M+H]+; GPCho(2:0/15:0)	ME479427	0.89	0.71	1.48	1.03	1.14	0.80	1.09	0.77	0.95	0.71	1.34	1.09
SM 39:1; [M+Na]+; SM(d15:0/24:1(15Z))	ME480234	0.93	0.73	1.28	0.86	1.05	0.94	1.21	0.86	1.06	0.83	1.25	0.99
plasmenyl-PC 36:1; [M+Na]+; PC(P-16:0/20:1(11E))	ME480179	0.87	0.77	1.36	1.04	1.01	0.81	1.14	0.92	1.06	0.81	1.29	0.94
plasmenyl-PC 36:1; [M+Na]+; PC(P-18:0/18:1(11E))	ME480180	0.85	0.71	1.38	1.02	0.99	0.94	1.14	0.92	1.09	0.78	1.27	0.91
PE 40:2; [M+H]+; GPEtn(18:1(11E)/22:1(13Z))	ME480144	0.97	0.85	1.39	0.79	0.95	1.09	0.78	1.03	1.20	0.73	1.30	0.92
TG 55:4; [M+Li]+; TG(16:0/19:0/20:4)	ME480543	0.98	0.85	1.23	0.75	1.14	0.97	0.96	0.91	1.09	0.81	1.29	1.03
PA 13:0; [M+Na2-H]+; GPA(5:0/8:0)	ME479410	0.83	0.32	1.66	0.76	1.28	0.93	1.04	1.07	1.19	0.66	1.51	0.74
PE 40:6; [M+H]+; GPEtn(20:2(11Z,14Z)/20:4(5E,8E,11E,14E))	ME480153	0.66	0.47	1.72	1.09	1.09	1.01	1.02	1.08	1.03	0.68	1.43	0.72
TG 56:2; [M+Na]+; TG(18:0/18:1/20:1)	ME480587	0.66	0.59	1.51	1.05	1.03	0.78	1.06	1.33	1.07	0.71	1.37	0.85
DG 36:5; [M+NH4]+; DG(18:2/18:3/0:0)	ME479280	0.90	0.81	1.60	0.82	1.28	0.69	0.91	1.01	1.04	0.54	1.52	0.88
PC 31:0; [M+H]+; GPCho(6:0/25:0)	ME479539	0.77	0.90	1.70	1.03	0.98	0.73	0.95	1.03	0.92	0.75	1.42	0.81
TG 55:5; [M+Li]+; TG(16:0/19:0/20:5)	ME480551	0.94	0.59	1.40	0.68	1.02	0.94	1.31	1.21	0.93	0.61	1.56	0.83
PE 39:1; [M+H]+; GPEtn(18:1(11E)/21:0)	ME480133	0.91	0.63	1.48	0.81	0.98	0.79	0.84	1.38	1.30	0.73	1.35	0.80
TG 54:2; [M+NH4]+; TG(16:0/18:2/20:0)	ME480458	1.05	0.82	1.44	0.87	0.87	0.68	1.03	1.22	1.11	0.68	1.45	0.79
TG 54:2; [M+NH4]+; TG(16:1/18:0/20:1)	ME480459	1.03	0.80	1.58	0.73	1.01	0.75	1.15	1.18	1.07	0.52	1.40	0.78
PC 42:5; [M+Na]+; GPCho(20:3(5Z,8Z,11Z)/22:2(13Z,16Z))	ME479894	1.03	0.27	1.82	1.21	1.17	0.91	1.01	0.65	0.99	0.67	0.90	1.39
PC 40:4; [M+Na]+; GPCho(20:2(11Z,14Z)/20:2(5Z,8Z))	ME479815	1.08	0.45	1.97	1.03	1.28	0.81	1.05	0.77	0.88	0.43	1.16	1.08
PC 41:0; [M+H]+; GPCho(18:0/23:0)	ME479833	1.05	0.40	1.76	1.14	1.30	0.87	0.97	0.85	0.92	0.45	1.14	1.14
PC 40:4; [M+Na]+; GPCho(18:0/22:4(7Z,10Z,13Z,16Z))	ME479810	1.07	0.58	1.62	0.91	1.39	1.14	0.99	0.83	0.83	0.54	1.06	1.05
PC 40:4; [M+Na]+; GPCho(18:2(2E,4E)/22:2(13Z,16Z))	ME479811	0.86	0.55	1.66	0.97	1.38	0.98	1.01	0.82	0.94	0.52	1.16	1.14
PC 40:4; [M+Na]+; GPCho(16:0/24:4(5Z,8Z,11Z,14Z))	ME479809	1.26	0.67	1.36	1.07	1.14	0.98	0.94	0.70	1.07	0.54	1.24	1.02
PC 41:0; [M+H]+; GPCho(16:0/25:0)	ME479831	1.24	0.65	1.33	1.06	1.04	0.96	0.92	0.68	1.05	0.69	1.21	1.16
PC 34:4; [M+H]+; GPCho(17:2(9Z,12Z)/17:2(9Z,12Z))	ME479594	1.00	0.49	1.33	1.13	1.20	0.89	0.95	0.95	1.08	0.69	1.10	1.20
PC 42:7; [M+H]+; GPCho(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))	ME479904	1.08	0.66	1.43	1.31	1.16	1.07	0.86	0.79	0.88	0.57	1.03	1.16
PC 40:4; [M+Na]+; GPCho(20:1(11E)/20:3(5Z,8Z,11Z))	ME479814	1.10	0.52	1.52	1.16	1.27	1.06	0.95	0.79	0.94	0.47	1.13	1.09
PC 42:7; [M+H]+; GPCho(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))	ME479903	1.09	0.56	1.45	1.22	1.21	1.05	0.90	0.78	0.96	0.52	1.11	1.14
PC 37:0; [M+Na]+; GPCho(15:0/22:0)	ME479656	1.15	0.50	1.53	1.29	1.11	1.08	1.08	0.53	0.79	0.57	1.11	1.26
PC 39:3; [M+H]+; GPCho(20:3(5Z,8Z,11Z)/19:0)	ME479751	1.25	0.60	1.29	1.36	1.33	0.90	1.07	0.69	0.71	0.56	0.94	1.30
TG 54:2; [M+NH4]+; TG(18:0/18:1/18:1)	ME480461	0.95	0.79	1.45	1.52	0.81	0.84	0.95	1.11	1.03	0.55	1.29	0.69
PC 31:0; [M+H]+; GPCho(10:0/21:0)	ME479537	0.82	0.85	1.53	1.39	1.01	0.72	1.00	0.92	0.89	0.73	1.27	0.88
PE 34:4; [M+H]+; GPEtn(10:0/24:4(5Z,8Z,11Z,14Z))	ME480057	0.69	0.83	1.45	1.55	1.15	0.80	0.94	0.69	1.10	0.62	1.23	0.95
PC 30:0; [M+Na]+; GPCho(20:0/10:0)	ME479520	0.83	0.59	1.46	1.34	1.14	0.92	0.88	0.90	1.11	0.73	0.96	1.13
PC 32:3; [M+H]+; GPCho(12:0/20:3(5Z,8Z,11Z))	ME479563	0.84	0.73	1.29	1.46	1.12	0.94	0.76	0.88	1.09	0.88	0.87	1.14
lysoPC 18:0; [M+H]+; PC(18:0/0:0)	ME479355	0.95	0.43	1.24	1.50	1.05	1.10	1.02	1.00	0.94	0.57	1.03	1.17
PC 17:0; [M+H]+; GPCho(7:0/10:0)	ME479428	0.95	0.48	1.17	1.54	1.00	1.14	0.95	0.99	0.93	0.62	1.00	1.22
PE 18:0; [M+H]+; GPEtn(7:0/11:0)	ME479977	0.90	0.53	1.29	1.48	1.04	0.94	1.16	0.93	0.86	0.68	1.08	1.11
PE 18:0; [M+H]+; GPEtn(16:0/2:0)	ME479972	0.89	0.46	1.36	1.43	1.10	0.90	1.27	0.93	0.88	0.61	1.11	1.06
PE 18:0; [M+H]+; GPEtn(4:0/14:0)	ME479974	0.89	0.47	1.35	1.44	1.09	0.90	1.26	0.93	0.88	0.62	1.11	1.07
lysoPC 17:0; [M+H]+; PC(17:0/0:0)	ME479354	1.00	0.57	1.50	1.48	1.09	0.94	1.21	0.98	0.82	0.51	0.95	0.95
lysoPC 18:0; [M+H]+; PC(O-18:0/0:0)	ME479356	0.95	0.68	1.39	1.55	1.06	0.98	1.09	0.94	0.82	0.58	0.92	1.05
TG 55:0; [M+Na]+; TG(16:0/18:0/21:0)	ME480508	0.97	0.44	1.53	1.44	0.98	1.11	0.88	1.25	1.02	0.83	0.79	0.76
SM 43:2; [M+Na]+; SM(d17:1(4E)/26:1(17Z))	ME480255	1.18	0.53	1.51	1.20	1.11	0.86	1.07	0.96	1.18	0.60	0.99	0.81
PE 21:0; [M+H]+; GPEtn(10:0/11:0)	ME479987	1.20	0.76	1.54	1.33	0.92	0.76	1.08	0.95	0.93	0.75	0.82	0.96
DG 40:10; [M+NH4]+; DG(18:4/22:6/0:0)	ME479318	1.01	0.76	1.50	1.22	1.01	1.06	1.01	1.08	0.93	0.68	0.80	0.96
TG 56:4; [M+NH4]+; TG(18:1/18:2/20:1)	ME480618	1.19	0.72	1.51	1.19	0.89	1.17	1.16	1.13	0.88	0.60	0.73	0.84
DG 40:7; [M+NH4]+; DG(18:1/22:6/0:0)	ME479325	0.95	0.71	1.55	1.08	1.35	1.08	0.51	0.70	1.01	1.07	0.88	1.11
PC 34:2; [M+H]+; GPCho(17:1(9Z)/17:1(9Z))	ME479582	0.98	0.60	1.42	1.12	1.20	0.88	0.59	0.81	0.99	0.84	1.32	1.26
PE 40:5; [M+H]+; GPEtn(20:1(11E)/20:4(5E,8E,11E,14E))	ME480149	0.90	0.73	1.20	0.82	1.32	1.16	0.69	0.71	1.23	0.70	1.31	1.23
PE 34:2; [M+Na]+; GPEtn(17:1(9Z)/17:1(9Z))	ME480054	0.61	0.80	1.76	1.22	1.28	1.03	0.71	0.77	0.96	0.48	1.24	1.12
PC 31:1; [M+H]+; GPCho(5:0/26:1(5Z))	ME479541	0.76	0.85	1.57	1.01	1.17	0.94	0.71	1.14	1.12	0.63	0.98	1.13
TG 55:0; [M+Na]+; TG(16:0/19:0/20:0)	ME480509	0.84	0.93	1.44	0.82	1.25	1.19	0.92	1.11	1.24	0.51	0.72	1.03
PC 28:3; [M+H]+; GPCho(10:0/18:3(6Z,9Z,12Z))	ME479501	0.83	0.85	1.50	1.38	0.98	0.83	0.61	1.07	1.29	0.40	1.17	1.10
PC 37:2; [M+H]+; GPCho(15:0/22:2(13Z,16Z))	ME479671	0.84	0.76	1.38	1.07	1.17	1.26	0.57	1.08	1.26	0.71	1.03	0.86
PE 43:5; [M+H]+; GPEtn(21:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME480170	0.95	0.63	1.47	1.21	0.93	1.02	0.52	1.07	1.21	0.78	1.18	1.03
PC 43:6; [M+H]+; GPCho(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479931	1.26	0.58	1.33	1.20	0.96	0.73	0.98	0.55	1.23	0.57	1.47	1.14
PC 44:8; [M+H]+; GPCho(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))	ME479942	1.10	0.53	1.11	0.68	1.08	0.81	1.18	1.08	1.25	0.62	1.45	1.12
PC 37:0; [M+Na]+; GPCho(23:0/14:0)	ME479658	1.20	0.68	1.09	0.99	0.92	0.92	1.14	0.69	1.25	0.61	1.22	1.29
PC 41:3; [M+Na]+; GPCho(15:1(9Z)/26:2(5E,9Z))	ME479851	1.28	0.67	1.03	0.81	1.01	0.75	1.23	0.64	1.44	0.66	1.30	1.19
PC 41:3; [M+Na]+; GPCho(17:2(9Z,12Z)/24:1(15Z))	ME479852	1.03	0.63	1.02	0.89	1.12	0.86	1.13	0.65	1.47	0.69	1.24	1.28
PC 42:4; [M+H]+; GPCho(20:2(11Z,14Z)/22:2(13Z,16Z))	ME479877	1.05	0.52	1.21	0.83	0.91	0.66	1.14	1.00	1.42	0.92	1.37	0.98
PC 41:3; [M+Na]+; GPCho(20:3(8Z,11Z,14Z)/21:0)	ME479855	1.16	0.57	1.28	1.09	0.95	0.56	1.19	0.70	1.44	0.77	1.28	1.02
PC 42:4; [M+Na]+; GPCho(20:0/22:4(7Z,10Z,13Z,16Z))	ME479881	1.20	0.68	1.22	0.90	0.94	0.75	1.33	0.76	1.23	0.76	1.20	1.03
PC 41:5; [M+H]+; GPCho(19:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME479859	1.21	0.78	1.37	0.85	1.37	0.70	1.03	0.63	1.58	0.52	1.22	0.73
PE 38:5; [M+H]+; GPEtn(18:3(6Z,9Z,12Z)/20:2(11Z,14Z))	ME480124	1.02	0.46	1.49	1.04	1.22	0.92	1.12	0.54	1.21	0.73	1.23	1.02
PC 42:4; [M+Na]+; GPCho(18:3(6Z,9Z,12Z)/24:1(15Z))	ME479879	1.14	0.64	1.51	0.80	1.33	0.87	1.18	0.49	1.37	0.54	1.07	1.04
PC 42:4; [M+Na]+; GPCho(18:4(6Z,9Z,12Z,15Z)/24:0)	ME479880	1.29	0.59	1.33	0.99	1.23	0.89	1.11	0.54	1.35	0.66	1.02	1.00
PC 42:4; [M+Na]+; GPCho(20:2(11Z,14Z)/22:2(13Z,16Z))	ME479882	1.19	0.68	1.66	1.00	0.80	0.92	1.37	0.64	1.30	0.55	0.95	0.95
PC 42:4; [M+Na]+; GPCho(20:4(5E,8E,11E,14E)/22:0)	ME479883	1.23	0.68	1.40	1.00	0.88	0.97	1.04	0.70	1.35	0.68	1.12	0.95
plasmenyl-PC 42:5; [M+Na]+; PC(P-20:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME480188	1.28	0.17	0.98	1.36	1.50	0.94	0.98	1.02	1.26	0.43	1.22	0.89
PC 39:2; [M+Na]+; GPCho(17:2(9Z,12Z)/22:0)	ME479745	1.14	0.68	0.94	0.89	1.37	1.31	0.82	0.86	1.12	0.75	1.24	0.88
PC 43:2; [M+H]+; GPCho(18:2(2E,4E)/25:0)	ME479927	1.34	0.59	0.88	1.04	1.41	1.26	1.01	0.85	1.22	0.52	1.21	0.68
TG 55:1; [M+Na]+; TG(16:0/18:1/21:0)	ME480515	0.99	0.40	0.92	0.99	1.54	1.08	0.89	1.16	1.01	0.76	1.26	1.00
TG 56:8; [M+Na]+; TG(16:1/18:2/22:5)	ME480661	0.83	0.38	1.17	1.11	1.35	1.12	0.90	0.94	1.22	0.79	1.21	0.98
PC 44:5; [M+H]+; GPCho(20:1(11E)/24:4(5Z,8Z,11Z,14Z))	ME479938	0.87	0.51	1.14	0.92	1.81	0.69	1.33	0.86	1.50	0.48	1.13	0.75
PC 40:1; [M+H]+; GPCho(23:0/17:1(9Z))	ME479786	0.88	0.47	1.16	0.96	1.71	0.89	0.99	1.10	1.02	0.57	1.45	0.82
PE 40:1; [M+H]+; GPEtn(18:1(11E)/22:0)	ME480142	0.96	0.46	1.00	1.02	1.54	0.80	0.87	1.24	1.33	0.56	1.43	0.80
DG 40:3; [M+NH4]+; DG(18:2/22:1/0:0)	ME479319	0.80	0.43	1.21	0.79	1.81	0.78	1.10	1.18	1.28	0.67	1.24	0.70
PC 26:2; [M+H]+; GPCho(4:0/22:2(13Z,16Z))	ME479469	0.83	0.44	1.42	0.79	1.69	0.84	1.17	1.00	1.23	0.40	1.45	0.73
PC 42:3; [M+H]+; GPCho(18:2(2E,4E)/24:1(15Z))	ME479870	0.65	0.51	1.00	0.98	1.72	0.62	1.30	1.00	1.14	0.74	1.10	1.23
TG 51:4; [M+Na]+; TG(16:0/17:2/18:2)	ME480351	1.00	0.61	0.87	1.05	1.42	0.69	1.14	0.89	1.23	0.75	1.23	1.11
PC 42:3; [M+H]+; GPCho(22:1(13Z)/20:2(11Z,14Z))	ME479873	1.10	0.69	1.09	1.12	1.60	0.86	1.13	1.05	0.98	0.38	1.13	0.89
TG 48:3; [M+NH4]+; TG(14:1/16:1/18:1)	ME480289	1.03	0.61	0.97	0.94	1.59	0.97	1.37	1.21	0.85	0.57	0.78	1.11
PC 36:3; [M+H]+; GPCho(18:1(11E)/18:2(2E,4E))	ME479632	0.79	0.34	1.33	0.98	1.47	0.97	1.11	1.18	0.89	0.84	0.97	1.14
TG 56:1; [M+Na]+; TG(16:0/20:0/20:1)	ME480577	1.23	0.27	1.30	0.89	1.53	1.02	0.96	1.03	0.69	0.74	1.02	1.32
PC 42:5; [M+H]+; GPCho(24:1(15Z)/18:4(6Z,9Z,12Z,15Z))	ME479893	1.11	0.57	1.26	0.98	1.11	0.74	0.76	1.07	1.15	0.86	1.72	0.68
SM 44:1; [M]+; SM(d18:0/26:1(17Z))	ME480259	1.27	0.51	1.13	1.11	1.25	1.00	1.00	0.97	1.00	0.71	1.44	0.61
plasmenyl-PC 41:0; [M+Na]+; PC(P-16:0/25:0)	ME480187	0.93	0.43	1.19	1.13	1.15	0.80	0.95	1.12	1.35	0.43	1.80	0.73
DG 34:4; [M+NH4]+; DG(16:1/18:3/0:0)	ME479260	0.81	0.73	1.10	1.08	1.17	0.61	1.10	1.15	1.36	0.56	1.55	0.78
SM 38:1; [M+Na]+; SM(d14:0/24:1(15Z))	ME480231	0.84	0.48	1.11	1.05	1.26	0.85	0.97	1.24	1.14	0.75	1.48	0.83
TG 54:6; [M+Na]+; TG(16:0/18:2/20:4)	ME480488	0.86	0.55	1.21	1.00	1.09	0.85	1.08	1.29	1.18	0.47	1.46	0.97
PC 38:6; [M+Na]+; GPCho(18:2(2E,4E)/20:4(5E,8E,11E,14E))	ME479718	1.20	0.64	0.86	1.01	1.10	0.93	1.09	1.29	1.21	0.60	1.45	0.60
PC 43:1; [M+H]+; GPCho(21:0/22:1(13Z))	ME479924	1.15	0.54	1.03	1.02	1.22	0.73	1.47	1.17	1.11	0.50	1.26	0.82
SM 42:1; [M+Na]+; SM(d16:0/26:1(17Z))	ME480248	0.97	0.53	0.98	0.97	1.26	0.91	1.29	1.16	1.10	0.65	1.38	0.80
SM 26:1; [M]+; SM(d14:1(4E)/12:0)	ME480219	1.48	0.66	1.43	0.82	1.24	0.77	1.34	0.91	1.14	0.44	1.06	0.72
PC 40:2; [M+H]+; GPCho(17:2(9Z,12Z)/23:0)	ME479790	1.17	0.80	1.15	0.64	1.36	0.85	1.31	1.08	1.22	0.58	1.09	0.75
PC 25:6; [M+Na]+; GPCho(3:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479458	1.15	0.56	1.28	0.69	1.36	0.95	1.27	1.13	0.98	0.56	1.13	0.93
TG 54:0; [M+NH4]+; TG(16:0/18:0/20:0)	ME480448	1.15	0.56	1.26	0.80	1.30	0.94	1.24	0.96	1.16	0.73	1.02	0.86
PC 42:7; [M+H]+; GPCho(24:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))	ME479905	0.94	0.59	1.16	1.15	1.36	0.85	1.24	0.91	1.14	0.69	1.11	0.86
PC 38:1; [M+Na]+; GPCho(17:1(9Z)/21:0)	ME479699	0.96	0.59	1.20	1.05	1.32	0.78	1.16	0.99	1.15	0.57	1.29	0.93
PC 40:4; [M+H]+; GPCho(18:0/22:4(7Z,10Z,13Z,16Z))	ME479804	0.98	0.59	1.19	1.03	1.33	0.80	1.18	1.00	1.16	0.57	1.24	0.94
TG 46:3; [M+NH4]+; TG(14:1/16:1/16:1)	ME480276	0.97	0.53	1.34	0.94	1.17	0.75	1.16	1.16	1.09	0.79	1.05	1.07
SM 43:0; [M+Na]+; SM(d17:0/26:0)	ME480252	0.96	0.50	1.21	0.93	1.15	0.84	1.08	1.12	1.19	0.68	1.34	1.00
PE 37:2; [M+H]+; GPEtn(18:2(2E,4E)/19:0)	ME480103	1.08	0.51	1.21	0.99	1.14	0.84	1.19	1.08	1.18	0.74	1.13	0.92
plasmenyl-PE 36:1; [M+H]+; PE(P-16:0/20:1(11E))	ME480196	1.05	0.47	1.27	0.91	1.28	0.80	1.23	1.05	1.07	0.62	1.12	1.14
PC 38:1; [M+Na]+; GPCho(14:0/24:1(15Z))	ME479696	1.00	0.39	1.17	1.01	1.23	0.81	1.22	1.08	1.15	0.69	1.24	1.00
plasmenyl-PC 39:0; [M+Na]+; PC(P-18:0/21:0)	ME480184	1.13	0.40	1.20	0.97	1.24	0.83	1.18	1.09	1.05	0.60	1.26	1.05
TG 51:3; [M+Na]+; TG(16:1/17:0/18:2)	ME480341	1.07	0.56	1.23	0.95	1.25	0.96	1.01	1.12	1.22	0.63	1.15	0.86
TG 56:5; [M+NH4]+; TG(18:2/18:3/20:0)	ME480630	0.99	0.50	1.13	1.08	1.33	0.94	0.94	1.11	1.24	0.76	1.19	0.78
TG 56:5; [M+NH4]+; TG(18:0/18:1/20:4)	ME480627	0.90	0.54	1.27	0.89	1.24	0.93	0.99	1.43	1.10	0.67	1.15	0.88
TG 56:5; [M+NH4]+; TG(18:1/18:3/20:1)	ME480628	0.92	0.45	1.31	0.88	1.32	0.91	1.04	1.45	1.22	0.66	1.11	0.71
TG 53:1; [M+Li]+; TG(16:0/18:1/19:0)	ME480407	1.06	0.46	1.28	0.79	1.33	0.95	0.92	1.30	1.14	0.80	1.14	0.84
TG 56:5; [M+NH4]+; TG(16:0/18:1/22:4)	ME480624	0.99	0.43	1.23	0.84	1.38	0.90	1.03	1.11	1.12	0.76	1.30	0.92
TG 56:5; [M+NH4]+; TG(16:0/18:2/22:3)	ME480625	0.95	0.37	1.24	0.86	1.34	0.89	1.04	1.29	1.18	0.70	1.23	0.90
PC 34:1; [M+H]+; GPCho(16:1(7Z)/18:0)	ME479578	0.81	0.46	1.33	1.04	1.15	0.75	1.21	1.26	1.37	0.69	1.10	0.83
PE 36:2; [M+H]+; GPEtn(10:0/26:2(5E,9Z))	ME480080	0.89	0.67	1.36	0.87	1.04	0.83	1.16	1.17	1.19	0.81	1.30	0.72
TG 44:1; [M+Na]+; TG(12:0/16:1/16:0)	ME480266	0.93	0.59	1.28	0.98	1.07	0.71	1.18	1.21	1.24	0.75	1.21	0.83
plasmenyl-PC 36:1; [M+Na]+; PC(P-20:0/16:1(7Z))	ME480181	0.84	0.59	1.45	0.94	1.00	0.88	1.27	1.02	1.10	0.71	1.29	0.91
TG 52:0; [M+NH4]+; TG(16:0/17:0/19:0)	ME480364	0.97	0.56	1.38	0.84	1.02	0.76	1.37	1.10	1.17	0.75	1.26	0.81
PC 42:5; [M+H]+; GPCho(20:3(8Z,11Z,14Z)/22:2(13Z,16Z))	ME479888	0.97	0.65	1.53	0.76	1.11	1.12	1.00	1.08	1.22	0.62	1.20	0.74
plasmenyl-PE 40:4; [M+H]+; PE(P-20:0/20:4(5E,8E,11E,14E))	ME480209	0.96	0.56	1.39	0.89	1.33	0.85	1.11	1.20	1.15	0.56	1.33	0.67
TG 54:1; [M+NH4]+; TG(18:0/18:0/18:1)	ME480452	1.06	0.56	1.53	0.84	1.13	0.80	1.03	1.23	1.18	0.70	1.20	0.75
TG 50:3; [M+NH4]+; TG(16:1/16:1/18:1)	ME480317	0.88	0.96	1.04	1.03	1.30	1.12	1.07	0.97	0.88	0.80	0.90	1.05
PC 37:0; [M+Na]+; GPCho(13:0/24:0)	ME479654	0.98	0.84	1.12	1.09	1.22	0.98	0.89	0.98	0.91	0.91	1.08	0.99
PE 34:4; [M+H]+; GPEtn(16:1(7Z)/18:3(6Z,9Z,12Z))	ME480059	0.90	0.73	1.09	1.07	1.20	0.96	1.09	0.82	1.03	0.94	1.17	1.00
TG 46:2; [M+Na]+; TG(12:0/18:1/16:1)	ME480274	0.98	0.75	1.25	0.92	1.12	0.85	1.13	0.99	1.06	0.69	1.11	1.15
TG 49:4; [M+NH4]+; TG(16:1/16:1/17:2)	ME480298	1.08	0.75	1.11	0.91	1.03	1.01	1.04	1.14	1.00	0.72	1.10	1.10
plasmenyl-PE 38:4; [M+H]+; PE(P-18:0/20:4(5E,8E,11E,14E))	ME480205	1.01	0.87	1.17	0.92	1.01	1.06	1.10	0.94	0.99	0.89	1.04	0.99
plasmenyl-PE 40:5; [M+H]+; PE(P-18:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME480210	1.02	0.62	1.24	0.98	1.16	1.09	1.13	0.99	1.00	0.82	1.04	0.91
PC 20:0; [M+H]+; GPCho(2:0/18:0)	ME479434	1.14	0.43	1.18	1.11	1.07	0.93	1.27	1.12	1.18	0.51	1.10	0.95
TG 51:3; [M+Na]+; TG(16:0/17:1/18:2)	ME480339	1.08	0.51	1.06	0.94	1.14	1.11	1.32	1.05	1.13	0.70	1.06	0.90
TG 49:2; [M+Na]+; TG(16:0/16:1/17:1)	ME480294	1.21	0.45	1.03	1.15	1.15	1.10	1.08	0.94	1.08	0.62	1.13	1.07
PE 44:5; [M+H]+; GPEtn(20:4(5E,8E,11E,14E)/24:1(15Z))	ME480173	1.21	0.69	0.91	0.92	1.35	0.95	1.04	0.95	1.08	0.83	1.13	0.95
SM 44:1; [M+Na]+; SM(d18:0/26:1(17Z))	ME480260	1.17	0.75	0.97	1.01	1.11	1.04	1.09	0.95	1.08	0.80	1.03	1.00
TG 51:3; [M+Na]+; TG(17:0/17:1/17:2)	ME480343	1.05	0.58	1.03	1.01	1.31	0.92	1.12	1.02	1.17	0.70	1.11	0.96
TG 51:3; [M+Na]+; TG(16:1/17:1/18:1)	ME480342	1.18	0.65	1.00	0.98	1.16	0.96	1.12	0.96	1.21	0.72	1.07	0.99
TG 51:3; [M+Na]+; TG(16:0/17:0/18:3)	ME480338	1.17	0.63	0.97	0.98	1.24	0.94	1.12	0.96	1.21	0.72	1.07	0.98
TG 51:3; [M+Na]+; TG(16:0/17:2/18:1)	ME480340	1.20	0.62	0.93	1.02	1.24	0.92	1.12	0.95	1.21	0.73	1.07	0.99
PC 43:0; [M+H]+; GPCho(17:0/26:0)	ME479916	1.10	0.62	0.83	1.04	1.33	0.94	1.14	0.99	1.06	0.87	0.82	1.26
PC 43:0; [M+H]+; GPCho(19:0/24:0)	ME479918	1.03	0.61	0.99	1.07	1.19	0.93	1.25	0.97	1.06	0.88	0.81	1.20
PE 39:0; [M+H]+; GPEtn(15:0/24:0)	ME480131	1.17	0.55	1.04	0.94	1.15	0.76	1.10	1.12	1.03	0.91	1.04	1.18
SM 40:2; [M+Na]+; SM(d14:1(4E)/26:1(17Z))	ME480238	1.10	0.66	1.05	1.08	1.16	0.70	1.08	1.08	1.01	0.80	1.06	1.20
PC 36:2; [M+Na]+; GPCho(18:0/18:2(2E,4E))	ME479627	0.94	0.63	1.10	1.04	1.16	0.85	1.04	0.96	1.25	0.74	1.09	1.21
PC 38:5; [M+H]+; GPCho(22:4(7Z,10Z,13Z,16Z)/16:1(7Z))	ME479717	0.89	0.78	1.10	0.99	1.18	0.84	1.03	0.98	1.04	0.92	1.05	1.22
PE 40:4; [M+H]+; GPEtn(16:0/24:4(5Z,8Z,11Z,14Z))	ME480145	0.83	0.89	0.99	0.86	1.33	0.88	0.98	1.07	1.41	0.89	0.88	0.99
MGDG 25:4; [M+Na]+; MGDG(3:0/22:4(7Z,10Z,13Z,16Z))	ME479387	1.09	0.73	1.12	0.88	1.36	0.86	0.96	1.24	1.11	0.88	0.86	0.92
PC 37:4; [M+Na]+; GPCho(19:0/18:4(6Z,9Z,12Z,15Z))	ME479682	1.12	0.99	1.11	0.84	1.21	0.67	1.06	1.21	1.14	0.76	1.00	0.88
PE 42:7; [M+H]+; GPEtn(20:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480167	1.08	0.87	1.09	0.88	1.20	0.68	1.05	1.17	1.18	0.89	0.97	0.95
TG 49:0; [M+Na]+; TG(16:0/16:0/17:0)	ME480290	1.01	0.66	0.91	0.84	1.19	0.90	1.18	1.21	1.39	0.88	0.98	0.86
plasmenyl-PE 42:4; [M+H]+; PE(P-18:0/24:4(5Z,8Z,11Z,14Z))	ME480212	0.86	0.75	1.04	0.97	1.22	0.86	1.17	1.15	1.11	0.84	1.05	0.98
TG 56:6; [M+Li]+; TG(16:0/18:0/22:6)	ME480631	0.94	0.61	1.14	0.85	1.42	0.77	1.18	1.18	1.13	0.74	1.16	0.88
TG 54:0; [M+Na]+; TG(16:0/18:0/20:0)	ME480445	1.07	0.63	1.18	0.84	1.25	0.84	1.24	1.18	1.13	0.70	1.01	0.92
TG 54:8; [M+Li]+; TG(16:0/18:3/20:5)	ME480497	1.07	0.58	1.08	0.80	1.19	0.93	1.12	1.21	1.13	0.87	1.11	0.92
SM 44:0; [M]+; SM(d18:0/26:0)	ME480258	1.04	0.67	1.29	1.21	1.23	0.75	1.36	0.82	1.16	0.86	0.84	0.78
PE 42:6; [M+H]+; GPEtn(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME480166	0.90	0.57	1.50	1.21	1.20	0.98	1.50	1.00	0.83	0.60	1.07	0.63
lysoPC 15:1; [M+H]+; PC(15:1(9Z)/0:0)	ME479352	0.82	0.55	1.56	0.90	1.16	1.03	1.44	1.11	0.84	0.66	1.01	0.92
PC 34:6; [M+H]+; GPCho(12:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479597	0.88	0.68	1.41	0.96	1.11	0.92	1.39	0.95	0.94	0.88	1.03	0.85
TG 56:4; [M+NH4]+; TG(18:2/18:2/20:0)	ME480619	0.99	0.71	1.67	1.10	0.91	0.81	1.17	1.17	0.90	0.60	1.06	0.89
PC 37:1; [M+Na]+; GPCho(17:1(9Z)/20:0)	ME479667	0.96	0.64	1.64	0.89	1.04	0.82	1.30	1.24	1.06	0.69	1.07	0.64
PC 35:0; [M+H]+; GPCho(12:0/23:0)	ME479601	1.05	0.55	1.50	0.92	1.20	0.89	1.27	1.19	0.94	0.70	0.97	0.82
plasmenyl-PE 40:6; [M+H]+; PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480211	1.13	0.52	1.61	0.86	1.18	0.81	1.37	1.22	0.99	0.58	1.04	0.72
TG 48:1; [M+Na]+; TG(14:0/16:0/18:1)	ME480278	1.17	0.69	1.34	0.93	1.26	0.58	1.40	1.26	1.05	0.60	0.90	0.83
TG 50:4; [M+Na]+; TG(16:0/16:1/18:3)	ME480318	0.90	0.69	1.37	1.10	1.19	0.62	1.23	1.27	0.96	0.75	0.99	0.91
TG 51:3; [M+Li]+; TG(16:1/17:0/18:2)	ME480337	0.99	0.71	1.45	1.14	1.11	0.66	1.28	1.33	0.87	0.64	0.95	0.86
PC 39:4; [M+H]+; GPCho(15:0/24:4(5Z,8Z,11Z,14Z))	ME479753	1.13	0.70	1.41	1.08	1.11	0.60	1.17	1.15	0.99	0.76	1.06	0.85
TG 48:2; [M+Na]+; TG(16:0/16:1/16:1)	ME480285	1.04	0.55	1.48	1.11	1.17	0.74	1.20	1.18	0.98	0.69	1.09	0.77
PE 38:3; [M+H]+; GPEtn(18:3(6Z,9Z,12Z)/20:0)	ME480114	1.01	0.60	1.39	0.99	0.97	0.70	1.53	1.40	1.12	0.49	1.12	0.67
TG 52:1; [M+NH4]+; TG(16:0/18:0/18:1)	ME480369	1.32	0.54	1.19	0.93	1.13	0.73	1.28	1.10	1.20	0.66	1.22	0.71
plasmenyl-PE 42:6; [M+H]+; PE(P-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480214	1.29	0.49	1.47	0.95	0.99	0.71	1.39	1.21	1.11	0.57	1.02	0.81
MGDG 38:5; [M+Na]+; MGDG(18:1(11E)/20:4(5E,8E,11E,14E))	ME479391	1.36	0.69	1.25	0.88	0.83	0.64	1.37	1.27	1.14	0.63	1.08	0.87
PC 40:10; [M+H]+; GPCho(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))	ME479789	1.26	0.69	1.17	0.88	1.01	0.66	1.37	1.23	1.06	0.70	1.09	0.88
N-(tetracosanoyl)-sphing-4-enine; [M+H]+; Cer(d18:1(4E)/24:0)	ME479408	1.42	0.76	1.47	1.06	1.06	0.83	0.79	1.28	0.96	0.45	0.87	1.07
PC 43:0; [M+H]+; GPCho(18:0/25:0)	ME479917	1.35	0.75	1.32	1.01	0.90	0.68	1.07	1.28	0.98	0.63	0.87	1.16
DG 38:2; [M+NH4]+; DG(18:0/20:2/0:0)	ME479293	1.09	0.70	1.28	0.89	1.23	0.65	1.01	1.23	1.04	0.61	0.97	1.30
TG 40:0; [M+NH4]+; TG(12:0/12:0/16:0)	ME480264	1.03	0.80	1.32	0.96	1.49	0.88	0.91	1.12	0.96	0.63	0.74	1.15
DG 35:2; [M+NH4]+; DG(17:0/18:2/0:0)	ME479263	1.03	0.74	1.16	1.12	1.39	0.81	0.87	1.33	1.16	0.56	0.90	0.93
DG 35:2; [M+NH4]+; DG(17:1/18:1/0:0)	ME479264	0.94	0.74	1.11	1.29	1.24	0.84	0.88	1.19	1.15	0.61	1.01	0.99
PE 40:4; [M+H]+; GPEtn(18:0/22:4(7Z,10Z,13Z,16Z))	ME480146	0.98	0.39	1.48	1.12	1.19	0.71	1.02	1.43	1.16	0.64	0.96	0.90
PE 35:3; [M+H]+; GPEtn(17:2(9Z,12Z)/18:1(11E))	ME480073	0.94	0.41	1.29	1.21	1.30	0.74	0.97	1.42	1.07	0.46	1.22	0.96
plasmenyl-PE 36:2; [M+H]+; PE(P-18:0/18:2(2E,4E))	ME480199	0.98	0.47	1.16	1.28	1.30	0.72	1.05	1.34	1.07	0.52	1.17	0.93
DG 35:3; [M+NH4]+; DG(17:1/18:2/0:0)	ME479265	1.09	0.77	1.12	0.91	1.43	0.92	0.69	1.55	0.91	0.84	0.95	0.83
DG 34:2; [M+NH4]+; DG(16:0/18:2/0:0)	ME479256	0.81	0.51	1.44	0.97	1.36	0.85	0.71	1.53	0.99	0.83	0.93	1.07
TG 55:5; [M+NH4]+; TG(17:0/18:1/20:4)	ME480553	1.00	0.66	1.34	1.03	1.12	1.14	0.67	1.43	1.07	0.73	0.90	0.92
DG 42:6; [M+NH4]+; DG(18:2/24:4/0:0)	ME479337	0.97	0.89	1.09	1.22	0.93	1.02	0.92	1.25	1.06	0.81	0.79	1.08
TG 55:4; [M+NH4]+; TG(17:0/18:0/20:4)	ME480546	0.84	1.05	1.17	1.19	0.93	0.87	0.95	1.31	0.91	0.89	0.90	1.01
TG 50:0; [M+NH4]+; TG(16:0/16:0/18:0)	ME480300	1.09	0.79	1.09	1.09	1.12	0.99	1.03	1.41	1.05	0.88	0.81	0.65
PE 42:6; [M+H]+; GPEtn(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480165	0.84	0.78	1.29	1.17	1.17	0.85	1.13	1.31	0.98	0.84	0.88	0.76
TG 54:7; [M+Li]+; TG(16:0/18:3/20:4)	ME480492	0.90	0.72	1.31	0.96	1.19	1.04	1.03	1.24	1.00	0.80	0.92	0.88
DG 33:3; [M+NH4]+; DG(15:1/18:2/0:0)	ME479253	0.94	0.62	1.17	1.12	1.20	0.70	0.91	1.56	1.06	0.95	1.00	0.77
TG 56:7; [M+Li]+; TG(18:1/18:3/20:3)	ME480649	0.96	0.62	1.22	1.15	1.17	0.87	0.72	1.29	1.03	1.01	0.98	1.00
DG 42:6; [M+NH4]+; DG(20:0/22:6/0:0)	ME479338	0.77	0.65	1.47	0.65	1.42	0.71	1.06	1.20	1.18	0.86	1.15	0.88
PC 41:6; [M+H]+; GPCho(17:2(9Z,12Z)/24:4(5Z,8Z,11Z,14Z))	ME479861	0.81	0.89	1.31	0.96	1.41	0.66	1.08	1.34	0.94	0.50	1.12	0.99
PE 35:1; [M+H]+; GPEtn(17:1(9Z)/18:0)	ME480066	0.86	0.87	1.46	0.78	1.30	0.52	1.27	1.28	1.01	0.59	1.04	1.02
PC 25:2; [M+Na]+; GPCho(7:0/18:2(2E,4E))	ME479456	0.70	1.11	1.68	0.85	1.46	0.69	0.91	0.94	1.18	0.46	1.31	0.71
PE 38:2; [M+H]+; GPEtn(18:1(11E)/20:1(11E))	ME480111	0.68	0.92	1.44	0.78	1.28	0.81	1.10	1.38	1.24	0.44	1.27	0.65
PC 37:1; [M+Na]+; GPCho(15:0/22:1(13Z))	ME479663	1.07	1.21	1.70	0.85	1.02	0.61	1.07	1.04	1.29	0.77	0.84	0.53
PC 30:0; [M+H]+; GPCho(5:0/25:0)	ME479516	0.79	1.02	1.65	0.86	1.04	0.73	1.05	1.17	1.27	0.50	1.00	0.91
PE 44:10; [M+H]+; GPEtn(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480172	1.00	1.16	1.66	0.66	1.08	1.03	0.96	0.96	1.24	0.63	0.80	0.83
DG 41:6; [M+NH4]+; DG(19:0/22:6/0:0)	ME479329	1.05	0.95	1.70	0.61	1.05	0.70	1.56	1.09	1.11	0.75	0.87	0.54
plasmenyl-PE 34:2; [M+H]+; PE(P-16:0/18:2(2E,4E))	ME480194	0.93	1.19	1.66	0.61	1.17	0.52	1.45	1.10	1.16	0.73	0.85	0.65
PE 35:1; [M+H]+; GPEtn(17:0/18:1(11E))	ME480065	0.89	0.85	1.67	0.77	1.09	0.79	1.49	1.19	1.09	0.55	1.15	0.47
PC 37:1; [M+Na]+; GPCho(16:1(7Z)/21:0)	ME479665	1.03	0.72	1.64	0.82	1.27	0.84	1.34	0.95	0.99	0.73	1.06	0.61
PC 39:4; [M+H]+; GPCho(17:2(9Z,12Z)/22:2(13Z,16Z))	ME479754	1.09	0.81	1.50	0.72	1.21	0.80	1.38	1.08	1.08	0.78	1.09	0.46
SM 41:0; [M+Na]+; SM(d15:0/26:0)	ME480239	1.00	0.99	1.27	0.80	1.38	0.93	1.46	1.24	0.90	0.63	0.91	0.50
MGDG 36:3; [M+Na]+; MGDG(18:1(11E)/18:2(2E,4E))	ME479390	1.14	1.08	1.55	0.70	0.94	0.84	1.11	1.13	1.00	0.70	1.06	0.74
TG 48:1; [M+Na]+; TG(16:0/16:0/16:1)	ME480280	1.06	0.97	1.40	0.94	0.93	1.03	1.18	1.18	0.98	0.73	1.09	0.51
DG 44:2; [M+NH4]+; DG(18:1/26:1/0:0)	ME479345	1.02	1.18	1.51	0.85	0.96	1.08	1.30	1.02	0.86	0.70	0.88	0.64
PA 36:0; [M+Na2-H]+; GPA(17:0/19:0)	ME479417	1.05	1.13	1.50	0.82	1.06	0.92	1.31	1.11	0.89	0.67	0.93	0.62
TG 46:0; [M+Na]+; TG(14:0/16:0/16:0)	ME480271	0.97	1.09	1.32	0.68	1.05	0.69	1.27	1.31	1.18	0.70	1.07	0.66
PC 36:2; [M+Na]+; GPCho(18:1(11E)/18:1(11E))	ME479628	0.75	0.95	1.30	0.98	1.21	0.98	1.18	1.13	1.00	0.84	0.98	0.70
TG 56:3; [M+NH4]+; TG(18:0/18:1/20:2)	ME480603	1.01	0.91	1.22	0.91	1.08	0.88	1.24	1.16	1.13	0.67	1.03	0.76
TG 56:6; [M+Na]+; TG(18:1/18:1/20:4)	ME480635	0.89	1.03	1.36	0.73	1.12	0.95	1.20	1.16	1.13	0.76	0.97	0.70
PE 33:2; [M+H]+; GPEtn(15:1(9Z)/18:1(11E))	ME480045	0.91	0.97	2.08	0.85	1.04	0.74	1.18	0.92	0.75	0.77	0.84	0.94
PC 30:3; [M+Na]+; GPCho(12:0/18:3(6Z,9Z,12Z))	ME479530	0.67	0.74	1.62	1.21	1.14	0.92	1.33	1.01	0.69	0.43	0.99	1.26
PC 40:1; [M+H]+; GPCho(16:0/24:1(15Z))	ME479778	0.89	0.76	1.72	1.06	0.98	0.90	1.23	0.87	0.65	0.62	1.25	1.07
TG 48:2; [M+NH4]+; TG(14:0/16:1/18:1)	ME480286	0.54	1.11	1.36	0.99	1.14	0.74	1.39	0.98	0.84	1.04	1.28	0.59
PE 19:0; [M+H]+; GPEtn(7:0/12:0)	ME479985	0.75	1.30	1.63	1.05	0.98	0.72	1.33	0.93	0.77	0.80	0.97	0.78
PE 19:0; [M+H]+; GPEtn(9:0/10:0)	ME479986	0.72	1.28	1.55	0.99	0.94	0.69	1.28	0.89	0.76	0.81	0.92	1.19
PE 17:0; [M+H]+; GPEtn(4:0/13:0)	ME479966	0.67	1.13	1.56	1.08	0.87	0.86	1.25	0.76	0.95	0.62	1.45	0.81
TG 50:3; [M+Na]+; TG(16:1/16:1/18:1)	ME480314	0.56	1.22	1.54	0.84	1.21	0.81	1.20	0.99	1.03	0.68	1.08	0.83
PC 38:4; [M+H]+; GPCho(22:4(7Z,10Z,13Z,16Z)/16:0)	ME479713	0.76	0.98	1.62	1.15	1.14	0.84	1.04	0.99	0.77	0.72	1.11	0.87
DG 40:4; [M+NH4]+; DG(18:2/22:2/0:0)	ME479321	0.78	0.91	1.71	1.08	1.12	0.94	1.13	0.78	0.99	0.68	1.08	0.80
DG 40:4; [M+NH4]+; DG(20:0/20:4/0:0)	ME479322	0.79	1.07	1.55	1.14	1.08	0.96	1.08	0.77	0.94	0.76	1.04	0.82
DG 38:3; [M+NH4]+; DG(18:0/20:3/0:0)	ME479296	0.68	1.13	1.69	0.84	0.96	0.46	1.60	0.95	0.89	0.39	1.19	1.21
PE 39:6; [M+H]+; GPEtn(17:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))	ME480138	0.75	1.18	1.83	0.86	0.93	0.80	1.66	0.60	0.99	0.61	1.15	0.64
PE 26:2; [M+H]+; GPEtn(6:0/20:2(11Z,14Z))	ME480005	0.86	1.07	1.61	0.48	1.09	0.54	1.87	1.32	1.03	0.48	1.16	0.49
PC 39:2; [M+H]+; GPCho(17:1(9Z)/22:1(13Z))	ME479741	0.82	1.43	1.60	0.75	1.00	0.61	1.20	1.39	0.95	0.64	0.92	0.69
PE 29:2; [M+H]+; GPEtn(7:0/22:2(13Z,16Z))	ME480020	0.77	1.63	1.84	0.44	0.99	0.60	1.25	1.18	0.97	0.34	1.23	0.75
PC 42:3; [M+H]+; GPCho(16:1(7Z)/26:2(5E,9Z))	ME479869	0.74	0.22	1.11	1.20	1.31	0.81	1.58	1.16	1.24	0.66	1.32	0.65
PC 35:1; [M+H]+; GPCho(9:0/26:1(5Z))	ME479609	0.59	0.83	1.09	1.22	1.24	0.69	1.42	0.87	0.79	0.70	1.40	1.16
DG 36:7; [M+NH4]+; DG(14:1/22:6/0:0)	ME479282	0.74	0.58	1.17	1.01	0.83	0.77	1.70	0.95	1.29	0.54	1.42	1.00
DG 32:1; [M+NH4]+; DG(16:0/16:1/0:0)	ME479247	1.31	0.96	1.26	0.79	0.96	0.55	1.69	0.93	1.10	0.46	1.23	0.76
PC 39:5; [M+H]+; GPCho(15:1(9Z)/24:4(5Z,8Z,11Z,14Z))	ME479759	1.03	0.89	1.20	1.09	0.88	0.66	1.57	0.94	1.09	0.54	1.52	0.60
TG 46:1; [M+Na]+; TG(14:0/16:0/16:1)	ME480272	1.16	0.70	1.15	0.96	1.10	0.75	1.41	0.93	1.02	0.63	1.45	0.74
DG 38:5; [M+NH4]+; DG(18:2/20:3/0:0)	ME479305	0.80	0.63	1.75	0.73	1.72	0.59	1.44	1.46	0.77	0.40	0.98	0.72
PC 43:3; [M+H]+; GPCho(17:1(9Z)/26:2(5E,9Z))	ME479929	0.90	0.48	1.44	0.84	1.48	0.78	1.76	1.42	0.93	0.50	0.86	0.60
TG 44:2; [M+NH4]+; TG(12:0/16:1/16:1)	ME480270	0.98	0.42	1.44	0.92	1.51	0.92	1.59	1.21	0.88	0.48	0.98	0.67
DG 39:3; [M+NH4]+; DG(19:0/20:3/0:0)	ME479313	0.83	0.64	1.35	0.88	1.37	0.58	1.90	0.83	0.96	0.60	1.15	0.91
PC 29:1; [M+Na]+; GPCho(12:0/17:1(9Z))	ME479506	0.70	0.41	1.51	0.83	1.67	0.68	1.56	0.75	1.13	0.75	1.27	0.75
PE 40:6; [M+H]+; GPEtn(18:1(11E)/22:5(4Z,7Z,10Z,13Z,16Z))	ME480151	0.89	0.46	1.75	1.06	1.41	0.84	1.38	0.66	0.94	0.70	1.08	0.82
DG 44:6; [M+NH4]+; DG(22:1/22:5/0:0)	ME479350	1.01	0.37	1.84	0.74	1.40	0.82	1.32	0.53	1.18	0.74	1.38	0.66
PE 38:5; [M+H]+; GPEtn(16:1(7Z)/22:4(7Z,10Z,13Z,16Z))	ME480122	0.95	0.37	1.69	0.88	1.35	0.96	1.39	0.57	1.06	0.57	1.32	0.88
PE 38:5; [M+H]+; GPEtn(18:1(11E)/20:4(5E,8E,11E,14E))	ME480123	1.01	0.40	1.65	0.91	1.30	0.91	1.47	0.50	1.11	0.61	1.28	0.84
PC 25:3; [M+H]+; GPCho(7:0/18:3(6Z,9Z,12Z))	ME479457	1.09	0.66	1.51	1.03	1.46	0.99	1.46	0.64	0.84	0.33	1.10	0.88
PE 17:0; [M+H]+; GPEtn(5:0/12:0)	ME479967	1.14	0.49	1.96	1.06	1.25	0.88	1.41	0.69	0.95	0.31	1.16	0.70
lysoPC 18:2; [M+H]+; PC(18:2(2E,4E)/0:0)	ME479357	0.80	0.26	1.92	0.77	1.46	0.64	1.62	1.16	1.18	0.33	1.29	0.57
lysoPC 18:3; [M+H]+; PC(18:3(6Z,9Z,12Z)/0:0)	ME479358	0.91	0.50	2.01	1.00	1.19	0.50	1.76	0.93	1.07	0.29	1.39	0.45
PE 19:0; [M+H]+; GPEtn(3:0/16:0)	ME479981	0.94	0.32	1.96	1.25	1.22	0.76	1.48	1.03	0.82	0.29	1.10	0.82
DG 26:2; [M+NH4]+; DG(8:0/18:2/0:0)	ME479243	0.92	0.27	1.56	1.06	1.38	0.69	1.65	1.08	0.94	0.38	1.18	0.89
PC 15:0; [M+H]+; GPCho(6:0/9:0)	ME479425	0.88	0.27	1.69	1.13	1.34	0.68	1.66	0.98	0.90	0.41	1.19	0.88
PE 18:0; [M+H]+; GPEtn(3:0/15:0)	ME479973	0.89	0.26	1.72	1.10	1.38	0.64	1.71	0.96	0.92	0.38	1.19	0.85
PE 18:0; [M+H]+; GPEtn(13:0/5:0)	ME479971	0.89	0.26	1.71	1.09	1.39	0.63	1.72	0.97	0.93	0.38	1.19	0.84
PE 18:0; [M+H]+; GPEtn(6:0/12:0)	ME479976	0.89	0.26	1.71	1.09	1.39	0.63	1.72	0.97	0.93	0.38	1.19	0.84
lysoPE 20:0; [M+H]+; PE(O-20:0/0:0)	ME479376	0.90	0.25	1.75	1.06	1.41	0.61	1.74	0.97	0.95	0.37	1.18	0.80
PE 18:0; [M+H]+; GPEtn(5:0/13:0)	ME479975	0.94	0.24	1.76	1.01	1.43	0.59	1.73	0.97	0.97	0.37	1.20	0.79
PE 18:0; [M+H]+; GPEtn(12:0/6:0)	ME479970	0.93	0.23	1.75	0.96	1.42	0.55	1.80	1.00	1.01	0.37	1.18	0.80
PE 18:0; [M+H]+; GPEtn(9:0/9:0)	ME479979	0.94	0.23	1.75	0.95	1.48	0.55	1.77	1.01	1.00	0.36	1.20	0.76
lysoPC 20:4; [M+H]+; PC(20:4(5E,8E,11E,14E)/0:0)	ME479362	1.05	0.24	1.92	0.85	1.51	0.73	1.44	1.00	1.10	0.29	1.08	0.79
PE 24:6; [M+H]+; GPEtn(2:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480001	0.94	0.29	1.81	1.01	1.41	0.96	1.28	1.02	1.02	0.34	1.03	0.89
PC 36:6; [M+Na]+; GPCho(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479646	0.81	0.37	1.91	0.75	1.28	0.68	1.25	1.24	1.10	0.59	1.32	0.70
PC 38:1; [M+H]+; GPCho(18:1(11E)/20:0)	ME479694	0.99	0.24	1.75	0.86	1.29	0.73	1.42	1.13	0.98	0.48	1.37	0.76
PE 38:6; [M+H]+; GPEtn(18:1(11E)/20:5(5Z,8Z,11Z,14Z,17Z))	ME480127	0.84	0.31	1.90	1.00	1.33	0.79	1.26	1.11	0.97	0.48	1.31	0.70
DG 44:3; [M+NH4]+; DG(20:2/24:1/0:0)	ME479346	1.10	0.49	1.86	0.85	1.16	0.87	1.47	1.14	0.89	0.51	1.07	0.59
PC 37:2; [M+H]+; GPCho(18:2(2E,4E)/19:0)	ME479672	0.96	0.35	2.10	0.75	1.27	0.72	1.46	1.23	0.85	0.45	1.11	0.77
DG 38:5; [M+NH4]+; DG(18:1/20:4/0:0)	ME479304	0.92	0.33	1.74	0.86	1.62	0.67	1.18	1.46	0.99	0.52	1.07	0.64
PC 40:1; [M+H]+; GPCho(14:1(9Z)/26:0)	ME479777	1.08	0.27	1.40	0.80	1.68	0.66	1.40	1.24	1.21	0.43	1.12	0.72
plasmenyl-PC 37:0; [M+Na]+; PC(P-16:0/21:0)	ME480182	0.95	0.25	1.67	0.90	1.44	0.66	1.29	1.28	1.15	0.46	1.16	0.80
SM 42:5; [M]+; SM(d18:1(4E)/24:4(5Z,8Z,11Z,14Z))	ME480251	1.02	0.33	1.56	0.82	1.37	0.54	1.36	1.33	1.09	0.47	1.30	0.80
PC 42:3; [M+H]+; GPCho(20:2(11Z,14Z)/22:1(13Z))	ME479872	0.89	0.39	1.81	0.89	1.23	0.72	1.23	1.02	1.12	0.70	0.96	1.04
TG 54:0; [M+NH4]+; TG(16:0/16:0/22:0)	ME480447	0.91	0.48	1.66	0.70	1.20	0.80	1.46	0.98	1.13	0.70	1.09	0.90
DG 32:2; [M+NH4]+; DG(14:0/18:2/0:0)	ME479248	1.05	0.34	1.54	1.08	1.24	0.78	1.45	0.88	1.13	0.40	1.04	1.07
PC 17:0; [M+Na]+; GPCho(15:0/2:0)	ME479429	1.13	0.42	1.38	1.12	1.13	0.85	1.39	0.91	1.15	0.57	0.97	0.97
PC 42:7; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/24:4(5Z,8Z,11Z,14Z))	ME479900	1.06	0.44	1.34	1.11	1.31	0.78	1.36	0.91	1.06	0.62	0.99	1.02
PC 42:7; [M+H]+; GPCho(20:1(11E)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479901	1.16	0.42	1.60	1.12	1.43	0.77	1.42	0.94	0.80	0.53	0.99	0.81
PC 42:7; [M+H]+; GPCho(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME479902	1.16	0.42	1.60	1.12	1.43	0.76	1.42	0.94	0.81	0.52	1.00	0.81
PC 38:5; [M+H]+; GPCho(14:1(9Z)/24:4(5Z,8Z,11Z,14Z))	ME479714	1.00	0.34	1.46	0.85	1.51	0.85	1.52	1.04	0.81	0.46	1.17	0.98
PC 38:5; [M+H]+; GPCho(16:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME479715	1.03	0.32	1.47	0.85	1.44	0.84	1.50	1.06	1.00	0.45	1.17	0.86
lysoPC 20:3; [M+H]+; PC(20:3(5Z,8Z,11Z)/0:0)	ME479361	1.14	0.44	1.50	0.78	1.48	0.75	1.50	0.97	1.23	0.39	0.94	0.86
PC 38:5; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/20:2(11Z,14Z))	ME479716	1.21	0.29	1.45	0.91	1.43	0.76	1.57	0.96	1.07	0.47	1.10	0.78
DG 34:3; [M+NH4]+; DG(16:0/18:3/0:0)	ME479258	1.00	0.36	1.70	0.93	1.33	0.70	1.40	0.96	1.23	0.52	1.02	0.86
PC 40:4; [M+Na]+; GPCho(20:0/20:4(5E,8E,11E,14E))	ME479813	1.14	0.39	1.46	0.94	1.40	0.65	1.36	0.99	1.08	0.62	1.00	0.97
DG 42:7; [M+NH4]+; DG(20:1/22:6/0:0)	ME479340	0.93	0.75	2.10	0.87	1.07	0.85	1.62	0.83	0.82	0.60	0.96	0.61
PE 40:5; [M+H]+; GPEtn(20:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME480148	1.02	0.71	1.92	1.07	0.97	0.76	1.36	0.97	0.83	0.65	1.25	0.50
PC 31:4; [M+H]+; GPCho(13:0/18:4(6Z,9Z,12Z,15Z))	ME479548	1.12	0.71	1.83	0.99	1.17	0.86	1.30	0.96	0.75	0.55	1.00	0.76
PE 19:0; [M+H]+; GPEtn(6:0/13:0)	ME479984	0.83	0.82	1.87	1.11	1.21	0.79	1.45	0.99	0.77	0.39	1.01	0.75
SM 26:0; [M]+; SM(d14:0/12:0)	ME480218	0.92	0.71	1.84	0.84	0.97	0.57	1.65	1.04	0.82	0.48	1.37	0.79
DG 44:9; [M+NH4]+; DG(22:4/22:5/0:0)	ME479351	1.16	0.66	1.84	0.62	1.19	0.72	1.67	0.88	0.86	0.49	1.17	0.73
PA 41:0; [M+Na2-H]+; GPA(19:0/22:0)	ME479420	1.28	0.48	1.66	0.85	1.20	0.71	1.65	0.92	1.04	0.37	1.24	0.61
PE 28:0; [M+H]+; GPEtn(10:0/18:0)	ME480013	0.72	0.41	1.66	0.52	1.16	0.72	1.70	1.11	1.33	0.48	1.29	0.92
PC 31:0; [M+H]+; GPCho(13:0/18:0)	ME479538	0.59	0.64	1.61	0.68	1.13	1.19	1.32	1.31	1.05	0.53	1.17	0.78
PC 30:1; [M+H]+; GPCho(14:0/16:1(7Z))	ME479523	0.89	0.57	1.81	0.94	1.29	0.96	1.36	1.02	1.21	0.37	1.10	0.48
PC 36:5; [M+H]+; GPCho(18:2(2E,4E)/18:3(6Z,9Z,12Z))	ME479642	0.81	0.47	1.63	0.70	1.09	0.86	1.59	0.88	1.18	0.69	1.38	0.73
DG 44:4; [M+NH4]+; DG(20:4/24:0/0:0)	ME479349	0.84	0.65	1.58	0.77	1.13	1.05	1.57	1.07	1.07	0.50	1.19	0.57
DG 44:4; [M+NH4]+; DG(18:2/26:2/0:0)	ME479347	0.77	0.57	1.61	0.73	1.22	1.01	1.66	1.08	1.07	0.47	1.27	0.53
DG 44:4; [M+NH4]+; DG(20:3/24:1/0:0)	ME479348	0.78	0.52	1.73	0.73	1.25	0.98	1.63	1.10	1.07	0.45	1.25	0.51
PC 42:2; [M+Na]+; GPCho(18:1(11E)/24:1(15Z))	ME479867	1.11	0.43	2.30	0.62	1.21	0.66	1.30	0.69	1.30	0.58	1.01	0.79
PC 40:1; [M+H]+; GPCho(14:0/26:1(5Z))	ME479776	1.16	0.45	2.04	1.06	1.17	0.76	1.13	1.39	1.00	0.45	0.56	0.82
PE 21:0; [M+H]+; GPEtn(3:0/18:0)	ME479988	1.23	0.40	2.03	1.05	1.16	0.62	1.36	1.01	0.97	0.46	0.86	0.84
PE 21:0; [M+H]+; GPEtn(9:0/12:0)	ME479989	1.22	0.40	2.01	1.05	1.23	0.62	1.33	1.00	0.96	0.45	0.86	0.85
PC 40:2; [M+Na]+; GPCho(18:2(2E,4E)/22:0)	ME479795	0.89	0.55	1.44	0.83	1.22	0.97	1.09	1.16	0.77	0.30	1.96	0.82
PC 40:1; [M+H]+; GPCho(16:1(7Z)/24:0)	ME479779	0.58	0.37	1.26	0.67	1.61	1.03	1.39	1.16	0.87	0.58	1.67	0.82
PC 40:1; [M+H]+; GPCho(18:0/22:1(13Z))	ME479782	0.64	0.39	1.33	0.70	1.39	1.00	1.49	1.14	0.85	0.57	1.70	0.81
PC 42:5; [M+H]+; GPCho(22:2(13Z,16Z)/20:3(5Z,8Z,11Z))	ME479892	0.77	0.33	1.53	1.15	1.26	0.80	1.42	0.90	1.25	0.42	1.37	0.80
PE 15:0; [M+H]+; GPEtn(6:0/9:0)	ME479961	0.80	0.30	1.65	1.15	1.04	0.87	1.49	0.76	1.04	0.37	1.77	0.76
PE 17:0; [M+H]+; GPEtn(3:0/14:0)	ME479965	0.71	0.32	1.61	1.33	1.03	1.04	1.23	0.80	1.06	0.48	1.52	0.88
PE 15:0; [M+H]+; GPEtn(3:0/12:0)	ME479960	0.76	0.40	1.54	1.34	0.98	0.95	1.36	0.71	0.98	0.47	1.63	0.88
PE 15:0; [M+H]+; GPEtn(2:0/13:0)	ME479959	0.75	0.40	1.56	1.33	0.98	0.92	1.37	0.72	1.02	0.47	1.64	0.85
PE 15:0; [M+H]+; GPEtn(12:0/3:0)	ME479958	0.74	0.40	1.53	1.33	0.99	0.92	1.38	0.72	1.02	0.47	1.65	0.85
PE 15:0; [M+H]+; GPEtn(9:0/6:0)	ME479962	0.74	0.40	1.54	1.33	0.99	0.91	1.38	0.73	1.03	0.47	1.63	0.85
PC 25:2; [M+Na]+; GPCho(3:0/22:2(13Z,16Z))	ME479455	0.67	0.30	1.51	1.07	1.41	0.85	1.22	0.89	1.01	0.54	1.96	0.59
PC 30:5; [M+H]+; GPCho(8:0/22:5(7Z,10Z,13Z,16Z,19Z))	ME479536	0.51	0.31	1.63	1.01	1.26	1.29	1.12	1.07	1.16	0.33	1.60	0.69
PC 32:4; [M+H]+; GPCho(14:1(9Z)/18:3(9Z,12Z,15Z))	ME479565	0.87	0.43	1.81	1.07	1.07	0.87	0.80	0.89	1.17	0.39	1.85	0.78
PC 42:5; [M+H]+; GPCho(20:1(11Z)/22:4(7Z,10Z,13Z,16Z))	ME479887	0.81	0.50	1.77	0.75	1.09	0.88	1.23	1.06	1.10	0.27	1.78	0.75
PC 30:1; [M+H]+; GPCho(6:0/24:1(15Z))	ME479526	0.71	0.53	1.92	0.93	1.25	0.88	1.22	0.92	1.21	0.35	1.58	0.50
PC 30:1; [M+H]+; GPCho(15:0/15:1(9Z))	ME479524	0.73	0.50	1.65	0.98	1.15	0.95	1.13	1.00	1.33	0.26	1.78	0.54
PC 30:1; [M+H]+; GPCho(8:0/22:1(13Z))	ME479527	0.74	0.50	1.66	0.99	1.17	0.92	1.15	1.00	1.33	0.27	1.76	0.52
PC 27:5; [M+Na]+; GPCho(7:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME479489	0.96	0.78	1.59	0.59	1.18	1.20	0.55	1.06	1.10	0.92	1.07	1.01
PC 38:9; [M+H]+; GPCho(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))	ME479722	1.22	0.64	1.43	0.82	1.32	0.86	0.72	1.33	1.24	0.91	0.85	0.65
TG 56:5; [M+NH4]+; TG(16:0/20:1/20:4)	ME480626	1.16	0.76	1.45	0.73	1.36	1.15	0.84	1.00	1.06	0.99	0.71	0.78
PE 40:6; [M+H]+; GPEtn(18:2(2E,4E)/22:4(7Z,10Z,13Z,16Z))	ME480152	0.90	1.08	0.82	0.88	0.61	1.51	0.89	1.36	0.94	1.23	1.09	0.70
MGDG 24:0; [M+Na]+; MGDG(3:0/21:0)	ME479383	0.87	0.56	1.09	0.85	1.09	1.26	0.59	1.64	1.20	1.08	1.06	0.70
TG 52:2; [M+NH4]+; TG(14:0/18:1/20:1)	ME480372	1.03	0.98	0.90	0.61	1.32	1.25	0.70	1.11	1.00	1.12	1.24	0.73
N-(5Z,8Z,11Z,14Z-tetracosatetraenoyl)-sphing-4-enine; [M+H]+; Cer(d18:1(4E)/24:4(5Z,8Z,11Z,14Z))	ME479404	0.98	0.90	1.31	0.89	0.89	1.62	0.55	1.15	0.91	1.10	0.97	0.71
PE 33:3; [M+H]+; GPEtn(15:1(9Z)/18:2(2E,4E))	ME480047	0.85	0.81	1.03	1.03	1.20	1.18	0.82	1.27	0.75	1.00	1.08	0.98
PC 44:2; [M+H]+; GPCho(20:2(11Z,14Z)/24:0)	ME479932	0.74	0.94	1.10	0.88	1.06	1.31	0.50	1.10	0.92	1.37	1.12	0.96
TG 54:4; [M+NH4]+; TG(16:1/18:1/20:2)	ME480476	0.73	0.70	1.16	0.98	1.10	1.35	0.52	1.23	0.99	1.16	1.19	0.89
DG 38:1; [M+NH4]+; DG(20:1/18:0/0:0)	ME479292	1.04	0.85	0.86	1.18	1.31	1.30	0.58	1.44	0.55	0.79	0.87	1.23
PC 42:6; [M+Na]+; GPCho(20:4(5E,8E,11E,14E)/22:2(13Z,16Z))	ME479899	0.92	0.73	0.76	1.13	1.36	1.30	0.94	1.30	0.99	0.68	0.81	1.07
TG 56:5; [M+Na]+; TG(16:0/18:1/22:4)	ME480621	0.53	0.84	1.43	1.13	1.07	1.26	0.77	1.73	0.81	1.05	0.69	0.68
TG 55:4; [M+NH4]+; TG(18:1/18:3/19:0)	ME480549	0.69	0.90	1.46	1.35	0.86	0.93	0.83	1.61	0.79	0.73	0.85	0.99
TG 56:1; [M+NH4]+; TG(18:0/18:1/20:0)	ME480580	0.77	0.58	1.29	1.30	1.17	0.99	0.87	1.58	0.83	0.71	0.93	0.97
TG 51:4; [M+NH4]+; TG(16:1/17:1/18:2)	ME480354	0.67	0.75	1.19	1.13	1.09	1.05	0.62	1.86	0.87	0.88	0.99	0.90
TG 54:6; [M+Li]+; TG(16:0/18:3/20:3)	ME480486	0.75	0.72	1.27	1.20	1.05	0.99	0.61	1.78	0.83	0.77	1.00	1.04
TG 55:2; [M+Na]+; TG(16:0/18:2/21:0)	ME480523	0.49	1.11	1.30	1.44	1.04	1.16	0.51	1.33	0.81	0.80	0.79	1.22
TG 51:4; [M+Li]+; TG(16:1/17:0/18:3)	ME480349	0.55	1.46	1.25	0.94	0.87	1.36	0.67	1.46	0.71	1.13	0.64	0.96
TG 51:4; [M+Li]+; TG(16:1/17:1/18:2)	ME480350	0.59	1.26	1.27	0.97	0.95	1.40	0.67	1.52	0.66	1.00	0.66	1.04
TG 52:3; [M+NH4]+; TG(16:0/16:1/20:2)	ME480379	0.64	0.97	1.23	0.93	1.20	1.09	0.72	1.63	0.83	0.92	0.83	1.02
PC 46:3; [M+H]+; GPCho(20:1(11E)/26:2(5E,9Z))	ME479948	0.70	1.16	1.27	0.79	1.13	1.18	0.84	1.40	0.75	0.90	0.94	0.94
TG 50:2; [M+NH4]+; TG(16:0/17:1/17:1)	ME480310	0.57	1.19	1.38	0.97	1.12	1.34	0.88	1.37	0.63	0.89	0.70	0.97
SM 32:2; [M]+; SM(d14:1(4E)/18:1(9Z))	ME480223	0.38	1.16	1.10	1.35	0.90	1.00	0.99	0.96	1.45	0.73	1.30	0.69
PC 24:0; [M+Na]+; GPCho(11:0/13:0)	ME479444	0.67	1.22	1.16	1.19	0.79	1.12	0.81	0.90	1.36	0.66	1.10	1.01
SM 34:2; [M]+; SM(d16:1(4E)/18:1(9Z))	ME480227	0.56	1.45	1.34	1.16	0.92	1.22	0.92	0.76	1.04	0.63	1.20	0.82
PC 42:5; [M+H]+; GPCho(18:1(11E)/24:4(5Z,8Z,11Z,14Z))	ME479884	0.92	0.88	1.01	1.52	0.91	1.11	0.90	0.78	1.46	0.67	0.76	1.08
PE 27:1; [M+H]+; GPEtn(9:0/18:1(11E))	ME480011	0.76	0.91	1.43	1.22	0.84	1.34	0.84	0.96	1.03	0.59	0.96	1.12
PC 39:3; [M+H]+; GPCho(17:2(9Z,12Z)/22:1(13Z))	ME479748	0.80	0.97	0.93	1.33	1.14	1.32	0.77	0.96	0.96	0.83	0.94	1.05
DG 39:4; [M+NH4]+; DG(19:0/20:4/0:0)	ME479314	0.84	1.12	1.19	1.28	1.08	1.25	0.89	0.88	0.99	0.54	0.87	1.06
PC 39:2; [M+Na]+; GPCho(13:0/26:2(5E,9Z))	ME479743	0.89	0.92	1.22	1.32	1.22	1.24	0.82	0.75	0.99	0.55	1.16	0.93
PC 31:5; [M+Na]+; GPCho(11:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME479550	0.47	0.74	1.24	1.58	1.49	1.54	0.69	0.93	0.99	0.49	1.05	0.79
PC 27:3; [M+Na]+; GPCho(9:0/18:3(6Z,9Z,12Z))	ME479487	0.80	0.99	1.47	1.12	1.26	1.30	0.87	1.13	0.91	0.32	1.31	0.52
PC 29:2; [M+H]+; GPCho(9:0/20:2(11Z,14Z))	ME479509	0.62	0.75	1.18	1.17	1.19	1.60	0.92	1.07	1.05	0.53	1.41	0.52
PC 34:5; [M+H]+; GPCho(14:1(9Z)/20:4(5E,8E,11E,14E))	ME479596	0.59	0.75	1.45	1.18	1.25	1.09	0.93	0.91	1.37	0.60	1.03	0.85
PC 29:2; [M+H]+; GPCho(12:0/17:2(9Z,12Z))	ME479507	0.52	0.72	1.56	1.13	1.34	1.30	0.88	0.96	0.92	0.62	1.37	0.69
PC 47:4; [M+H]+; GPCho(23:0/24:4(5Z,8Z,11Z,14Z))	ME479954	0.67	0.66	1.51	1.02	0.99	1.26	0.81	1.15	1.20	0.79	1.22	0.71
PE 34:4; [M+H]+; GPEtn(24:4(5Z,8Z,11Z,14Z)/10:0)	ME480060	0.54	0.50	1.51	1.24	1.05	1.43	0.79	0.99	1.22	0.59	1.36	0.78
PC 30:4; [M+H]+; GPCho(6:0/24:4(5Z,8Z,11Z,14Z))	ME479534	0.81	0.60	1.37	1.19	0.66	1.03	0.65	1.11	1.71	0.50	1.50	0.86
PC 30:4; [M+H]+; GPCho(8:0/22:4(7Z,10Z,13Z,16Z))	ME479535	0.79	0.60	1.38	1.12	0.68	0.99	0.70	1.05	1.73	0.52	1.63	0.81
PC 35:1; [M+Na]+; GPCho(13:0/22:1(13Z))	ME479610	0.66	0.73	1.27	1.07	1.00	0.98	0.80	0.67	1.40	1.06	1.41	0.94
PC 37:4; [M+H]+; GPCho(17:2(9Z,12Z)/20:2(11Z,14Z))	ME479680	0.51	0.89	1.24	1.44	0.84	0.98	0.72	0.74	1.44	1.20	1.41	0.60
PC 31:0; [M+Na]+; GPCho(9:0/22:0)	ME479540	0.48	0.92	1.06	1.46	0.93	1.23	0.53	1.17	1.31	1.09	1.11	0.72
PC 37:5; [M+H]+; GPCho(17:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME479685	0.48	0.53	1.43	1.49	1.11	0.91	0.62	1.32	1.24	0.90	1.33	0.64
PC 35:0; [M+Na]+; GPCho(9:0/26:0)	ME479607	0.69	1.21	1.62	1.31	0.93	0.74	0.71	1.06	0.58	0.86	1.53	0.78
PC 39:5; [M+Na]+; GPCho(22:5(4Z,7Z,10Z,13Z,16Z)/17:0)	ME479763	0.84	1.35	1.56	1.62	0.69	0.87	0.48	0.96	0.74	0.79	1.14	0.96
PC 33:1; [M+H]+; GPCho(9:0/24:1(15Z))	ME479569	0.76	1.37	1.22	0.86	0.87	0.95	0.75	0.89	0.84	0.72	1.46	1.32
PC 40:3; [M+H]+; GPCho(14:1(9Z)/26:2(5E,9Z))	ME479796	0.87	1.17	1.59	0.65	0.75	0.93	0.54	1.13	0.75	0.80	1.49	1.32
DG 38:6; [M+NH4]+; DG(16:0/22:6/0:0)	ME479306	0.94	1.37	1.55	0.84	1.01	0.71	0.82	0.80	0.71	1.09	1.11	1.05
DG 38:6; [M+NH4]+; DG(18:2/20:4/0:0)	ME479307	0.76	1.29	1.52	0.80	1.23	0.73	0.78	0.88	0.95	0.97	1.11	0.99
plasmenyl-PE 38:2; [M+H]+; PE(P-20:0/18:2(2E,4E))	ME480202	0.98	1.23	1.46	0.86	1.22	0.76	0.88	0.87	0.78	0.89	1.18	0.89
PE 19:0; [M+H]+; GPEtn(2:0/17:0)	ME479980	1.12	1.34	1.54	0.69	0.93	1.03	0.64	0.98	0.83	1.03	1.19	0.66
PE 19:0; [M+H]+; GPEtn(4:0/15:0)	ME479982	1.11	1.43	1.67	0.55	1.03	1.00	0.84	0.97	0.93	0.80	1.00	0.65
PE 38:4; [M+H]+; GPEtn(22:4(7Z,10Z,13Z,16Z)/16:0)	ME480120	0.87	1.16	1.04	0.71	1.55	0.56	0.71	0.90	1.37	1.05	1.00	1.08
DG 38:4; [M+NH4]+; DG(18:1/20:3/0:0)	ME479302	1.31	1.38	0.83	0.57	1.25	0.76	1.05	0.57	1.04	1.16	0.97	1.11
DG 38:4; [M+NH4]+; DG(18:0/20:4/0:0)	ME479301	1.28	1.42	1.08	0.57	1.00	0.68	1.05	0.76	1.11	0.95	0.80	1.29
PA 30:1; [M+Na2-H]+; GPA(6:0/24:1(15Z))	ME479414	1.27	1.37	1.06	0.53	1.07	0.71	1.08	0.76	1.08	0.96	0.84	1.28
lysoPC 26:0; [M+H]+; PC(26:0/0:0)	ME479372	0.70	1.20	0.78	0.64	1.10	1.47	1.13	1.07	1.11	0.54	1.31	0.95
SM 20:0; [M]+; SM(d18:0/2:0)	ME480216	0.81	1.29	0.86	0.91	1.03	0.84	1.19	0.97	1.14	0.65	1.26	1.06
TG 53:4; [M+Na]+; TG(17:1/18:1/18:2)	ME480426	1.02	1.31	0.80	0.72	1.06	0.84	1.04	0.92	1.14	0.78	1.42	0.95
lysoPE 18:1; [M+Na]+; PE(18:1(11E)/0:0)	ME479375	0.68	0.98	0.65	1.42	1.25	0.86	1.06	0.99	1.41	0.68	1.10	0.91
PC 24:6; [M+Na]+; GPCho(2:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479448	0.79	1.45	0.71	0.80	1.02	1.30	1.09	0.92	1.51	0.73	0.67	0.99
PE 29:3; [M+H]+; GPEtn(9:0/20:3(5Z,8Z,11Z))	ME480021	0.74	1.66	0.84	1.11	0.81	1.13	0.81	0.83	1.40	0.59	1.09	0.98
PC 45:0; [M+H]+; GPCho(20:0/25:0)	ME479946	0.72	1.53	0.49	1.26	1.21	0.98	1.03	0.73	1.23	0.98	1.00	0.84
TG 56:10; [M+NH4]+; TG(16:1/18:3/22:6)	ME480581	0.87	1.33	0.75	1.07	0.99	1.03	0.79	1.05	1.33	0.86	1.04	0.88
TG 56:10; [M+NH4]+; TG(18:2/18:3/20:5)	ME480582	0.71	1.40	0.59	1.10	1.09	1.15	0.90	0.91	1.32	1.05	1.03	0.75
PC 34:3; [M+H]+; GPCho(14:0/20:3(5Z,8Z,11Z))	ME479588	0.92	1.27	0.93	0.85	0.88	0.57	0.75	0.76	1.60	1.23	1.32	0.93
PC 34:3; [M+H]+; GPCho(16:0/18:3(6Z,9Z,12Z))	ME479590	1.02	1.31	0.75	1.04	0.86	0.59	0.77	0.68	1.59	1.37	1.37	0.64
PE 38:4; [M+H]+; GPEtn(18:1(11E)/20:3(5Z,8Z,11Z))	ME480117	0.80	1.16	0.96	1.22	0.54	0.77	0.81	1.06	1.47	1.19	1.01	0.99
PE 38:4; [M+H]+; GPEtn(18:0/20:4(5E,8E,11E,14E))	ME480116	0.83	1.23	0.75	1.29	0.70	0.72	0.79	1.12	0.98	1.13	1.39	1.07
PC 34:3; [M+H]+; GPCho(16:1(7Z)/18:2(6Z,9Z))	ME479592	0.91	1.42	0.80	1.17	0.86	0.69	0.70	0.83	1.30	1.09	1.39	0.83
plasmenyl-PE 18:0; [M+Na]+; PE(P-16:0/2:0)	ME480190	0.89	1.21	0.69	1.19	0.98	0.79	0.55	1.01	1.23	1.06	1.42	0.99
PC 21:0; [M+Na]+; GPCho(10:0/11:0)	ME479438	0.67	1.50	1.04	1.01	0.78	0.52	0.88	1.08	1.36	0.55	1.36	1.25
PE 40:0; [M+H]+; GPEtn(19:0/21:0)	ME480141	1.02	1.04	1.15	1.29	1.21	0.58	0.80	0.75	1.57	0.74	1.08	0.77
PC 23:0; [M+Na]+; GPCho(10:0/13:0)	ME479441	0.71	1.41	1.22	0.95	1.21	0.78	0.74	0.81	1.37	0.77	0.99	1.03
PC 25:0; [M+Na]+; GPCho(12:0/13:0)	ME479450	0.77	1.47	1.27	1.16	0.95	0.74	0.71	0.78	1.59	0.54	1.09	0.94
PE 38:9; [M+H]+; GPEtn(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))	ME480130	1.31	0.68	1.23	1.12	0.90	1.06	0.82	0.46	0.86	1.19	1.20	1.16
PC 40:10; [M+H]+; GPCho(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))	ME479788	1.04	0.82	0.78	1.23	0.88	1.00	1.04	0.73	0.91	1.44	1.13	1.00
PE 36:4; [M+H]+; GPEtn(18:2(2E,4E)/18:2(2E,4E))	ME480089	0.66	0.73	0.82	1.16	0.95	1.13	0.80	0.75	1.07	1.43	1.57	0.94
PC 39:0; [M+Na]+; GPCho(14:0/25:0)	ME479729	1.37	0.75	1.06	0.80	1.62	0.84	0.77	0.73	1.07	0.65	1.31	1.02
PC 40:9; [M+Na]+; GPCho(20:4(5E,8E,11E,14E)/20:5(5Z,8Z,11Z,14Z,17Z))	ME479830	1.40	0.88	1.10	0.75	1.27	0.89	0.99	0.80	0.86	0.64	1.36	1.05
PC 44:2; [M+Na]+; GPCho(20:1(11E)/24:1(15Z))	ME479933	1.11	0.94	0.77	0.80	1.27	1.04	1.22	1.04	0.78	0.77	1.50	0.76
TG 56:9; [M+NH4]+; TG(18:2/18:2/20:5)	ME480674	1.31	1.08	1.03	0.57	0.91	1.01	1.16	0.89	1.07	0.83	1.21	0.95
PC 39:5; [M+H]+; GPCho(19:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME479761	1.37	0.92	1.17	0.83	0.94	0.83	1.43	0.87	0.73	0.74	1.35	0.84
PC 41:3; [M+Na]+; GPCho(18:3(9Z,12Z,15Z)/23:0)	ME479853	1.43	0.76	0.98	0.83	0.97	1.00	1.22	0.80	0.95	0.56	1.56	0.94
CE(18:2); [M+NH4]+; 18:2 Cholesteryl ester	ME479236	0.80	0.94	1.13	0.59	1.22	1.05	1.36	0.81	1.06	1.11	1.10	0.83
DG 37:7; [M+NH4]+; DG(15:1/22:6/0:0)	ME479288	0.92	1.04	1.24	1.27	1.13	0.91	1.21	1.25	0.78	1.01	0.72	0.52
TG 54:2; [M+NH4]+; TG(16:0/18:1/20:1)	ME480457	0.83	0.86	0.94	1.39	1.04	1.24	1.25	1.03	0.95	0.92	0.72	0.82
DG 37:5; [M+NH4]+; DG(17:2/20:3/0:0)	ME479286	1.33	0.99	1.17	0.88	1.25	1.08	0.87	1.10	0.89	0.86	0.75	0.82
N-(docosanoyl)-sphing-4-enine; [M+H]+; Cer(d18:1(4E)/22:0)	ME479405	1.27	0.98	1.05	0.99	1.35	0.92	1.21	1.21	0.67	0.89	0.73	0.75
PE 42:3; [M+H]+; GPEtn(18:2(2E,4E)/24:1(15Z))	ME480163	1.21	0.88	1.02	1.21	1.03	1.40	0.82	0.75	0.87	1.02	1.00	0.80
SM 43:4; [M]+; SM(d19:0/24:4(5Z,8Z,11Z,14Z))	ME480256	1.36	0.94	0.99	1.07	1.14	1.14	0.96	0.82	0.76	1.16	0.90	0.76
PE 35:0; [M+H]+; GPEtn(9:0/26:0)	ME480062	0.99	0.87	1.08	1.18	1.07	1.28	1.17	0.73	0.95	0.96	0.93	0.78
plasmenyl-PC 38:2; [M+Na]+; PC(P-18:0/20:2(11Z,14Z))	ME480183	1.05	1.06	1.02	1.43	1.06	1.13	0.92	0.79	0.90	0.90	0.88	0.84
PC 37:1; [M+Na]+; GPCho(14:1(9Z)/23:0)	ME479662	1.14	0.97	1.01	1.08	1.08	1.16	0.89	1.04	1.01	0.89	0.90	0.84
PC 37:1; [M+Na]+; GPCho(15:1(9Z)/22:0)	ME479664	1.05	0.92	1.02	1.07	1.11	1.19	0.82	1.09	1.02	0.97	0.90	0.82
PC 37:1; [M+Na]+; GPCho(26:1(5Z)/11:0)	ME479670	1.04	0.91	1.02	1.14	1.11	1.19	0.82	1.09	1.01	0.96	0.90	0.82
PC 35:0; [M+H]+; GPCho(9:0/26:0)	ME479606	1.17	0.96	0.97	1.12	1.00	1.08	1.02	0.92	0.95	1.03	0.91	0.86
PC 35:0; [M+H]+; GPCho(19:0/16:0)	ME479604	1.08	0.79	1.12	1.06	1.09	1.00	1.09	1.07	0.91	0.93	0.97	0.89
PC 35:0; [M+H]+; GPCho(16:0/19:0)	ME479602	1.15	0.83	1.08	1.15	1.04	1.06	1.02	1.04	0.89	0.96	0.93	0.86
PC 35:0; [M+H]+; GPCho(17:0/18:0)	ME479603	1.16	0.77	1.10	1.10	1.08	1.03	1.08	1.06	0.90	0.97	0.92	0.85
PC 40:6; [M+H]+; GPCho(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))	ME479823	1.01	0.71	0.92	1.30	0.99	1.27	0.81	1.04	0.95	1.00	1.16	0.85
TG 49:1; [M+NH4]+; TG(16:0/16:1/17:0)	ME480292	1.05	0.99	0.79	1.21	1.05	1.20	0.93	0.99	0.97	0.95	1.03	0.85
TG 51:4; [M+NH4]+; TG(17:1/17:1/17:2)	ME480357	0.99	0.89	0.79	1.19	0.93	1.15	1.03	1.11	1.16	0.90	1.09	0.77
PC 37:0; [M+Na]+; GPCho(14:0/23:0)	ME479655	1.24	0.84	0.87	1.32	1.34	1.09	0.90	0.99	0.78	0.84	1.02	0.76
PC 37:1; [M+Na]+; GPCho(24:1(15Z)/13:0)	ME479669	1.07	0.61	1.12	1.11	1.33	1.17	1.01	1.08	0.72	0.73	1.10	0.97
SM 41:2; [M+Na]+; SM(d15:1(4E)/26:1(17Z))	ME480242	1.30	0.73	1.28	1.31	1.21	1.00	1.00	0.98	0.82	0.67	0.98	0.71
SM 43:5; [M]+; SM(d19:1(4E)/24:4(5Z,8Z,11Z,14Z))	ME480257	1.05	0.79	1.26	1.36	1.16	1.07	0.96	1.03	0.83	0.72	1.03	0.76
PC 28:0; [M+H]+; GPCho(2:0/26:0)	ME479490	0.92	0.91	1.12	1.38	1.01	1.22	0.72	1.11	0.95	0.72	1.22	0.73
SM 37:0; [M]+; SM(d15:0/22:0)	ME480230	1.08	0.87	0.98	1.33	1.09	0.97	0.85	0.86	1.12	0.77	1.32	0.74
SM 42:2; [M+Na]+; SM(d16:1(4E)/26:1(17Z))	ME480249	0.88	0.47	1.07	1.28	1.20	1.10	0.93	1.37	0.95	0.76	1.18	0.82
DG 40:8; [M+NH4]+; DG(18:2/22:6/0:0)	ME479326	1.02	0.84	1.07	1.01	1.04	0.99	1.09	1.11	1.04	0.93	1.22	0.67
DG 40:9; [M+NH4]+; DG(18:3/22:6/0:0)	ME479327	1.09	0.73	1.10	0.98	0.99	1.03	1.12	1.13	1.06	0.89	1.23	0.65
PC 41:1; [M+H]+; GPCho(16:1(7Z)/25:0)	ME479837	0.99	0.72	0.97	1.22	1.10	1.09	1.06	1.03	1.07	0.76	1.22	0.78
PC 42:8; [M+H]+; GPCho(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))	ME479909	0.97	0.69	1.12	1.23	1.26	1.09	1.06	1.13	1.04	0.71	1.05	0.67
TG 52:7; [M+NH4]+; TG(16:1/16:1/20:5)	ME480400	0.94	0.86	0.56	0.65	1.28	0.86	1.29	1.01	1.33	1.07	1.21	0.94
TG 52:7; [M+NH4]+; TG(16:1/18:3/18:3)	ME480401	0.97	0.93	0.49	0.88	1.26	0.89	1.22	0.96	1.28	1.17	1.14	0.81
TG 52:6; [M+NH4]+; TG(16:1/16:1/20:4)	ME480397	1.12	0.97	0.78	0.97	0.97	0.77	1.30	0.91	1.40	0.84	1.02	0.96
TG 52:5; [M+NH4]+; TG(16:1/18:1/18:3)	ME480392	1.30	1.27	0.80	0.91	1.15	0.72	1.11	0.87	1.17	0.82	1.01	0.88
TG 52:6; [M+NH4]+; TG(16:1/18:2/18:3)	ME480398	1.23	1.21	0.66	0.81	1.04	0.77	1.12	0.87	1.36	0.88	0.99	1.05
TG 52:6; [M+NH4]+; TG(16:0/16:1/20:5)	ME480395	1.22	1.15	0.64	0.84	1.09	0.73	1.18	0.90	1.33	0.86	1.03	1.05
TG 52:6; [M+NH4]+; TG(16:0/18:3/18:3)	ME480396	1.24	1.17	0.64	0.82	1.06	0.74	1.18	0.87	1.36	0.85	1.01	1.05
TG 54:7; [M+NH4]+; TG(16:1/18:2/20:4)	ME480495	1.26	1.14	0.79	1.18	1.00	0.82	1.13	0.66	1.28	0.83	1.07	0.84
TG 54:7; [M+NH4]+; TG(18:2/18:2/18:3)	ME480496	1.42	0.95	0.88	1.03	1.14	0.77	1.26	0.69	1.03	0.82	1.11	0.90
TG 56:8; [M+NH4]+; TG(16:1/20:3/20:4)	ME480664	1.04	0.91	0.71	0.87	1.34	0.82	1.24	0.73	1.00	1.13	1.01	1.20
TG 50:4; [M+NH4]+; TG(16:0/16:1/18:3)	ME480320	1.38	0.85	0.90	0.82	1.16	1.10	1.26	0.85	0.90	1.04	0.84	0.89
TG 56:3; [M+NH4]+; TG(16:1/18:1/22:1)	ME480602	0.99	0.89	0.85	0.92	1.02	0.98	0.97	0.93	1.25	1.31	1.00	0.88
TG 56:3; [M+NH4]+; TG(18:1/18:2/20:0)	ME480604	1.04	0.90	0.84	0.92	1.02	0.99	0.96	0.92	1.23	1.31	1.00	0.87
PC 40:4; [M+Na]+; GPCho(18:2(6Z,9Z)/22:2(13Z,16Z))	ME479812	1.34	0.98	0.91	0.88	1.03	0.95	1.06	0.81	1.06	1.07	0.87	1.03
PE 36:1; [M+H]+; GPEtn(18:0/18:1(11E))	ME480079	1.02	0.94	0.86	0.97	0.99	1.12	1.10	0.84	1.15	1.03	0.90	1.08
TG 54:8; [M+NH4]+; TG(16:1/16:1/22:6)	ME480500	1.14	1.02	0.84	0.91	1.16	1.01	1.00	0.80	1.18	1.08	0.86	1.00
TG 54:8; [M+NH4]+; TG(16:1/18:3/20:4)	ME480502	1.14	1.02	0.83	0.91	1.16	1.02	1.00	0.80	1.18	1.08	0.86	1.00
TG 54:8; [M+NH4]+; TG(18:2/18:3/18:3)	ME480503	1.13	1.01	0.91	0.87	1.08	1.01	1.05	0.74	1.22	1.04	0.86	1.09
PC 44:5; [M+H]+; GPCho(22:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME479939	1.10	1.00	0.87	0.88	1.11	1.00	1.10	0.77	1.22	1.05	0.85	1.07
TG 54:8; [M+NH4]+; TG(16:0/18:3/20:5)	ME480499	1.10	0.99	0.86	0.87	1.09	1.00	1.16	0.75	1.21	1.04	0.85	1.07
TG 50:3; [M+Li]+; TG(16:0/16:1/18:2)	ME480311	1.19	0.65	1.08	0.91	1.04	0.84	1.04	1.06	1.14	1.15	1.02	0.89
PC 43:1; [M+H]+; GPCho(20:1(11E)/23:0)	ME479923	0.98	0.76	0.87	0.74	1.10	1.06	1.31	1.07	1.13	0.94	1.09	0.94
SM 44:2; [M]+; SM(d18:1(4E)/26:1(17Z))	ME480261	1.30	0.93	0.80	0.76	1.12	0.91	1.14	1.00	1.18	0.90	0.99	0.96
TG 50:4; [M+NH4]+; TG(16:1/16:1/18:2)	ME480321	1.12	0.95	0.91	0.82	1.10	0.94	1.15	0.99	1.12	0.91	1.08	0.91
TG 50:3; [M+NH4]+; TG(16:0/16:0/18:3)	ME480315	1.00	0.77	0.90	0.92	1.10	0.87	1.22	1.04	1.01	1.03	1.09	1.06
TG 54:8; [M+NH4]+; TG(16:1/18:2/20:5)	ME480501	1.08	0.82	0.89	0.85	1.10	0.89	1.01	1.06	1.21	1.03	1.02	1.04
PE 18:0; [M+H]+; GPEtn(8:0/10:0)	ME479978	0.89	0.87	1.01	1.60	0.85	1.04	0.87	0.86	0.82	0.99	0.97	1.22
DG 34:3; [M+NH4]+; DG(16:1/18:2/0:0)	ME479259	1.08	0.95	1.15	1.19	1.07	0.89	0.99	0.89	1.00	0.85	0.71	1.24
PC 32:1; [M+Na]+; GPCho(10:0/22:1(13Z))	ME479559	1.00	0.87	1.04	1.28	0.98	1.07	0.77	0.82	1.04	0.96	0.94	1.25
PC 32:1; [M+Na]+; GPCho(12:0/20:1(11E))	ME479560	1.00	0.87	1.04	1.28	0.98	1.07	0.76	0.81	1.04	0.97	0.93	1.25
PE 38:0; [M+Na]+; GPEtn(12:0/26:0)	ME480108	1.30	0.64	0.60	1.25	1.14	0.99	0.67	1.11	1.11	0.99	1.10	1.10
PC 38:1; [M+Na]+; GPCho(14:1(9Z)/24:0)	ME479697	1.21	0.92	0.79	1.19	0.79	0.99	0.93	0.83	1.09	0.97	1.04	1.24
PC 38:1; [M+Na]+; GPCho(12:0/26:1(5Z))	ME479695	1.27	0.79	0.79	1.16	0.97	0.94	0.97	0.86	1.09	0.92	1.01	1.21
PC 40:4; [M+H]+; GPCho(18:4(6Z,9Z,12Z,15Z)/22:0)	ME479806	1.23	0.82	0.78	1.17	0.97	0.95	0.96	0.89	1.08	0.94	1.00	1.22
PC 36:3; [M+H]+; GPCho(14:1(9Z)/22:2(13Z,16Z))	ME479629	1.30	0.77	0.92	1.04	1.00	0.79	0.92	0.89	0.98	0.91	1.20	1.30
PC 36:3; [M+H]+; GPCho(18:0/18:3(6Z,9Z,12Z))	ME479631	1.42	0.89	0.84	1.00	0.90	0.86	0.80	0.74	1.08	1.04	1.14	1.28
PC 35:5; [M+H]+; GPCho(15:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME479622	1.03	0.77	1.20	1.17	1.09	1.02	0.98	0.51	1.09	0.94	1.14	1.07
PC 41:3; [M+Na]+; GPCho(20:3(5Z,8Z,11Z)/21:0)	ME479854	1.03	1.05	0.91	1.03	0.98	0.84	1.10	0.56	1.20	0.92	1.16	1.22
PC 44:9; [M+H]+; GPCho(20:5(5Z,8Z,11Z,14Z,17Z)/24:4(5Z,8Z,11Z,14Z))	ME479943	0.88	0.95	0.88	1.09	1.04	0.98	1.13	0.90	0.75	0.89	1.36	1.16
SM 40:1; [M+Na]+; SM(d14:0/26:1(17Z))	ME480237	1.04	0.88	0.83	1.18	1.05	1.27	0.99	0.83	0.83	0.91	1.07	1.13
SM 42:4; [M]+; SM(d18:0/24:4(5Z,8Z,11Z,14Z))	ME480250	1.03	0.70	0.94	1.14	1.12	1.22	1.04	0.89	0.87	0.78	1.18	1.10
PC 39:0; [M+H]+; GPCho(26:0/13:0)	ME479728	1.10	1.22	0.82	1.01	0.83	1.28	0.99	0.70	0.98	0.95	1.15	0.99
DG 28:1; [M+NH4]+; DG(10:0/18:1/0:0)	ME479245	1.00	1.24	0.83	1.14	0.79	1.11	0.69	0.86	1.08	0.99	1.12	1.15
PC 37:1; [M+Na]+; GPCho(18:1(11E)/19:0)	ME479668	0.99	1.09	0.84	1.24	0.93	1.23	0.73	0.78	1.12	0.97	0.98	1.08
PC 37:4; [M+Na]+; GPCho(18:4(6Z,9Z,12Z,15Z)/19:0)	ME479681	0.95	0.82	1.20	1.18	0.97	0.83	0.91	0.89	1.07	1.03	1.21	0.94
PC 33:0; [M+Na]+; GPCho(9:0/24:0)	ME479568	0.99	0.93	0.99	1.05	1.01	0.82	1.00	1.04	1.09	0.96	1.13	0.99
TG 54:2; [M+NH4]+; TG(16:1/18:1/20:0)	ME480460	1.05	1.07	1.01	1.15	0.88	0.80	0.87	0.89	1.05	1.08	1.17	0.98
PC 39:2; [M+Na]+; GPCho(15:1(9Z)/24:1(15Z))	ME479744	0.74	1.15	0.89	1.21	1.14	1.11	0.91	0.82	1.08	0.67	1.32	0.96
PC 41:1; [M+H]+; GPCho(18:1(11Z)/23:0)	ME479840	0.89	1.23	1.10	1.17	1.02	1.00	0.81	0.74	1.16	0.73	1.18	0.97
TG 54:3; [M+NH4]+; TG(16:1/18:0/20:2)	ME480470	0.95	1.20	0.92	1.07	0.80	1.03	0.84	0.90	1.03	0.97	1.44	0.86
TG 51:5; [M+NH4]+; TG(16:1/17:1/18:3)	ME480359	1.00	1.14	0.82	1.03	0.90	0.96	0.98	0.89	1.15	0.80	1.31	1.02
PC 40:6; [M+Na]+; GPCho(20:1(11E)/20:5(5Z,8Z,11Z,14Z,17Z))	ME479824	0.92	1.10	0.84	1.05	0.87	1.07	0.97	0.93	1.08	0.88	1.28	1.00
TG 51:5; [M+NH4]+; TG(16:1/17:2/18:2)	ME480360	0.92	1.10	0.83	1.05	0.94	1.08	0.96	0.90	1.13	0.90	1.23	0.97
PC 34:3; [M+H]+; GPCho(16:1(7Z)/18:2(2E,4E))	ME479591	0.91	1.09	0.88	1.27	0.94	0.86	0.93	0.83	1.15	0.89	1.35	0.90
TG 51:5; [M+NH4]+; TG(16:0/17:2/18:3)	ME480358	0.97	0.95	0.83	1.21	1.05	1.00	0.93	0.89	1.14	0.88	1.19	0.94
PC 40:4; [M+H]+; GPCho(20:2(11Z,14Z)/20:2(11Z,14Z))	ME479808	1.10	1.18	1.14	1.25	0.64	0.99	0.83	1.06	0.85	1.08	1.08	0.79
TG 51:4; [M+NH4]+; TG(17:0/17:2/17:2)	ME480356	0.87	1.12	1.43	1.06	0.99	0.88	0.92	1.22	0.74	1.06	0.89	0.82
PC 41:0; [M+H]+; GPCho(19:0/22:0)	ME479834	0.82	1.23	1.42	1.45	0.83	0.95	0.89	0.95	0.78	1.06	0.93	0.69
TG 48:2; [M+NH4]+; TG(16:0/16:1/16:1)	ME480287	0.69	1.11	1.45	1.13	0.77	1.09	1.16	0.96	0.71	1.10	1.11	0.71
PC 28:0; [M+H]+; GPCho(9:0/19:0)	ME479492	1.16	1.43	0.87	1.23	1.09	1.00	1.04	0.68	0.83	0.92	1.16	0.59
PC 37:5; [M+Na]+; GPCho(17:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME479687	1.14	1.39	1.10	1.25	1.06	0.99	0.88	0.75	0.89	1.09	1.02	0.44
PC 32:1; [M+H]+; GPCho(14:1(9Z)/18:0)	ME479558	1.29	1.12	1.38	1.16	1.11	0.76	0.85	0.91	0.66	0.77	1.35	0.64
TG 48:3; [M+Na]+; TG(14:1/16:1/18:1)	ME480288	1.29	0.96	1.29	1.08	1.08	1.04	1.07	0.80	0.70	0.83	1.29	0.57
N-(15Z-tetracosenoyl)-sphing-4-enine; [M+H]+; Cer(d18:1(4E)/24:1(15Z))	ME479402	1.36	1.09	1.20	0.97	0.82	1.06	0.95	0.98	0.78	0.92	1.15	0.71
SM 41:1; [M+Na]+; SM(d15:0/26:1(17Z))	ME480241	1.07	1.35	1.18	1.01	0.95	0.94	0.88	0.88	0.84	0.91	1.33	0.65
DG 44:11; [M+NH4]+; DG(22:5/22:6/0:0)	ME479344	1.22	1.20	1.25	1.01	0.95	0.78	1.02	0.93	1.00	0.82	1.19	0.64
PE 35:1; [M+H]+; GPEtn(16:1(7Z)/19:0)	ME480064	1.15	1.20	1.24	1.05	0.89	0.80	1.12	0.80	1.01	0.73	1.35	0.67
PC 40:3; [M+Na]+; GPCho(14:1(9Z)/26:2(5E,9Z))	ME479801	1.12	1.42	1.32	1.05	1.21	0.75	1.08	0.54	1.07	0.81	0.76	0.87
TG 52:4; [M+NH4]+; TG(16:1/18:1/18:2)	ME480388	0.88	1.11	1.35	0.98	1.26	0.72	1.43	0.70	1.18	0.77	0.82	0.81
TG 56:8; [M+NH4]+; TG(16:1/18:1/22:6)	ME480662	0.90	1.27	1.38	0.80	1.04	1.01	1.44	0.64	1.10	0.70	0.85	0.86
PC 34:3; [M+H]+; GPCho(14:1(9Z)/20:2(11Z,14Z))	ME479589	1.03	1.11	1.23	1.19	1.04	0.78	1.01	0.92	1.01	1.22	0.76	0.69
PC 38:3; [M+H]+; GPCho(18:1(11E)/20:2(11Z,14Z))	ME479706	1.05	1.32	1.40	1.05	1.09	0.63	0.92	0.98	0.96	0.97	1.02	0.63
PC 37:1; [M+Na]+; GPCho(17:0/20:1(11E))	ME479666	1.06	1.11	1.40	0.92	1.45	0.78	1.17	0.97	0.96	0.77	0.83	0.57
TG 48:0; [M+Na]+; TG(14:0/16:0/18:0)	ME480277	0.94	0.89	1.57	1.03	1.26	0.71	1.17	0.85	0.90	1.04	0.99	0.65
PE 34:0; [M+H]+; GPEtn(8:0/26:0)	ME480049	0.67	1.02	1.24	0.95	0.99	1.17	1.24	0.93	0.93	0.93	1.01	0.92
PE 33:0; [M+H]+; GPEtn(10:0/23:0)	ME480032	0.99	0.80	1.40	0.88	1.05	1.31	1.28	0.90	1.02	0.71	0.89	0.76
PE 33:1; [M+H]+; GPEtn(15:0/18:1(11E))	ME480040	1.02	0.88	1.27	1.00	1.01	1.05	1.31	0.95	0.98	0.79	0.98	0.75
TG 50:3; [M+NH4]+; TG(16:0/16:1/18:2)	ME480316	0.88	0.96	1.24	1.02	1.06	1.17	1.26	1.06	0.89	0.73	0.97	0.76
PC 34:6; [M+H]+; GPCho(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))	ME479598	0.97	1.03	1.12	1.16	0.88	0.94	1.17	0.95	0.83	1.09	0.95	0.92
PE 33:0; [M+H]+; GPEtn(14:0/19:0)	ME480035	1.04	1.02	1.24	0.93	0.94	1.26	1.11	0.80	0.91	0.79	1.05	0.90
SM 41:4; [M]+; SM(d17:0/24:4(5Z,8Z,11Z,14Z))	ME480243	1.05	1.01	1.15	0.99	0.96	1.23	0.98	0.82	1.01	0.97	1.00	0.84
PE 33:0; [M+H]+; GPEtn(17:0/16:0)	ME480036	1.02	1.19	1.23	0.90	0.89	1.16	1.15	0.84	1.03	0.89	0.89	0.81
PE 33:1; [M+H]+; GPEtn(7:0/26:1(5Z))	ME480043	0.99	1.32	1.01	1.12	0.86	1.17	1.10	0.87	0.94	0.99	0.84	0.80
plasmenyl-PE 34:0; [M+H]+; PE(P-18:0/16:0)	ME480192	1.03	1.14	1.10	1.07	0.92	1.13	1.17	0.89	0.95	0.93	0.88	0.79
PE 42:1; [M+H]+; GPEtn(18:0/24:1(15Z))	ME480159	1.11	1.33	1.37	0.95	0.85	1.05	1.25	0.91	0.83	0.79	0.74	0.83
PE 34:0; [M+H]+; GPEtn(10:0/24:0)	ME480048	0.81	1.37	1.28	0.72	1.05	1.03	1.28	0.91	0.90	0.79	1.08	0.77
plasmenyl-PE 36:0; [M+H]+; PE(P-20:0/16:0)	ME480195	0.94	1.36	1.19	0.92	0.97	1.10	1.22	0.95	0.97	0.77	1.04	0.57
PE 32:1; [M+H]+; GPEtn(16:0/16:1(7Z))	ME480029	0.83	1.18	1.15	1.01	1.07	0.79	1.25	0.94	1.21	0.95	0.96	0.65
TG 52:5; [M+NH4]+; TG(16:1/18:2/18:2)	ME480393	1.05	1.23	0.97	0.94	1.10	0.66	1.27	0.93	1.24	0.79	1.10	0.73
TG 54:6; [M+NH4]+; TG(16:1/18:2/20:3)	ME480490	0.90	1.23	1.16	0.81	1.02	0.81	1.33	0.86	1.21	0.71	1.08	0.88
TG 53:2; [M+Na]+; TG(17:0/18:0/18:2)	ME480413	0.92	1.24	1.05	1.36	0.97	0.93	1.31	0.82	1.01	0.69	0.94	0.76
TG 54:6; [M+NH4]+; TG(16:0/18:2/20:4)	ME480489	1.00	1.04	0.96	1.10	0.99	0.86	1.35	0.88	1.09	0.75	1.06	0.92
PC 37:2; [M+H]+; GPCho(22:2(13Z,16Z)/15:0)	ME479673	1.15	0.92	1.11	0.87	1.06	0.53	1.34	1.29	1.09	0.91	0.95	0.76
PC 41:5; [M+H]+; GPCho(20:5(5Z,8Z,11Z,14Z,17Z)/21:0)	ME479860	1.07	1.20	1.03	1.02	1.22	0.74	1.10	0.88	0.82	0.90	1.07	0.94
TG 50:2; [M+Li]+; TG(16:0/16:1/18:1)	ME480304	0.98	1.23	1.26	0.94	1.20	0.81	1.09	1.03	0.84	0.85	0.96	0.80
PC 40:1; [M+Na]+; GPCho(18:0/22:1(13Z))	ME479787	1.08	0.86	1.18	0.90	1.13	0.70	1.22	1.16	0.81	0.82	1.20	0.92
PC 39:4; [M+H]+; GPCho(19:0/20:4(5E,8E,11E,14E))	ME479755	1.14	0.96	1.13	1.14	1.01	0.67	1.10	1.10	0.94	0.90	1.00	0.91
PC 41:6; [M+H]+; GPCho(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/19:0)	ME479862	0.98	0.94	1.20	1.15	1.08	0.79	1.07	1.23	0.95	0.82	0.94	0.85
PC 35:2; [M+H]+; GPCho(17:2(9Z,12Z)/18:0)	ME479612	0.82	0.91	1.20	1.02	1.24	0.69	0.86	1.14	0.83	0.99	1.55	0.75
PC 36:8; [M+H]+; GPCho(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))	ME479650	0.77	0.91	1.30	1.03	1.34	0.46	0.56	1.35	0.96	0.92	1.60	0.79
PE 44:6; [M+H]+; GPEtn(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480174	0.86	1.20	0.96	1.19	1.25	1.00	0.76	1.14	1.04	0.89	0.58	1.13
PC 23:3; [M+H]+; GPCho(3:0/20:3(5Z,8Z,11Z))	ME479442	0.78	1.30	0.92	0.80	1.40	1.18	0.81	1.09	1.30	0.75	0.84	0.82
PC 39:6; [M+H]+; GPCho(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/17:0)	ME479766	0.69	1.18	0.96	1.00	1.46	1.10	0.58	1.31	1.08	0.77	1.07	0.80
PC 39:1; [M+Na]+; GPCho(18:1(13Z)/21:0)	ME479738	0.75	0.77	1.08	1.06	1.56	0.94	0.66	1.21	0.85	0.59	1.28	1.25
DG 36:0; [M+NH4]+; DG(18:0/18:0/0:0)	ME479270	0.98	0.71	1.18	0.77	1.72	0.98	0.83	1.26	0.98	0.62	1.27	0.73
plasmenyl-PC 40:0; [M+Na]+; PC(P-20:0/20:0)	ME480185	0.84	0.90	1.19	0.98	1.47	0.98	0.67	1.15	0.87	0.73	1.45	0.77
PC 37:1; [M+Na]+; GPCho(11:0/26:1(5Z))	ME479661	0.89	1.13	1.26	1.18	1.30	1.07	0.55	0.85	0.88	0.85	1.23	0.81
PC 42:5; [M+H]+; GPCho(20:4(5E,8E,11E,14E)/22:1(13Z))	ME479889	0.97	0.97	1.00	1.33	1.42	1.24	0.65	0.75	0.82	0.80	1.37	0.67
PC 39:2; [M+Na]+; GPCho(18:2(9E,10E)/21:0)	ME479746	1.05	0.86	1.37	1.17	1.22	0.95	0.80	0.81	1.01	0.73	1.11	0.92
PC 40:1; [M+H]+; GPCho(16:1(9Z)/24:0)	ME479780	1.10	1.06	1.13	1.07	1.25	0.96	0.92	0.89	1.01	0.79	1.03	0.79
TG 49:3; [M+NH4]+; TG(16:0/16:1/17:2)	ME480296	0.77	1.14	1.37	1.11	1.24	0.88	0.84	0.98	1.14	0.68	1.09	0.76
PC 39:1; [M+Na]+; GPCho(16:1(7Z)/23:0)	ME479736	0.84	0.94	1.47	1.01	1.47	0.82	0.71	0.90	1.17	0.67	1.15	0.85
PC 41:4; [M+H]+; GPCho(23:0/18:4(6Z,9Z,12Z,15Z))	ME479857	0.87	0.88	1.38	0.98	1.45	0.83	0.67	0.87	1.11	0.69	1.32	0.97
PC 34:2; [M+H]+; GPCho(16:0/18:2(2E,4E))	ME479580	0.72	1.14	1.24	1.05	1.00	0.98	0.61	1.25	1.42	0.82	1.18	0.58
TG 49:1; [M+NH4]+; TG(16:0/16:0/17:1)	ME480291	1.09	0.88	1.13	0.91	1.23	0.97	0.92	1.13	1.24	1.03	1.02	0.45
PC 40:1; [M+H]+; GPCho(20:0/20:1(11E))	ME479785	1.08	1.03	0.99	1.02	1.09	1.07	0.67	0.86	1.33	1.02	1.10	0.75
PC 42:5; [M+H]+; GPCho(20:5(5Z,8Z,11Z,14Z,17Z)/22:0)	ME479891	1.03	1.12	1.05	0.80	1.42	0.91	0.63	0.94	1.45	0.87	1.07	0.70
MGDG 34:3; [M+Na]+; MGDG(16:1(7Z)/18:2(2E,4E))	ME479389	0.80	0.90	1.03	0.83	1.17	0.84	0.88	1.35	1.18	1.01	1.13	0.89
PE 38:1; [M+H]+; GPEtn(18:0/20:1(11E))	ME480110	0.84	0.76	1.03	0.84	1.18	0.87	0.91	1.40	1.13	0.98	1.17	0.90
PC 37:1; [M+H]+; GPCho(14:1(9Z)/23:0)	ME479660	1.04	0.57	0.97	1.02	1.19	0.97	0.80	1.15	1.28	0.93	1.20	0.89
PE 37:3; [M+H]+; GPEtn(17:1(9Z)/20:2(11Z,14Z))	ME480104	0.85	0.69	0.98	1.11	0.97	0.90	0.82	1.10	1.24	1.03	1.18	1.12
TG 55:5; [M+Li]+; TG(16:1/19:0/20:4)	ME480552	0.99	1.02	0.99	0.91	1.12	0.76	0.69	1.19	1.02	0.98	1.40	0.92
TG 56:2; [M+Na]+; TG(16:0/18:1/22:1)	ME480584	0.99	1.10	1.00	1.02	1.05	0.98	0.68	1.06	0.97	1.05	1.36	0.73
MGDG 38:6; [M+Na]+; MGDG(18:2(2E,4E)/20:4(5E,8E,11E,14E))	ME479392	1.14	0.84	1.05	1.07	1.28	0.99	0.61	1.10	0.91	0.79	1.20	1.01
PC 41:2; [M+H]+; GPCho(19:0/22:2(13Z,16Z))	ME479845	1.22	0.69	0.96	1.17	1.30	0.80	0.67	1.34	0.91	0.82	1.26	0.85
PC 39:3; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/21:0)	ME479749	1.27	0.71	1.14	0.60	1.08	0.85	0.62	1.14	1.22	0.74	1.36	1.27
TG 52:2; [M+NH4]+; TG(16:1/18:0/18:1)	ME480375	1.08	0.97	0.89	0.69	1.38	1.03	0.92	1.25	1.19	0.65	1.00	0.96
TG 52:2; [M+NH4]+; TG(16:0/18:0/18:2)	ME480373	1.16	0.75	0.91	0.73	1.27	1.02	0.99	1.25	1.21	0.64	1.11	0.95
TG 52:2; [M+NH4]+; TG(16:0/18:1/18:1)	ME480374	1.06	0.79	0.90	0.67	1.36	1.02	0.93	1.43	1.22	0.65	1.03	0.95
PC 39:1; [M+Na]+; GPCho(22:1(13Z)/17:0)	ME479740	1.03	0.88	1.01	0.69	1.36	0.81	0.88	1.09	1.26	0.69	1.15	1.16
TG 51:3; [M+Li]+; TG(16:0/17:1/18:2)	ME480336	0.94	0.93	0.96	0.69	1.29	0.98	0.75	0.97	1.17	0.84	1.26	1.22
TG 53:2; [M+NH4]+; TG(16:0/18:2/19:0)	ME480415	0.16	1.66	1.95	1.58	0.61	1.43	0.09	2.08	0.29	0.81	0.49	0.85
TG 53:6; [M+Li]+; TG(17:1/18:2/18:3)	ME480434	0.55	1.37	1.45	1.21	0.79	1.33	0.48	1.84	0.49	1.02	0.49	1.00
PC 39:4; [M+Na]+; GPCho(18:4(6Z,9Z,12Z,15Z)/21:0)	ME479757	0.35	1.69	1.12	1.25	0.86	1.72	0.22	1.43	0.60	1.14	0.51	1.11
PC 39:4; [M+Na]+; GPCho(19:0/20:4(5E,8E,11E,14E))	ME479758	0.35	1.33	1.29	1.24	0.94	1.69	0.23	1.57	0.65	1.06	0.55	1.10
TG 48:1; [M+NH4]+; TG(14:0/16:1/18:0)	ME480282	0.42	1.36	1.72	0.93	0.82	1.87	0.52	1.34	0.62	0.68	0.66	1.06
PC 33:4; [M+Na]+; GPCho(11:0/22:4(7Z,10Z,13Z,16Z))	ME479574	0.30	1.93	1.74	1.40	0.88	1.86	0.37	1.10	0.50	0.50	0.52	0.91
PC 33:4; [M+Na]+; GPCho(9:0/24:4(5Z,8Z,11Z,14Z))	ME479575	0.44	1.66	1.65	1.27	0.95	1.47	0.40	1.24	0.56	0.50	0.72	1.13
PC 40:8; [M+H]+; GPCho(20:4(5E,8E,11E,14E)/20:4(5E,8E,11E,14E))	ME479829	0.81	1.14	1.59	0.72	0.43	0.67	0.53	2.31	0.85	0.98	0.78	1.19
TG 48:1; [M+NH4]+; TG(14:0/16:0/18:1)	ME480281	0.71	1.42	1.80	0.62	0.80	1.37	1.01	1.22	0.62	0.66	0.69	1.07
TG 50:2; [M+NH4]+; TG(16:0/16:0/18:2)	ME480308	0.49	1.14	2.05	0.94	0.80	0.96	0.62	1.60	0.70	1.04	0.73	0.91
PC 29:2; [M+Na]+; GPCho(15:1(9Z)/14:1(9Z))	ME479511	0.42	1.10	1.99	1.06	0.78	0.89	0.87	1.66	0.56	0.73	1.05	0.90
PC 29:2; [M+Na]+; GPCho(7:0/22:2(13Z,16Z))	ME479512	0.43	1.21	2.02	1.29	0.68	0.80	0.89	1.83	0.70	0.62	0.67	0.85
TG 51:1; [M+Li]+; TG(16:0/16:1/19:0)	ME480327	0.90	0.92	0.72	1.22	0.86	1.95	1.06	0.95	0.79	0.85	0.89	0.89
TG 44:1; [M+NH4]+; TG(14:0/16:1/14:0)	ME480268	1.14	1.05	1.06	1.54	0.75	1.29	0.80	0.63	0.97	1.04	1.11	0.62
PC 42:5; [M+H]+; GPCho(20:4(5Z,8Z,11Z,14Z)/22:1(13Z))	ME479890	0.89	1.00	0.96	1.65	1.05	1.66	0.90	0.77	1.04	0.68	0.81	0.60
TG 56:4; [M+NH4]+; TG(16:0/20:1/20:3)	ME480617	0.89	0.82	0.95	1.78	0.87	1.54	0.82	1.03	0.94	0.87	0.90	0.58
TG 56:3; [M+NH4]+; TG(16:0/18:0/22:3)	ME480600	0.66	0.95	0.80	1.53	0.88	2.34	0.68	1.59	0.70	0.72	0.67	0.49
TG 56:6; [M+Na]+; TG(16:0/20:3/20:3)	ME480634	0.64	1.09	0.90	1.62	0.71	1.90	0.85	1.53	0.66	0.76	0.82	0.53
PC 44:9; [M+H]+; GPCho(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME479944	0.71	1.60	1.13	1.18	0.88	1.62	0.75	1.73	0.52	0.77	0.48	0.63
TG 56:3; [M+NH4]+; TG(16:0/18:2/22:1)	ME480601	0.80	1.21	1.03	1.36	0.78	1.46	0.92	1.73	0.74	0.63	0.85	0.48
TG 56:7; [M+Na]+; TG(16:0/18:1/22:6)	ME480650	0.62	1.31	1.21	1.34	0.67	1.24	0.89	1.69	0.47	0.71	0.87	0.96
PA 38:0; [M+Na2-H]+; GPA(19:0/19:0)	ME479418	0.91	1.87	1.17	0.71	0.71	1.16	1.03	2.02	0.65	0.36	0.76	0.66
PA 40:0; [M+Na2-H]+; GPA(16:0/24:0)	ME479419	0.34	1.29	1.33	0.60	0.99	2.01	1.08	1.49	0.80	0.48	0.96	0.65
lysoPC 22:4; [M+H]+; PC(22:4(7Z,10Z,13Z,16Z)/0:0)	ME479366	0.55	2.39	1.05	1.06	0.68	0.65	0.47	0.57	0.78	1.24	0.59	1.98
PE 26:0; [M+H]+; GPEtn(8:0/18:0)	ME480002	1.27	1.78	0.53	0.79	1.35	0.88	1.04	1.23	0.77	0.39	0.61	1.37
PE 38:6; [M+H]+; GPEtn(18:2(2E,4E)/20:4(5E,8E,11E,14E))	ME480128	0.94	1.14	0.71	0.96	1.76	1.19	1.00	0.72	0.65	0.69	0.83	1.42
PC 36:3; [M+H]+; GPCho(16:0/20:3(5Z,8Z,11Z))	ME479630	1.54	2.33	0.68	1.01	0.81	0.60	0.34	0.50	1.29	1.54	0.63	0.73
PC 33:2; [M+H]+; GPCho(16:0/17:2(9Z,12Z))	ME479571	0.66	1.95	1.23	0.98	0.56	0.73	0.52	0.88	1.10	0.68	1.68	1.02
PE 36:2; [M+H]+; GPEtn(18:0/18:2(2E,4E))	ME480084	0.66	1.95	1.23	0.98	0.56	0.73	0.52	0.88	1.10	0.68	1.68	1.02
DG 40:1; [M+Li]+; DG(20:0/20:1/0:0)	ME479316	0.77	2.57	1.18	0.95	0.60	0.83	0.86	0.62	0.67	0.36	1.71	0.87
PE 32:3; [M+H]+; GPEtn(15:1(9Z)/17:2(9Z,12Z))	ME480031	0.68	2.40	1.06	0.66	1.16	0.84	0.52	0.69	0.87	0.39	1.90	0.83
lysoPC 26:2; [M+H]+; PC(26:2(5E,9Z)/0:0)	ME479374	0.63	2.51	1.14	0.76	0.96	0.62	1.27	0.81	0.88	0.49	1.48	0.46
PC 22:1; [M+H]+; GPCho(2:0/20:1(11E))	ME479440	0.72	2.59	0.87	0.40	0.93	0.62	1.33	1.17	0.76	0.56	1.23	0.83
TG 53:4; [M+Na]+; TG(17:0/18:2/18:2)	ME480425	0.72	2.27	0.91	0.64	1.05	0.72	0.96	0.89	1.00	0.67	1.27	0.89
DG 42:2; [M+NH4]+; DG(18:1/24:1/0:0)	ME479330	0.80	1.74	1.27	0.79	1.24	0.71	0.67	0.96	1.11	0.65	1.30	0.76
TG 52:4; [M+Na]+; TG(16:0/16:0/20:4)	ME480382	0.70	1.90	1.25	0.83	1.24	1.13	0.95	0.67	0.82	0.62	1.28	0.61
TG 52:4; [M+Na]+; TG(16:0/18:1/18:3)	ME480383	0.55	2.02	1.12	0.77	1.14	1.07	0.79	0.62	0.93	0.65	1.62	0.71
PC 27:3; [M+H]+; GPCho(7:0/20:3(5Z,8Z,11Z))	ME479484	1.04	1.78	1.63	0.88	1.13	0.59	0.87	0.68	0.69	0.65	1.39	0.66
PE 35:2; [M+H]+; GPEtn(17:0/18:2(2E,4E))	ME480069	0.82	1.97	1.70	0.85	0.86	0.46	0.80	0.88	0.87	0.75	1.44	0.61
DG 42:5; [M+NH4]+; DG(18:1/24:4/0:0)	ME479335	0.84	1.80	1.51	0.95	0.91	0.55	1.03	0.95	0.90	0.77	1.25	0.53
PE 34:2; [M+H]+; GPEtn(12:0/22:2(13Z,16Z))	ME480051	0.92	1.85	1.46	0.82	0.71	0.54	1.09	1.05	0.84	0.70	1.53	0.47
PC 27:3; [M+H]+; GPCho(9:0/18:3(6Z,9Z,12Z))	ME479485	0.62	1.91	1.32	0.62	1.29	0.74	1.37	0.84	0.96	0.75	1.01	0.57
PE 34:0; [M+H]+; GPEtn(9:0/25:0)	ME480050	1.00	2.00	1.49	0.69	0.99	0.80	1.42	0.63	0.78	0.55	1.07	0.58
PC 42:2; [M+Na]+; GPCho(16:0/26:2(5E,9Z))	ME479866	0.82	2.20	1.62	0.79	0.81	0.65	1.15	0.82	0.81	0.92	0.87	0.53
PC 25:0; [M+Na]+; GPCho(9:0/16:0)	ME479452	0.66	2.14	1.28	0.57	1.05	0.50	1.24	1.12	0.92	0.97	0.87	0.68
PE 38:2; [M+H]+; GPEtn(18:2(2E,4E)/20:0)	ME480112	0.60	2.14	1.36	0.71	1.00	0.59	0.95	1.09	0.82	0.85	1.15	0.75
PC 40:0; [M+Na]+; GPCho(14:0/26:0)	ME479772	0.66	2.52	1.32	0.44	1.46	0.62	1.04	0.68	0.86	1.05	0.85	0.51
DG 42:3; [M+NH4]+; DG(18:2/24:1/0:0)	ME479332	0.90	2.69	1.41	0.65	0.95	0.78	1.19	0.66	0.79	0.47	0.92	0.58
DG 42:4; [M+NH4]+; DG(20:3/22:1/0:0)	ME479334	0.70	3.34	1.33	0.65	0.74	0.68	1.05	0.79	0.72	0.56	0.87	0.57
lysoPC 20:0; [M+H]+; PC(P-20:0/0:0)	ME479360	1.01	2.50	0.63	0.62	0.92	0.46	0.98	0.87	1.19	0.97	1.09	0.76
MGDG 42:8; [M+Na]+; MGDG(20:4(5E,8E,11E,14E)/22:4(7Z,10Z,13Z,16Z))	ME479396	0.77	2.55	0.86	0.65	0.61	0.89	1.17	0.65	1.27	1.19	0.95	0.44
PC 38:3; [M+Na]+; GPCho(18:3(6Z,9Z,12Z)/20:0)	ME479711	1.19	2.30	0.50	0.69	0.96	1.14	1.14	0.52	0.88	1.06	0.73	0.90
TG 52:2; [M+Na]+; TG(16:1/18:0/18:1)	ME480371	1.54	2.50	0.49	0.64	0.63	0.92	1.03	0.68	0.82	1.11	1.17	0.47
DG 36:1; [M+NH4]+; DG(18:0/18:1/0:0)	ME479272	0.89	3.05	0.79	0.74	0.84	1.05	0.77	0.86	0.74	0.63	0.54	1.10
CE(18:1); [M+NH4]+; 18:1 Cholesteryl ester	ME479235	0.77	2.68	0.47	0.75	0.67	1.29	0.72	0.72	0.84	1.17	0.57	1.34
MGDG 38:7; [M+Na]+; MGDG(18:2(2E,4E)/20:5(5Z,8Z,11Z,14Z,17Z))	ME479393	0.67	2.69	0.83	0.69	0.77	1.43	0.76	0.92	0.66	1.18	0.47	0.93
TG 54:8; [M+Li]+; TG(16:1/18:3/20:4)	ME480498	0.39	1.94	0.90	0.80	0.63	1.21	1.16	1.11	0.74	1.07	1.23	0.82
TG 53:7; [M+NH4]+; TG(16:1/17:2/20:4)	ME480438	0.62	2.52	0.70	1.17	0.84	1.24	1.07	0.83	0.73	0.69	0.90	0.69
TG 51:4; [M+NH4]+; TG(16:0/17:1/18:3)	ME480352	0.66	2.42	0.89	1.22	0.70	1.03	1.10	1.08	0.58	0.89	0.80	0.63
TG 51:4; [M+NH4]+; TG(16:0/17:2/18:2)	ME480353	0.68	2.35	0.87	1.19	0.68	0.99	1.36	1.06	0.56	0.87	0.78	0.62
PE 36:2; [M+H]+; GPEtn(14:1(9Z)/22:1(13Z))	ME480081	0.76	2.48	1.15	0.81	0.62	0.87	0.78	1.28	0.93	0.97	0.74	0.61
PC 28:1; [M+H]+; GPCho(12:0/16:1(7Z))	ME479493	0.66	2.41	0.80	0.75	1.00	1.14	0.74	1.14	0.93	0.64	0.89	0.89
PC 28:1; [M+H]+; GPCho(4:0/24:1(15Z))	ME479494	0.66	2.54	0.79	0.74	1.01	1.14	0.74	1.05	0.93	0.64	0.88	0.89
DG 36:2; [M+NH4]+; DG(18:0/18:2/0:0)	ME479273	0.92	3.16	0.60	0.94	0.57	1.01	0.51	0.82	0.75	1.05	0.89	0.78
TG 53:7; [M+NH4]+; TG(17:1/18:3/18:3)	ME480439	0.88	2.96	0.72	1.13	0.64	0.98	0.91	0.78	0.67	0.67	1.17	0.49
PC 42:2; [M+Na]+; GPCho(20:1(11E)/22:1(13Z))	ME479868	0.55	3.06	0.84	0.66	0.66	0.86	0.92	0.91	0.79	1.35	0.79	0.59
DG 36:4; [M+NH4]+; DG(16:0/20:4/0:0)	ME479277	0.50	2.86	0.98	0.47	1.10	0.62	0.87	1.05	0.96	1.10	0.93	0.55
PE 28:2; [M+H]+; GPEtn(2:0/26:2(5E,9Z))	ME480018	0.50	2.64	0.88	0.76	1.02	0.84	0.95	0.92	0.89	1.21	0.68	0.71
PC 41:0; [M+H]+; GPCho(26:0/15:0)	ME479836	0.61	2.76	1.46	1.06	0.89	0.95	0.61	0.96	0.61	0.72	0.71	0.68
TG 51:1; [M+Li]+; TG(16:0/17:0/18:1)	ME480328	0.99	2.53	1.02	0.95	0.94	0.83	0.62	0.55	0.71	1.00	0.99	0.87
PC 36:1; [M+Na]+; GPCho(17:1(9Z)/19:0)	ME479625	0.71	2.70	1.02	0.99	0.70	0.86	0.78	0.85	0.60	1.32	0.62	0.85
PC 37:6; [M+H]+; GPCho(17:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))	ME479688	0.61	2.86	1.43	0.85	0.73	0.62	0.59	0.65	0.83	1.29	0.77	0.76
PC 39:6; [M+H]+; GPCho(17:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))	ME479765	0.58	1.43	0.48	1.53	0.58	0.83	0.42	0.52	1.12	1.32	1.98	1.23
PC 37:4; [M+H]+; GPCho(17:0/20:4(5E,8E,11E,14E))	ME479677	0.42	1.91	0.84	0.99	0.59	1.13	0.54	0.65	1.24	1.73	1.12	0.84
PE 34:2; [M+H]+; GPEtn(14:1(9Z)/20:1(11E))	ME480052	0.72	1.75	0.69	1.04	0.71	0.99	0.88	0.58	1.44	1.68	1.16	0.37
PC 35:2; [M+Na]+; GPCho(13:0/22:2(13Z,16Z))	ME479613	0.48	1.43	0.58	0.89	0.60	1.30	0.52	1.00	1.31	1.29	1.57	1.02
PC 35:2; [M+Na]+; GPCho(17:0/18:2(2E,4E))	ME479617	0.47	1.33	0.91	0.85	0.60	0.94	0.44	0.89	1.65	1.86	1.40	0.64
PC 37:4; [M+H]+; GPCho(17:1(9Z)/20:3(5Z,8Z,11Z))	ME479679	0.49	1.38	0.82	0.96	1.09	1.15	0.32	0.79	1.48	1.53	1.32	0.68
TG 56:9; [M+NH4]+; TG(16:0/20:4/20:5)	ME480672	0.82	2.39	0.62	0.70	0.85	1.01	0.75	0.99	0.72	1.77	0.49	0.89
PA 35:1; [M+Na2-H]+; GPA(9:0/26:1(5Z))	ME479415	0.74	2.12	0.58	0.97	0.64	0.67	0.84	0.66	0.85	1.96	0.75	1.23
TG 56:7; [M+NH4]+; TG(16:1/18:1/22:5)	ME480654	0.98	2.29	0.43	0.98	0.80	0.89	0.64	0.50	0.84	2.11	0.48	1.07
TG 56:1; [M+Na]+; TG(18:0/18:1/20:0)	ME480579	0.61	2.27	1.17	1.22	0.51	1.06	0.56	0.85	0.59	1.49	0.62	1.04
PC 36:7; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))	ME479649	0.97	2.27	0.82	1.03	0.57	1.00	0.72	0.97	0.63	1.32	0.59	1.10
PC 34:6; [M+H]+; GPCho(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))	ME479599	0.97	1.94	1.02	0.91	0.54	1.24	0.82	0.86	0.77	1.42	0.75	0.75
PE 35:1; [M+H]+; GPEtn(9:0/26:1(5Z))	ME480067	0.86	2.03	0.93	0.94	0.85	1.16	0.90	0.89	0.74	1.30	0.72	0.67
PE 33:0; [M+H]+; GPEtn(11:0/22:0)	ME480033	0.90	2.09	0.77	1.09	0.69	1.43	0.81	0.70	0.77	1.31	0.64	0.82
PE 33:0; [M+H]+; GPEtn(26:0/7:0)	ME480037	0.89	2.16	0.76	1.09	0.67	1.44	0.78	0.68	0.76	1.33	0.66	0.80
PC 34:4; [M+Na]+; GPCho(16:1(7Z)/18:3(6Z,9Z,12Z))	ME479595	1.02	2.21	0.80	0.93	0.69	1.19	0.58	0.63	0.72	1.54	0.68	1.01
PC 36:7; [M+H]+; GPCho(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479648	1.03	2.17	0.82	0.94	0.70	1.19	0.62	0.65	0.73	1.44	0.70	1.00
DG 42:7; [M+Li]+; DG(20:3/22:4/0:0)	ME479339	0.93	2.06	0.75	1.57	0.65	0.91	0.41	0.68	0.84	1.80	0.46	0.93
PE 33:2; [M+H]+; GPEtn(15:0/18:2(2E,4E))	ME480044	0.98	1.81	0.89	1.56	0.63	0.90	0.57	0.69	0.75	1.58	0.48	1.17
PC 36:5; [M+H]+; GPCho(18:1(11Z)/18:4(6Z,9Z,12Z,15Z))	ME479641	0.70	1.86	0.66	1.24	0.58	1.10	0.41	0.73	1.10	1.62	0.85	1.14
PE 22:0; [M+H]+; GPEtn(4:0/18:0)	ME479990	0.68	2.08	0.60	1.41	0.74	0.83	0.49	0.67	0.94	1.76	0.78	1.04
TG 53:3; [M+Na]+; TG(17:0/18:1/18:2)	ME480421	0.87	1.80	0.60	0.97	0.92	1.15	0.74	0.71	0.91	1.60	0.70	1.01
TG 56:6; [M+Li]+; TG(16:0/20:3/20:3)	ME480632	0.81	1.86	0.53	0.99	0.76	1.18	0.54	0.93	0.73	1.83	0.91	0.94
PC 40:5; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/22:2(13Z,16Z))	ME479817	0.85	1.93	0.52	1.29	0.79	1.36	0.64	0.67	0.80	1.46	0.89	0.81
DG 40:6; [M+NH4]+; DG(18:2/22:4/0:0)	ME479324	0.73	1.90	0.74	1.34	0.95	1.21	0.54	0.85	0.68	1.27	0.62	1.17
plasmenyl-PE 38:3; [M+H]+; PE(P-18:0/20:3(5Z,8Z,11Z))	ME480203	0.88	1.95	0.65	1.34	0.68	1.17	0.51	0.58	0.86	1.49	0.70	1.18
TG 56:7; [M+Li]+; TG(16:0/20:3/20:4)	ME480647	0.91	1.84	0.57	1.18	0.93	1.17	0.40	0.72	0.76	1.67	0.70	1.14
PC 36:5; [M+H]+; GPCho(16:1(7Z)/20:4(5E,8E,11E,14E))	ME479640	0.83	2.62	0.58	1.38	0.69	1.37	0.39	0.57	0.75	0.95	0.93	0.94
TG 56:6; [M+NH4]+; TG(16:0/20:2/20:4)	ME480639	0.50	2.51	0.40	1.48	0.60	1.91	0.39	0.36	0.68	1.56	0.56	1.05
PC 42:9; [M+Na]+; GPCho(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479915	0.64	2.68	0.35	1.29	0.49	1.53	0.24	0.43	0.55	1.88	0.42	1.49
TG 54:3; [M+NH4]+; TG(16:0/16:0/22:3)	ME480465	0.51	2.95	0.53	1.21	0.51	1.59	0.42	0.61	0.55	1.39	0.53	1.21
TG 52:3; [M+Na]+; TG(16:0/18:0/18:3)	ME480376	0.69	2.38	0.47	1.48	0.61	1.54	0.34	0.63	0.52	1.45	0.51	1.39
TG 53:4; [M+NH4]+; TG(16:0/17:0/20:4)	ME480427	0.55	2.73	0.59	1.39	0.53	1.25	0.29	0.79	0.61	1.65	0.54	1.07
TG 54:3; [M+NH4]+; TG(16:0/18:2/20:1)	ME480468	0.58	2.54	0.52	1.29	0.54	1.53	0.42	0.58	0.69	1.60	0.55	1.14
TG 54:3; [M+NH4]+; TG(17:1/18:2/19:0)	ME480471	0.57	2.54	0.60	1.29	0.52	1.52	0.41	0.56	0.70	1.62	0.54	1.14
PE 36:3; [M+H]+; GPEtn(14:1(9Z)/22:2(13Z,16Z))	ME480085	0.88	2.74	0.48	1.01	0.61	1.02	0.58	0.43	0.81	1.70	0.75	1.00
PE 37:2; [M+H]+; GPEtn(11:0/26:2(5E,9Z))	ME480101	0.87	2.57	0.43	1.08	0.62	1.06	0.73	0.63	0.76	1.65	0.62	0.97
plasmenyl-PE 42:4; [M+H]+; PE(P-20:0/22:4(7Z,10Z,13Z,16Z))	ME480213	0.87	2.42	0.59	1.01	0.72	1.05	0.69	0.65	0.72	1.53	0.70	1.04
PE 41:6; [M+H]+; GPEtn(19:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480158	0.80	2.32	0.43	1.03	0.70	1.12	0.60	0.63	0.78	1.77	0.65	1.18
TG 56:8; [M+NH4]+; TG(18:1/18:2/20:5)	ME480666	0.86	2.50	0.45	1.06	0.68	0.93	0.52	0.59	0.96	1.60	0.65	1.20
TG 56:8; [M+NH4]+; TG(18:2/18:2/20:4)	ME480668	0.88	2.54	0.45	1.05	0.67	0.94	0.52	0.57	0.91	1.63	0.66	1.19
TG 51:6; [M+NH4]+; TG(16:1/17:2/18:3)	ME480361	0.94	2.42	0.47	1.00	0.64	1.21	0.69	0.52	0.91	1.44	0.87	0.90
TG 50:2; [M+Na]+; TG(16:0/16:0/18:2)	ME480305	0.94	2.50	0.49	1.00	0.63	1.23	0.63	0.45	0.86	1.45	0.91	0.92
TG 50:2; [M+Na]+; TG(16:0/16:1/18:1)	ME480306	0.93	2.59	0.47	0.99	0.62	1.22	0.62	0.44	0.85	1.47	0.89	0.91
PC 35:2; [M+Na]+; GPCho(17:1(9Z)/18:1(11E))	ME479618	0.80	2.11	0.79	1.20	0.66	1.14	0.56	0.65	0.82	1.40	0.95	0.92
PC 35:2; [M+Na]+; GPCho(15:1(9Z)/20:1(11E))	ME479616	0.72	2.47	0.68	1.19	0.60	1.18	0.55	0.57	0.80	1.38	0.91	0.94
PC 37:5; [M+H]+; GPCho(15:1(9Z)/22:4(7Z,10Z,13Z,16Z))	ME479684	0.72	2.47	0.68	1.19	0.60	1.18	0.55	0.57	0.80	1.38	0.91	0.94
PC 34:2; [M+Na]+; GPCho(8:0/26:2(5E,9Z))	ME479587	0.63	2.22	0.48	1.35	0.58	1.32	0.43	0.63	0.75	1.55	0.91	1.15
PC 34:2; [M+Na]+; GPCho(16:1(7Z)/18:1(11E))	ME479585	0.77	2.22	0.40	1.40	0.61	1.24	0.42	0.51	0.94	1.52	0.90	1.08
PC 36:5; [M+H]+; GPCho(16:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME479639	0.76	2.15	0.39	1.40	0.56	1.35	0.39	0.55	0.95	1.51	0.91	1.08
plasmenyl-PC 35:1; [M+Na]+; PC(P-20:0/15:1(9Z))	ME480178	0.77	2.33	0.66	1.38	0.56	1.26	0.43	0.52	0.93	1.37	0.76	1.03
plasmenyl-PE 38:4; [M+H]+; PE(P-16:0/22:4(7Z,10Z,13Z,16Z))	ME480204	0.82	2.19	0.59	1.59	0.74	1.23	0.47	0.52	0.94	1.30	0.70	0.92
plasmenyl-PE 34:1; [M+H]+; PE(P-16:0/18:1(11E))	ME480193	0.56	2.27	0.74	1.35	0.64	1.18	0.76	0.66	0.72	1.60	0.63	0.88
TG 53:0; [M+Li]+; TG(17:0/18:0/18:0)	ME480402	0.70	2.26	0.67	1.17	0.73	1.32	0.43	0.80	0.67	1.52	0.65	1.08
TG 54:4; [M+NH4]+; TG(17:1/18:3/19:0)	ME480478	0.53	2.22	0.59	1.30	0.61	1.52	0.41	0.74	0.62	1.60	0.79	1.07
PC 33:0; [M+H]+; GPCho(9:0/24:0)	ME479567	0.66	2.47	0.51	1.20	0.54	1.46	0.56	0.36	0.56	2.17	0.73	0.77
TG 53:3; [M+Li]+; TG(16:0/18:3/19:0)	ME480420	0.43	2.95	0.64	1.03	0.70	1.17	0.57	0.61	0.55	1.94	0.52	0.89
CE(18:3); [M+NH4]+; 18:3 Cholesteryl ester	ME479237	0.73	2.78	0.55	1.05	0.59	1.12	0.34	0.81	0.63	1.85	0.43	1.11
PC 32:0; [M+Na]+; GPCho(13:0/19:0)	ME479556	0.73	2.56	0.49	1.15	0.54	1.08	0.51	0.57	0.82	1.96	0.60	1.00
PC 38:2; [M+Na]+; GPCho(12:0/26:2(5E,9Z))	ME479703	0.67	2.67	0.54	1.27	0.55	1.36	0.51	0.50	0.66	1.77	0.68	0.82
PC 38:2; [M+Na]+; GPCho(18:2(2E,4E)/20:0)	ME479704	0.65	2.58	0.83	1.11	0.66	1.18	0.49	0.60	0.67	1.72	0.60	0.91
PC 40:5; [M+H]+; GPCho(18:4(9E,11E,13E,15E)/22:1(13Z))	ME479819	0.66	2.72	0.67	1.14	0.63	1.27	0.44	0.56	0.61	1.79	0.60	0.92
TG 54:4; [M+NH4]+; TG(16:1/18:2/20:1)	ME480477	0.95	1.49	0.97	1.15	0.74	0.66	0.54	0.84	0.75	2.02	1.12	0.78
DG 32:3; [M+NH4]+; DG(14:1/18:2/0:0)	ME479250	0.40	1.68	1.13	1.44	0.56	1.05	0.32	0.96	0.77	2.24	0.42	1.04
TG 56:6; [M+NH4]+; TG(16:0/18:0/22:6)	ME480636	0.59	1.16	1.06	1.40	0.80	0.91	0.41	1.29	0.74	2.03	0.66	0.96
TG 56:6; [M+NH4]+; TG(18:0/18:2/20:4)	ME480642	0.59	1.27	1.08	0.95	0.78	0.93	0.40	1.32	0.76	2.21	0.69	1.01
TG 55:1; [M+Na]+; TG(16:0/19:0/20:1)	ME480516	0.47	1.87	0.55	1.47	0.57	1.79	0.57	0.65	0.57	1.81	0.62	1.07
TG 56:6; [M+NH4]+; TG(18:2/18:3/20:1)	ME480645	0.48	1.53	0.49	1.54	0.62	1.84	0.36	0.64	0.63	2.17	0.54	1.16
DG 37:5; [M+Li]+; DG(17:0/20:5/0:0)	ME479285	0.90	2.00	0.48	1.37	0.66	1.32	0.25	0.74	0.68	1.97	0.66	0.95
TG 54:2; [M+Na]+; TG(18:0/18:0/18:2)	ME480455	0.45	2.14	0.65	1.39	0.72	1.52	0.17	0.69	0.60	2.12	0.43	1.11
TG 56:3; [M+Na]+; TG(16:0/20:0/20:3)	ME480596	0.51	1.87	0.68	1.65	0.76	1.22	0.23	0.70	0.60	2.00	0.67	1.10
PC 35:3; [M+H]+; GPCho(17:2(9Z,12Z)/18:1(11E))	ME479620	0.76	1.28	0.84	1.15	0.47	1.42	0.67	0.64	0.78	1.85	0.54	1.62
PE 40:0; [M+H]+; GPEtn(14:0/26:0)	ME480140	0.99	1.53	0.55	1.34	0.69	1.29	0.50	0.63	0.85	1.48	0.66	1.49
TG 51:0; [M+Li]+; TG(16:0/16:0/19:0)	ME480324	0.67	1.47	0.79	1.33	0.98	1.36	0.71	1.12	0.58	1.48	0.66	0.84
DG 36:4; [M+NH4]+; DG(18:1/18:3/0:0)	ME479278	0.92	1.24	0.70	1.41	0.81	1.34	0.30	0.95	0.80	1.73	0.84	0.98
PC 30:4; [M+H]+; GPCho(24:4(5Z,8Z,11Z,14Z)/6:0)	ME479533	0.70	1.10	1.03	1.32	0.75	1.63	0.57	1.08	0.74	1.24	1.03	0.82
DG 35:4; [M+NH4]+; DG(17:2/18:2/0:0)	ME479267	0.80	1.25	0.94	1.29	0.87	1.36	0.35	1.22	0.92	1.25	0.78	0.96
TG 54:4; [M+NH4]+; TG(16:1/18:0/20:3)	ME480475	0.59	1.25	0.82	1.25	0.89	1.38	0.40	1.05	0.93	1.51	1.02	0.91
TG 50:2; [M+NH4]+; TG(16:0/16:1/18:1)	ME480309	0.48	2.12	0.88	1.12	0.93	1.36	0.28	1.27	0.71	1.36	0.56	0.95
TG 52:3; [M+NH4]+; TG(17:1/17:1/18:1)	ME480381	0.68	1.79	0.76	1.12	0.81	1.33	0.39	1.06	0.67	1.77	0.62	1.02
TG 56:3; [M+Na]+; TG(18:0/18:0/20:3)	ME480597	0.44	1.56	0.73	1.33	0.82	1.44	0.26	0.97	0.66	1.88	0.79	1.12
TG 56:3; [M+Na]+; TG(18:0/18:2/20:1)	ME480598	0.44	1.71	0.76	1.41	0.85	1.36	0.24	0.89	0.63	1.81	0.82	1.08
PC 42:0; [M+H]+; GPCho(20:0/22:0)	ME479863	0.48	1.67	0.95	1.07	0.91	1.39	0.45	0.91	0.63	1.50	0.66	1.38
TG 55:6; [M+NH4]+; TG(16:0/17:1/22:5)	ME480559	0.53	1.34	1.16	1.29	0.97	1.38	0.26	1.05	0.62	1.54	0.67	1.19
TG 56:5; [M+NH4]+; TG(18:2/18:2/20:1)	ME480629	1.32	0.70	0.85	1.26	1.22	1.60	0.43	0.46	0.98	0.97	0.91	1.29
PC 38:4; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/20:1(13E))	ME479712	1.18	1.40	0.64	1.07	0.65	0.95	0.45	0.48	1.33	1.45	1.07	1.33
PE 40:10; [M+H]+; GPEtn(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480143	1.44	1.31	0.69	1.08	0.66	0.95	0.52	0.71	1.06	1.22	1.09	1.27
PC 39:1; [M+Na]+; GPCho(17:1(9Z)/22:0)	ME479737	0.99	0.88	0.53	1.22	0.92	1.04	0.60	0.65	1.35	1.18	0.96	1.70
PC 42:11; [M+H]+; GPCho(20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479864	0.97	1.06	0.43	1.24	0.76	1.22	0.51	0.59	1.26	1.37	0.82	1.78
PC 39:0; [M+Na]+; GPCho(17:0/22:0)	ME479730	1.49	1.02	0.42	1.12	0.78	1.23	0.50	0.56	1.09	1.26	0.99	1.54
PC 41:3; [M+H]+; GPCho(15:1(9Z)/26:2(5E,9Z))	ME479848	1.59	0.68	0.51	1.07	0.90	1.10	0.58	0.64	1.19	0.98	1.20	1.55
DG 27:0; [M+NH4]+; DG(9:0/18:0/0:0)	ME479244	1.11	2.47	0.85	1.02	0.62	0.95	0.73	0.90	1.04	0.34	1.12	0.85
lysoPE 20:0; [M+Na]+; PE(20:0/0:0)	ME479377	0.90	2.03	0.66	1.32	0.69	0.77	1.13	0.57	1.34	0.53	0.94	1.11
PC 35:2; [M+Na]+; GPCho(17:2(9Z,12Z)/18:0)	ME479619	0.44	2.15	0.52	0.84	0.74	1.14	0.48	0.94	1.22	1.16	1.41	0.95
PE 30:1; [M+H]+; GPEtn(14:0/16:1(7Z))	ME480022	0.56	2.19	0.63	0.91	0.92	0.90	0.51	0.77	1.20	1.17	1.26	0.98
PC 36:0; [M+Na]+; GPCho(12:0/24:0)	ME479624	0.52	1.80	0.94	1.08	0.83	0.83	0.53	0.53	0.85	1.45	1.21	1.43
MG 21:0; [M+Li]+; MG(21:0/0:0/0:0)	ME479379	0.71	1.85	0.68	1.12	0.88	0.89	0.79	0.79	0.83	0.89	1.12	1.46
PE 16:0; [M+H]+; GPEtn(7:0/9:0)	ME479964	0.88	2.09	0.51	1.02	0.70	1.09	0.61	1.02	1.00	0.90	0.77	1.40
SM 35:1; [M]+; SM(d15:1(4E)/20:0)	ME480229	0.71	1.89	0.56	0.82	0.88	1.08	0.58	1.42	1.42	0.63	0.87	1.14
SM 33:0; [M]+; SM(d15:0/18:0)	ME480224	0.61	1.52	0.87	0.47	1.27	1.11	0.73	1.29	1.39	0.61	1.09	1.04
PC 19:2; [M+H]+; GPCho(2:0/17:2(9Z,12Z))	ME479432	0.59	1.57	0.76	0.60	1.08	0.81	1.05	1.42	0.96	0.85	0.99	1.32
PE 16:0; [M+H]+; GPEtn(13:0/3:0)	ME479963	0.68	1.75	0.68	0.68	0.92	1.24	0.79	1.32	0.93	0.80	1.03	1.19
PC 21:0; [M+Na]+; GPCho(9:0/12:0)	ME479439	0.70	2.04	0.97	1.06	0.92	0.75	0.68	1.16	1.08	0.28	1.00	1.36
PC 19:0; [M+H]+; GPCho(2:0/17:0)	ME479430	0.53	2.32	0.69	0.66	0.53	0.73	0.90	1.04	1.11	0.57	1.36	1.56
PE 24:1; [M+H]+; GPEtn(2:0/22:1(13Z))	ME479998	0.66	2.15	0.79	0.54	1.07	0.82	1.08	1.21	1.01	0.42	1.01	1.25
PE 26:1; [M+H]+; GPEtn(6:0/20:1(11E))	ME480003	0.43	2.47	0.71	0.67	0.81	0.73	0.92	1.40	0.88	0.49	1.11	1.38
PC 19:2; [M+H]+; GPCho(17:2(9Z,12Z)/2:0)	ME479431	1.27	1.03	1.20	1.84	0.91	0.83	0.69	0.55	0.97	0.69	1.09	0.92
PC 36:4; [M+Na]+; GPCho(16:0/20:4(5E,8E,11E,14E))	ME479635	1.13	1.02	1.22	1.77	0.64	0.80	0.51	0.77	1.05	1.40	0.62	1.07
PC 38:7; [M+H]+; GPCho(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))	ME479720	1.20	1.21	1.26	1.71	0.69	0.87	0.46	0.74	1.15	1.22	0.51	0.98
PC 37:4; [M+H]+; GPCho(13:0/24:4(5Z,8Z,11Z,14Z))	ME479675	0.51	0.92	1.19	1.79	0.82	1.03	0.65	0.71	0.76	1.53	1.30	0.79
PC 37:4; [M+H]+; GPCho(17:0/20:4(7E,10E,13E,16E))	ME479678	0.46	1.32	1.11	1.58	0.84	1.10	0.58	0.78	0.70	1.41	1.36	0.75
PC 33:4; [M+H]+; GPCho(13:0/20:4(5E,8E,11E,14E))	ME479573	0.67	1.29	1.07	1.66	0.68	0.65	1.30	0.53	0.92	1.19	0.87	1.16
PE 36:4; [M+H]+; GPEtn(18:1(11E)/18:3(6Z,9Z,12Z))	ME480088	0.67	1.05	1.25	1.28	0.72	0.67	1.17	0.56	0.83	1.48	1.29	1.02
PC 37:3; [M+H]+; GPCho(17:0/20:3(5Z,8Z,11Z))	ME479674	0.62	1.72	0.85	1.70	0.78	0.94	0.60	1.01	1.03	1.11	0.84	0.78
PE 36:2; [M+H]+; GPEtn(17:2(9Z,12Z)/19:0)	ME480083	0.55	1.77	1.01	1.80	1.11	0.94	0.51	0.63	1.13	0.72	1.00	0.84
PC 32:0; [M+H]+; GPCho(9:0/23:0)	ME479553	1.14	1.48	0.62	1.27	0.82	1.33	0.37	0.61	1.48	1.02	0.54	1.30
DG 34:0; [M+Li]+; DG(14:0/20:0/0:0)	ME479254	0.82	1.64	0.82	1.91	0.65	0.99	0.56	0.62	1.12	0.87	0.62	1.38
MGDG 25:2; [M+Na]+; MGDG(3:0/22:2(13Z,16Z))	ME479386	0.84	2.03	0.58	1.46	0.58	1.14	0.40	0.46	1.16	1.09	0.77	1.49
DG 36:3; [M+NH4]+; DG(16:0/20:3/0:0)	ME479275	1.65	1.56	1.03	0.85	0.67	1.54	0.65	0.68	0.89	0.77	0.95	0.77
TG 53:6; [M+NH4]+; TG(17:1/18:2/18:3)	ME480436	1.54	1.82	0.59	1.38	0.63	1.20	0.90	0.68	0.69	1.05	0.91	0.60
DG 37:6; [M+NH4]+; DG(15:0/22:6/0:0)	ME479287	1.34	1.82	0.84	1.08	0.18	0.81	0.70	1.05	1.07	1.04	0.94	1.13
PC 38:7; [M+H]+; GPCho(16:1(7Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479719	1.63	1.33	1.49	1.03	0.36	1.07	0.55	0.94	0.78	1.27	0.62	0.93
MGDG 44:9; [M+Na]+; MGDG(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME479398	0.54	1.65	0.87	1.03	1.40	1.53	1.17	0.81	0.63	0.81	1.02	0.54
SM 39:5; [M]+; SM(d15:1(4E)/24:4(5Z,8Z,11Z,14Z))	ME480236	0.77	1.91	1.13	1.22	1.45	1.32	0.58	0.58	0.51	0.89	0.92	0.71
PC 31:2; [M+H]+; GPCho(5:0/26:2(5E,9Z))	ME479546	1.05	1.71	0.78	1.02	0.90	1.74	0.58	0.35	1.28	0.93	0.91	0.74
PE 38:4; [M+Na]+; GPEtn(18:0/20:4(5E,8E,11E,14E))	ME480121	0.53	1.59	0.99	1.08	1.07	1.33	0.66	0.52	0.89	1.40	1.06	0.88
TG 50:1; [M+NH4]+; TG(16:0/16:0/18:1)	ME480302	0.79	1.70	0.65	0.75	1.04	1.67	0.56	0.75	0.93	1.45	0.89	0.82
TG 42:0; [M+NH4]+; TG(12:0/14:0/16:0)	ME480265	0.67	1.98	0.65	1.04	1.48	0.73	0.74	0.72	0.64	1.31	0.87	1.17
DG 40:4; [M+NH4]+; DG(18:0/22:4/0:0)	ME479320	0.69	1.34	1.04	0.87	1.51	0.81	0.94	1.20	0.63	1.05	1.27	0.66
TG 54:7; [M+Na]+; TG(18:1/18:3/18:3)	ME480493	1.01	1.56	0.96	0.73	1.59	0.62	0.80	0.93	0.78	1.22	1.00	0.79
plasmenyl-PC 22:0; [M+Na]+; PC(P-18:0/4:0)	ME480176	0.53	1.50	1.46	0.63	0.95	0.86	0.77	0.86	0.96	1.39	0.75	1.32
TG 55:8; [M+NH4]+; TG(17:1/18:2/20:5)	ME480571	0.51	1.67	1.12	0.77	1.01	0.96	0.91	0.91	0.72	1.08	0.77	1.55
PC 31:2; [M+H]+; GPCho(14:0/17:2(9Z,12Z))	ME479544	0.68	1.41	1.24	0.78	0.52	1.64	0.74	0.76	0.87	1.14	0.98	1.25
PE 38:4; [M+H]+; GPEtn(18:3(6Z,9Z,12Z)/20:1(11E))	ME480118	0.62	1.46	1.06	0.32	1.08	1.30	0.86	0.96	1.21	1.20	0.86	1.06
TG 49:2; [M+Li]+; TG(16:0/16:1/17:1)	ME480293	0.84	1.81	0.87	0.59	0.80	1.46	1.09	0.86	1.07	1.02	0.50	1.09
PC 38:0; [M+Na]+; GPCho(19:0/19:0)	ME479692	0.94	1.83	0.78	0.62	0.92	0.80	0.66	1.27	1.06	1.37	1.06	0.68
TG 55:4; [M+NH4]+; TG(16:0/19:0/20:4)	ME480545	0.81	1.74	0.78	0.96	0.60	1.08	0.61	1.60	0.77	1.40	0.72	0.94
TG 54:7; [M+Na]+; TG(18:2/18:2/18:3)	ME480494	0.71	1.53	1.37	1.37	0.71	0.92	0.97	0.57	1.13	1.37	0.68	0.68
PE 35:2; [M+H]+; GPEtn(15:1(9Z)/20:1(11E))	ME480068	0.52	1.51	1.31	1.03	0.84	0.68	0.91	0.73	1.26	1.26	1.21	0.72
PE 37:4; [M+H]+; GPEtn(17:0/20:4(5E,8E,11E,14E))	ME480107	0.54	1.52	1.16	0.94	0.91	0.82	0.76	0.72	1.15	1.55	0.94	0.99
PC 32:0; [M+Na]+; GPCho(12:0/20:0)	ME479555	0.71	1.66	1.01	1.09	1.17	0.85	0.63	0.73	1.23	1.09	1.16	0.67
PC 32:0; [M+Na]+; GPCho(16:0/16:0)	ME479557	0.59	1.83	1.00	0.76	1.05	0.86	0.69	0.73	1.41	1.11	1.17	0.80
lysoPC 24:4; [M+H]+; PC(24:4(5Z,8Z,11Z,14Z)/0:0)	ME479370	0.57	1.87	1.27	1.06	0.95	0.77	0.74	0.67	1.20	1.16	0.78	0.96
PC 36:6; [M+H]+; GPCho(18:2(2E,4E)/18:4(6Z,9Z,12Z,15Z))	ME479645	0.61	2.15	1.13	0.84	0.92	0.66	0.80	0.57	1.33	1.19	1.00	0.79
PE 35:0; [M+H]+; GPEtn(16:0/19:0)	ME480061	1.11	1.64	1.22	0.68	1.12	0.88	1.40	0.96	1.07	0.76	0.68	0.49
SM 39:0; [M]+; SM(d15:0/24:0)	ME480233	1.09	1.44	1.02	0.86	0.87	0.86	1.69	0.79	0.84	0.94	0.85	0.74
TG 52:1; [M+NH4]+; TG(16:0/16:0/20:1)	ME480368	1.39	1.65	0.75	0.86	0.73	1.05	1.34	0.89	0.83	0.97	0.68	0.85
PC 26:1; [M+H]+; GPCho(6:0/20:1(11E))	ME479463	1.28	1.87	0.98	0.70	0.85	1.04	0.75	0.70	1.51	0.73	0.91	0.66
PC 36:2; [M+H]+; GPCho(18:1(11E)/18:1(11E))	ME479626	0.76	2.17	1.05	0.73	0.99	1.02	0.85	0.88	1.31	0.80	0.88	0.56
TG 50:5; [M+Na]+; TG(16:1/16:1/18:3)	ME480322	1.48	2.13	0.72	0.92	0.94	1.11	0.88	0.81	0.62	0.98	0.74	0.68
TG 56:7; [M+NH4]+; TG(16:1/18:2/22:4)	ME480655	1.34	2.35	0.68	0.94	0.92	0.88	0.65	0.83	0.86	0.89	0.85	0.82
PS 9:0; [M+Na]+; GPSer(2:0/7:0)	ME480215	1.08	2.19	1.15	0.67	0.79	1.04	0.73	0.80	0.91	0.87	0.95	0.82
PC 26:0; [M+Na]+; GPCho(2:0/24:0)	ME479459	1.29	1.90	1.09	0.79	0.84	0.80	0.86	1.04	0.89	0.75	0.89	0.85
PC 30:0; [M+Na]+; GPCho(10:0/20:0)	ME479517	1.35	1.97	1.00	0.81	0.79	0.96	0.67	0.91	0.90	1.09	0.73	0.83
PC 20:0; [M+H]+; GPCho(7:0/13:0)	ME479437	0.86	2.18	0.93	0.95	0.94	0.81	0.78	0.93	1.00	0.87	0.82	0.94
PC 40:3; [M+H]+; GPCho(18:1(11E)/22:2(13Z,16Z))	ME479797	0.95	2.11	0.81	0.77	0.80	0.64	1.03	1.20	1.00	1.07	0.78	0.85
SM 44:2; [M+Na]+; SM(d18:1(4E)/26:1(17Z))	ME480262	0.89	2.37	0.75	0.82	0.91	0.75	0.90	0.96	0.74	1.21	0.82	0.87
PC 39:3; [M+H]+; GPCho(21:0/18:3(6Z,9Z,12Z))	ME479752	1.07	1.85	0.74	1.07	0.85	0.75	0.71	0.84	0.76	1.10	1.25	1.02
DG 34:2; [M+NH4]+; DG(16:1/18:1/0:0)	ME479257	1.00	1.99	1.01	1.07	0.72	0.54	1.01	0.83	0.84	1.09	0.94	0.97
TG 51:4; [M+NH4]+; TG(16:1/17:2/18:1)	ME480355	1.19	1.99	0.73	1.07	0.75	0.73	0.93	0.74	0.92	1.28	0.79	0.89
PE 34:3; [M+H]+; GPEtn(16:1(7Z)/18:2(2E,4E))	ME480056	0.86	1.95	1.02	1.12	1.09	1.03	0.75	0.73	0.72	0.88	0.66	1.20
PC 40:0; [M+H]+; GPCho(15:0/25:0)	ME479768	1.03	1.34	1.10	0.94	1.10	1.00	1.12	0.60	0.75	0.81	0.97	1.24
PE 36:0; [M+H]+; GPEtn(16:0/20:0)	ME480075	0.91	1.51	0.98	1.04	1.03	1.01	0.98	0.85	0.71	1.04	0.82	1.12
PE 38:4; [M+H]+; GPEtn(16:0/22:4(7Z,10Z,13Z,16Z))	ME480115	0.81	1.49	1.15	0.78	0.76	1.14	1.09	1.00	0.90	0.84	1.06	0.97
TG 55:3; [M+Li]+; TG(16:0/19:0/20:3)	ME480532	0.80	1.60	1.25	0.79	0.86	1.11	0.90	1.24	0.87	0.79	1.07	0.74
PE 31:0; [M+H]+; GPEtn(9:0/22:0)	ME480026	1.15	1.42	0.97	1.22	1.05	1.05	1.02	0.87	0.80	0.99	0.75	0.71
PA 35:2; [M+Na2-H]+; GPA(9:0/26:2(5E,9Z))	ME479416	1.00	1.39	1.04	1.07	0.94	0.92	1.08	0.87	0.92	0.92	1.05	0.79
TG 51:3; [M+NH4]+; TG(16:1/17:0/18:2)	ME480346	1.15	1.35	1.06	1.02	0.97	0.90	1.24	1.04	0.75	0.88	0.84	0.81
TG 51:3; [M+NH4]+; TG(17:0/17:1/17:2)	ME480348	0.91	1.66	1.01	1.01	1.02	0.87	1.21	1.10	0.88	0.94	0.70	0.69
TG 56:9; [M+NH4]+; TG(16:0/18:3/22:6)	ME480671	1.08	1.70	0.95	0.86	1.14	0.90	1.18	0.79	0.93	0.80	0.79	0.88
MGDG 40:6; [M+Na]+; MGDG(20:2(11Z,14Z)/20:4(5E,8E,11E,14E))	ME479394	0.78	1.47	1.04	1.07	1.04	1.22	1.09	0.90	1.10	0.72	0.80	0.79
TG 50:3; [M+Na]+; TG(16:0/16:0/18:3)	ME480312	0.98	1.65	1.17	0.92	0.87	0.88	1.21	1.01	1.10	0.54	0.88	0.78
PC 31:1; [M+Na]+; GPCho(9:0/22:1(13Z))	ME479542	1.06	1.75	0.88	0.85	1.00	0.74	0.95	0.90	1.02	1.10	0.93	0.83
PC 37:0; [M+Na]+; GPCho(11:0/26:0)	ME479652	0.95	1.61	0.94	0.90	1.12	0.80	0.89	0.95	0.90	0.98	1.05	0.90
TG 52:5; [M+NH4]+; TG(16:0/18:2/18:3)	ME480391	1.00	1.57	0.78	0.89	1.09	0.87	0.97	0.91	1.01	0.89	1.10	0.93
PC 40:3; [M+H]+; GPCho(20:1(11E)/20:2(11Z,14Z))	ME479800	1.04	1.76	0.98	0.69	0.95	0.84	0.77	0.98	1.20	0.94	1.07	0.77
PC 40:4; [M+H]+; GPCho(16:0/24:4(5Z,8Z,11Z,14Z))	ME479803	0.86	1.90	1.03	0.95	0.88	0.81	0.81	1.03	1.06	0.95	0.97	0.76
PC 42:9; [M+H]+; GPCho(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))	ME479914	0.96	1.44	0.93	0.75	1.24	0.91	1.01	1.24	0.96	0.94	0.86	0.77
DG 36:0; [M+NH4]+; DG(16:0/20:0/0:0)	ME479269	0.93	1.49	1.20	1.18	0.92	0.92	0.75	1.21	0.96	0.87	0.80	0.78
TG 52:7; [M+Na]+; TG(16:1/16:1/20:5)	ME480399	1.04	1.40	1.07	0.94	0.85	0.80	0.91	1.41	1.02	0.89	0.93	0.73
PE 36:5; [M+H]+; GPEtn(16:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME480090	0.50	1.44	1.55	1.08	1.13	0.99	0.66	0.93	0.88	0.80	1.01	1.03
CE(20:4); [M+NH4]+; 20:4 Cholesteryl ester	ME479239	0.75	1.75	1.27	1.12	1.16	0.92	0.73	0.84	1.02	0.96	0.78	0.69
CE(22:2); [M+NH4]+; 22:2 Cholesteryl ester	ME479240	0.77	1.84	1.14	0.94	0.97	1.04	0.95	0.89	0.90	0.91	0.86	0.77
TG 46:2; [M+NH4]+; TG(12:0/18:1/16:1)	ME480275	0.57	1.52	1.49	1.26	1.22	1.01	0.90	0.83	1.03	0.71	0.71	0.75
PC 30:0; [M+Na]+; GPCho(14:0/16:0)	ME479518	0.77	1.72	1.31	1.15	1.05	0.72	0.92	0.82	0.94	0.75	0.97	0.88
PC 32:3; [M+H]+; GPCho(14:0/18:3(6Z,9Z,12Z))	ME479564	0.75	1.48	1.38	1.21	1.07	0.75	0.95	0.84	1.00	0.67	0.96	0.92
PC 42:8; [M+H]+; GPCho(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME479908	0.82	1.87	1.24	1.17	0.70	0.68	1.03	1.25	0.85	0.81	0.88	0.69
CE(22:6); [M+NH4]+; 22:6 Cholesteryl ester	ME479241	0.70	1.99	1.13	0.95	0.89	0.98	0.82	1.11	1.18	0.55	0.81	0.89
PC 20:0; [M+H]+; GPCho(5:0/15:0)	ME479436	0.63	1.74	1.01	1.06	1.30	0.90	0.85	1.22	0.93	0.66	0.80	0.89
PC 20:0; [M+H]+; GPCho(12:0/8:0)	ME479433	0.66	1.80	1.00	1.09	0.96	0.89	0.84	1.23	1.02	0.70	0.85	0.95
PC 20:0; [M+H]+; GPCho(3:0/17:0)	ME479435	0.65	1.80	1.01	1.09	0.95	0.89	0.85	1.28	1.00	0.70	0.84	0.94
TG 52:4; [M+Na]+; TG(16:1/18:1/18:2)	ME480385	0.77	1.42	0.82	1.58	1.24	0.67	1.02	1.09	0.74	0.92	0.98	0.75
TG 52:6; [M+Li]+; TG(16:0/18:3/18:3)	ME480394	0.67	1.52	1.19	1.34	0.80	0.67	1.35	0.94	0.93	0.72	0.86	1.01
lysoPC 16:0; [M+H]+; PC(16:0/0:0)	ME479353	1.06	1.75	0.95	0.91	0.99	0.76	0.94	1.02	0.65	1.70	0.75	0.53
PC 40:2; [M+H]+; GPCho(20:1(11E)/20:1(11E))	ME479792	0.87	2.01	1.03	0.94	0.81	0.91	1.08	0.81	0.74	1.12	1.12	0.55
plasmenyl-PC 40:5; [M+Na]+; PC(P-18:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME480186	0.84	2.01	0.82	0.88	0.86	1.19	0.75	0.77	0.68	1.54	1.11	0.54
DG 36:3; [M+NH4]+; DG(18:1/18:2/0:0)	ME479276	1.06	1.48	1.60	1.08	0.75	1.28	0.57	0.89	0.84	1.01	0.87	0.57
PA 26:4; [M+Na2-H]+; GPA(2:0/24:4(5Z,8Z,11Z,14Z))	ME479413	0.79	1.79	1.36	1.03	0.85	1.25	0.66	1.00	0.75	1.18	0.73	0.62
PC 38:3; [M+H]+; GPCho(18:0/20:3(5Z,8Z,11Z))	ME479705	0.78	1.95	1.33	0.84	0.82	1.15	0.86	0.87	0.59	1.34	0.72	0.75
PC 39:1; [M+H]+; GPCho(19:0/20:1(11E))	ME479732	0.96	1.81	1.08	0.60	0.80	0.77	1.28	1.05	0.66	1.24	0.87	0.87
PE 40:7; [M+H]+; GPEtn(18:2(2E,4E)/22:5(4Z,7Z,10Z,13Z,16Z))	ME480155	0.81	1.62	1.53	0.97	1.23	0.92	0.85	0.74	0.82	1.05	0.57	0.90
PE 37:4; [M+H]+; GPEtn(15:0/22:4(7Z,10Z,13Z,16Z))	ME480106	0.76	1.62	1.48	0.88	0.83	0.92	1.12	0.87	0.70	1.16	0.88	0.78
PE 32:0; [M+H]+; GPEtn(16:0/16:0)	ME480027	0.90	1.53	1.34	0.71	1.03	0.80	0.95	0.83	0.92	1.49	0.78	0.71
PE 41:2; [M+H]+; GPEtn(19:0/22:2(13Z,16Z))	ME480157	1.11	1.70	1.41	0.81	1.04	0.69	1.02	0.76	0.87	1.25	0.65	0.69
SM 42:1; [M]+; SM(d16:0/26:1(17Z))	ME480247	0.98	1.69	1.41	0.81	1.09	0.68	1.05	0.83	0.90	1.26	0.65	0.65
TG 53:5; [M+NH4]+; TG(17:2/18:1/18:2)	ME480433	0.67	1.77	1.10	1.24	0.51	1.42	1.19	0.97	0.68	1.01	0.61	0.84
PC 39:4; [M+H]+; GPCho(22:4(7Z,10Z,13Z,16Z)/17:0)	ME479756	0.49	1.41	0.83	1.24	1.09	1.53	0.79	1.14	0.91	0.96	0.79	0.82
PE 42:8; [M+H]+; GPEtn(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME480169	0.74	1.43	0.87	1.30	0.79	1.51	1.04	1.02	0.78	0.74	0.99	0.79
TG 46:1; [M+NH4]+; TG(14:0/16:0/16:1)	ME480273	0.70	1.87	0.85	1.33	0.70	1.60	0.61	1.00	0.70	0.89	0.95	0.80
TG 52:3; [M+Na]+; TG(16:0/18:1/18:2)	ME480377	0.94	1.91	0.72	1.18	0.56	1.23	0.75	1.11	1.01	0.97	0.82	0.81
PC 42:6; [M+Na]+; GPCho(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479897	0.75	1.65	0.81	1.36	1.07	0.94	1.01	1.70	0.53	0.88	0.56	0.75
PE 17:0; [M+H]+; GPEtn(7:0/10:0)	ME479968	1.05	1.53	0.80	1.43	0.97	0.99	0.62	1.50	0.53	1.30	0.41	0.86
PE 17:0; [M+H]+; GPEtn(9:0/8:0)	ME479969	1.13	1.68	0.88	1.52	1.20	1.28	0.73	1.30	0.41	0.84	0.36	0.69
PE 39:5; [M+H]+; GPEtn(19:0/20:5(5Z,8Z,11Z,14Z,17Z))	ME480137	0.95	1.50	0.98	1.27	1.08	1.14	0.53	1.35	0.60	0.72	0.80	1.07
TG 48:1; [M+NH4]+; TG(16:0/16:0/16:1)	ME480283	1.22	1.25	1.26	1.08	0.81	1.21	0.63	1.20	0.68	0.79	0.61	1.24
PC 40:6; [M+H]+; GPCho(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479822	0.92	1.54	0.67	0.76	1.10	1.30	0.89	1.39	1.00	1.19	0.52	0.71
PC 40:7; [M+H]+; GPCho(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))	ME479827	0.73	1.70	0.82	0.87	1.11	1.30	0.77	1.32	0.73	1.00	0.78	0.88
TG 49:3; [M+NH4]+; TG(16:1/16:1/17:1)	ME480297	0.79	1.72	0.87	0.94	1.15	1.31	0.73	1.12	0.62	1.14	0.55	1.08
PC 44:5; [M+H]+; GPCho(18:4(6Z,9Z,12Z,15Z)/26:1(5Z))	ME479937	0.74	1.63	0.75	1.09	1.01	1.13	0.95	1.12	0.79	0.96	0.99	0.84
SM 43:1; [M+Na]+; SM(d17:0/26:1(17Z))	ME480253	1.12	1.41	0.67	1.05	0.98	1.17	0.94	1.16	0.99	0.91	0.78	0.81
DG 38:4; [M+NH4]+; DG(16:0/22:4/0:0)	ME479300	1.04	1.69	0.99	1.05	0.98	1.03	0.86	1.28	0.53	0.95	0.74	0.86
MG 16:0; [M+Li]+; MG(16:0/0:0/0:0)	ME479378	1.34	1.34	0.78	1.09	0.98	1.18	0.90	1.23	0.57	0.99	0.66	0.96
TG 56:7; [M+NH4]+; TG(16:0/20:3/20:4)	ME480653	1.23	1.58	0.50	1.17	1.07	1.10	0.96	0.73	0.73	1.39	0.42	1.12
PC 42:4; [M+H]+; GPCho(18:0/24:4(5Z,8Z,11Z,14Z))	ME479874	1.01	1.48	0.44	0.62	1.16	1.06	1.17	0.67	0.99	1.52	1.08	0.80
TG 54:9; [M+NH4]+; TG(16:1/18:3/20:5)	ME480506	0.90	1.53	0.60	0.83	1.06	0.92	1.20	0.74	0.86	1.64	0.71	1.02
TG 52:3; [M+Na]+; TG(16:1/18:1/18:1)	ME480378	0.71	1.41	0.38	1.52	0.68	1.15	1.04	1.02	1.05	1.19	0.91	0.95
PC 46:6; [M+H]+; GPCho(22:2(13Z,16Z)/24:4(5Z,8Z,11Z,14Z))	ME479951	0.77	1.31	0.65	1.30	0.64	1.23	1.21	1.33	0.83	1.28	0.84	0.62
TG 56:9; [M+NH4]+; TG(16:1/18:2/22:6)	ME480673	0.77	1.32	0.85	1.27	0.68	1.04	1.28	0.89	0.88	1.54	0.84	0.62
MGDG 6:0; [M+NH4]+; MGDG(2:0/4:0)	ME479400	0.70	1.13	0.70	0.87	0.68	1.08	0.74	1.17	1.32	1.46	0.87	1.28
DG 36:2; [M+NH4]+; DG(18:1/18:1/0:0)	ME479274	1.19	0.81	0.85	1.25	0.96	1.01	0.66	1.15	0.83	1.16	0.77	1.35
PC 39:3; [M+H]+; GPCho(17:1(9Z)/22:2(13Z,16Z))	ME479747	1.07	0.78	0.96	1.20	1.13	1.01	0.67	1.12	1.00	1.25	0.73	1.07
PC 37:0; [M+Na]+; GPCho(22:0/15:0)	ME479657	1.10	0.87	1.04	1.28	0.89	1.10	0.65	1.00	0.78	1.24	1.09	0.97
PC 40:4; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/22:1(13Z))	ME479805	1.01	0.97	0.88	1.20	1.00	1.14	0.82	0.98	0.93	1.18	0.90	1.00
TG 52:4; [M+NH4]+; TG(16:0/18:1/18:3)	ME480386	0.86	1.03	0.81	1.23	0.98	1.22	0.61	0.99	0.95	1.23	0.95	1.15
MGDG 24:6; [M+NH4]+; MGDG(2:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479384	0.98	1.25	0.83	1.28	1.11	0.99	0.65	1.15	0.83	1.11	0.70	1.10
TG 55:5; [M+NH4]+; TG(18:2/18:3/19:0)	ME480556	0.93	1.24	0.87	1.23	1.03	1.05	0.54	1.00	0.83	1.27	0.90	1.09
DG 36:1; [M+NH4]+; DG(16:0/20:1/0:0)	ME479271	1.12	1.10	0.76	1.27	0.85	0.98	0.60	1.01	0.82	1.53	0.70	1.27
PC 36:4; [M+H]+; GPCho(18:2(2E,4E)/18:2(2E,4E))	ME479634	1.02	1.12	0.92	1.58	0.86	0.85	0.63	0.87	0.84	1.47	0.92	0.92
PC 35:1; [M+H]+; GPCho(17:1(9Z)/18:0)	ME479608	0.78	1.25	1.05	0.87	1.31	0.87	0.63	1.06	1.07	1.23	0.99	0.90
PC 39:0; [M+H]+; GPCho(19:0/20:0)	ME479725	0.77	1.30	1.19	1.03	1.06	1.01	0.82	1.02	1.08	0.88	1.05	0.80
PE 19:0; [M+H]+; GPEtn(5:0/14:0)	ME479983	1.00	1.36	1.35	0.90	1.08	0.93	0.65	0.95	1.02	0.99	1.01	0.75
TG 49:2; [M+NH4]+; TG(16:0/16:1/17:1)	ME480295	0.71	1.48	0.93	0.85	0.94	0.94	0.83	0.96	1.00	1.09	1.18	1.09
PC 37:5; [M+H]+; GPCho(15:0/22:5(7Z,10Z,13Z,16Z,19Z))	ME479683	0.80	1.37	1.04	1.17	0.85	0.97	0.86	0.82	0.95	1.11	1.08	0.98
PA 42:0; [M+Na2-H]+; GPA(16:0/26:0)	ME479421	0.76	1.28	1.01	0.91	0.84	0.97	1.00	0.76	0.95	1.23	1.13	1.16
PC 39:3; [M+H]+; GPCho(19:0/20:3(8Z,11Z,14Z))	ME479750	0.67	1.26	1.12	0.98	0.95	0.89	0.85	0.92	1.02	1.19	1.07	1.10
PC 37:0; [M+Na]+; GPCho(12:0/25:0)	ME479653	0.56	1.25	1.17	1.22	1.11	1.03	0.78	0.69	0.94	1.21	0.94	1.11
PC 37:0; [M+Na]+; GPCho(24:0/13:0)	ME479659	0.76	1.21	1.09	0.95	1.09	1.14	0.83	0.85	0.99	1.14	0.86	1.08
PE 34:4; [M+H]+; GPEtn(14:0/20:4(5E,8E,11E,14E))	ME480058	0.77	1.09	1.01	1.05	1.18	0.97	0.80	0.77	1.08	1.12	1.08	1.06
TG 50:4; [M+Na]+; TG(16:1/16:1/18:2)	ME480319	0.87	1.30	1.00	0.72	1.14	1.35	0.67	0.88	1.08	1.09	1.01	0.90
TG 56:2; [M+NH4]+; TG(16:0/18:1/22:1)	ME480588	0.89	1.04	1.03	0.81	1.01	1.26	0.80	1.10	1.00	1.20	0.84	1.02
PC 32:2; [M+Na]+; GPCho(14:0/18:2(2E,4E))	ME479561	0.95	1.18	0.98	0.93	0.92	1.15	0.96	0.87	0.96	1.11	0.94	1.06
TG 54:0; [M+Na]+; TG(16:0/19:0/19:0)	ME480446	0.92	1.04	0.83	0.92	1.03	1.12	0.89	0.92	1.02	1.30	0.96	1.05
PC 35:4; [M+H]+; GPCho(13:0/22:4(7Z,10Z,13Z,16Z))	ME479621	1.33	1.68	0.51	1.00	0.58	0.86	0.91	0.90	0.99	1.52	0.80	0.92
TG 52:4; [M+Na]+; TG(16:0/18:2/18:2)	ME480384	1.21	1.55	0.57	1.31	0.76	1.19	0.74	0.61	1.01	1.32	0.91	0.84
TG 55:3; [M+NH4]+; TG(17:2/18:1/20:0)	ME480541	0.71	1.40	0.58	1.32	0.88	1.26	0.72	0.83	0.88	1.44	0.80	1.17
TG 55:3; [M+NH4]+; TG(16:0/19:0/20:3)	ME480536	0.73	1.45	0.62	1.12	0.93	1.09	0.79	0.79	0.94	1.50	0.86	1.17
TG 55:3; [M+NH4]+; TG(17:0/18:0/20:3)	ME480537	0.75	1.35	0.66	1.07	0.95	1.11	0.77	0.81	0.95	1.52	0.87	1.19
PC 32:5; [M+Na]+; GPCho(10:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME479566	1.02	1.21	0.74	1.00	0.89	1.16	1.02	0.74	0.84	1.45	0.82	1.09
PE 36:1; [M+H]+; GPEtn(12:0/24:1(15Z))	ME480077	0.96	1.48	0.72	1.00	0.80	1.14	0.87	0.71	0.76	1.62	0.90	1.04
lysoPC 22:1; [M+H]+; PC(22:1(13Z)/0:0)	ME479364	1.03	1.21	0.85	1.12	0.76	1.04	0.77	0.86	1.04	1.32	1.10	0.89
PC 41:0; [M+H]+; GPCho(17:0/24:0)	ME479832	0.92	1.35	1.07	0.94	0.97	1.01	0.86	0.92	0.85	1.27	1.09	0.76
PC 40:5; [M+H]+; GPCho(18:4(6Z,9Z,12Z,15Z)/22:1(13Z))	ME479818	1.00	1.38	0.72	1.26	0.92	1.29	0.77	0.78	0.84	1.18	0.97	0.91
PC 41:1; [M+H]+; GPCho(18:1(11E)/23:0)	ME479839	0.92	1.49	0.95	1.13	0.91	1.15	0.62	0.67	1.05	1.12	1.00	1.00
TG 55:3; [M+Li]+; TG(18:1/18:2/19:0)	ME480533	0.89	1.49	0.92	1.05	0.69	1.08	0.84	1.05	1.06	1.21	0.84	0.87
TG 54:1; [M+NH4]+; TG(16:0/18:1/20:0)	ME480450	1.14	1.54	0.88	0.92	0.70	1.18	0.83	0.77	0.90	1.25	0.95	0.94
TG 54:1; [M+NH4]+; TG(16:1/18:0/20:0)	ME480451	0.99	1.45	0.98	0.90	0.74	1.10	0.85	0.81	0.97	1.32	1.02	0.87
TG 55:2; [M+Li]+; TG(18:0/18:2/19:0)	ME480522	0.93	1.39	0.75	0.98	0.81	1.27	0.93	0.71	0.93	1.23	0.99	1.08
DG 44:1; [M+NH4]+; DG(18:1/26:0/0:0)	ME479343	0.96	1.47	0.85	0.93	0.84	1.19	0.86	0.81	0.92	1.24	0.87	1.07
PC 42:6; [M+H]+; GPCho(18:2(2E,4E)/24:4(5Z,8Z,11Z,14Z))	ME479896	0.99	1.54	0.82	0.95	0.82	1.10	0.95	0.86	0.80	1.22	0.82	1.12
TG 56:1; [M+Na]+; TG(17:0/19:0/20:1)	ME480578	0.74	1.59	0.77	1.06	0.87	1.28	0.60	0.93	0.89	1.30	0.93	1.04
TG 57:0; [M+Li]+; TG(18:0/19:0/20:0)	ME480677	0.81	1.72	0.64	1.07	0.94	1.30	0.51	0.78	0.68	1.40	1.03	1.09
PE 42:5; [M+H]+; GPEtn(20:4(5E,8E,11E,14E)/22:1(13Z))	ME480164	1.08	1.62	0.99	1.14	0.75	1.30	0.62	0.68	0.83	1.34	0.78	0.88
PA 12:0; [M+Na2-H]+; GPA(6:0/6:0)	ME479409	0.82	1.79	0.76	1.11	0.84	1.11	1.08	0.72	0.80	1.17	0.80	1.01
TG 52:0; [M+NH4]+; TG(16:0/16:0/20:0)	ME480363	0.87	1.75	0.95	1.07	0.72	1.15	0.81	0.62	0.93	1.27	0.86	1.01
PC 35:2; [M+Na]+; GPCho(15:0/20:2(5Z,8Z))	ME479615	0.77	1.72	0.95	1.15	0.73	1.08	0.81	0.73	0.86	1.18	1.07	0.97
PC 35:2; [M+Na]+; GPCho(15:0/20:2(11Z,14Z))	ME479614	0.76	1.80	0.90	1.16	0.73	1.07	0.72	0.71	0.84	1.27	1.08	0.96
PE 40:5; [M+H]+; GPEtn(16:1(7Z)/24:4(5Z,8Z,11Z,14Z))	ME480147	0.78	1.88	0.87	1.15	0.72	1.12	0.69	0.69	0.82	1.30	1.03	0.95
PC 40:3; [M+Na]+; GPCho(20:0/20:3(5Z,8Z,11Z))	ME479802	1.06	1.26	0.62	1.19	1.09	0.92	0.79	0.64	0.98	1.17	1.01	1.27
TG 56:8; [M+NH4]+; TG(18:2/18:3/20:3)	ME480669	1.20	1.34	0.48	0.90	1.11	1.19	0.95	0.63	0.85	1.21	0.98	1.16
PC 42:2; [M+H]+; GPCho(20:0/22:2(13Z,16Z))	ME479865	1.14	1.15	0.71	0.84	0.92	1.13	0.87	0.89	1.08	1.22	0.93	1.12
TG 52:5; [M+NH4]+; TG(16:0/16:0/20:5)	ME480389	1.18	1.37	0.62	0.91	0.93	1.11	0.81	0.87	0.98	1.25	0.92	1.04
PC 38:0; [M+H]+; GPCho(19:0/19:0)	ME479690	1.06	1.77	0.72	0.85	1.01	1.00	0.77	0.67	1.15	1.00	0.78	1.21
SM 42:0; [M]+; SM(d16:0/26:0)	ME480245	1.24	1.71	0.84	0.82	0.95	1.01	0.73	0.65	1.16	1.01	0.74	1.17
TG 56:8; [M+NH4]+; TG(16:1/18:2/22:5)	ME480663	1.14	1.68	0.66	1.11	0.93	0.88	0.72	0.58	0.90	1.39	0.64	1.39
TG 54:6; [M+NH4]+; TG(18:1/18:2/18:3)	ME480491	1.29	1.53	0.63	1.01	0.76	0.99	0.83	0.77	0.90	1.13	0.85	1.29
DG 38:1; [M+NH4]+; DG(16:0/22:1/0:0)	ME479289	1.14	1.53	0.85	0.98	0.90	0.76	0.83	0.73	0.89	1.12	0.88	1.38
PC 38:0; [M+H]+; GPCho(24:0/14:0)	ME479691	1.35	1.47	0.88	1.05	0.99	0.73	0.79	0.72	0.89	1.01	0.84	1.26
PE 35:1; [M+H]+; GPEtn(11:0/24:1(15Z))	ME480063	0.84	1.18	0.89	1.02	0.88	0.60	1.10	1.02	1.00	1.26	0.86	1.34
TG 53:6; [M+NH4]+; TG(16:0/17:2/20:4)	ME480435	1.17	1.24	0.63	1.02	0.72	0.88	1.23	1.03	0.81	1.47	0.86	0.95
TG 53:6; [M+NH4]+; TG(17:2/18:1/18:3)	ME480437	1.15	1.39	0.87	1.00	0.80	0.62	1.14	1.12	0.75	1.33	0.87	0.95
PC 42:9; [M+H]+; GPCho(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME479911	0.88	1.71	0.60	1.15	0.77	0.86	0.94	1.16	0.74	1.24	1.02	0.93
TG 53:5; [M+NH4]+; TG(17:1/18:2/18:2)	ME480432	0.84	1.63	0.99	0.95	0.82	0.81	1.06	1.27	0.69	1.25	0.88	0.82
DG 38:4; [M+Li]+; DG(16:0/22:4/0:0)	ME479299	1.22	1.78	0.98	1.14	0.80	0.69	0.79	0.97	0.66	0.94	0.78	1.24
PC 30:0; [M+Na]+; GPCho(9:0/21:0)	ME479522	1.21	1.49	0.92	1.27	0.75	0.89	0.83	0.99	0.85	1.02	0.79	1.00
PC 30:0; [M+Na]+; GPCho(15:0/15:0)	ME479519	1.25	1.51	0.93	1.22	0.74	0.89	0.83	0.99	0.86	1.03	0.77	0.98
PE 35:3; [M+H]+; GPEtn(17:0/18:3(6Z,9Z,12Z))	ME480071	1.25	1.51	0.93	1.21	0.74	0.89	0.83	0.99	0.86	1.02	0.78	0.98
TG 48:1; [M+Na]+; TG(14:0/16:1/18:0)	ME480279	1.24	1.43	0.86	1.01	0.86	0.71	0.95	0.93	1.00	1.12	0.86	1.03
TG 48:2; [M+Na]+; TG(14:0/16:1/18:1)	ME480284	1.18	1.28	0.98	1.23	0.89	0.74	0.91	0.82	0.91	1.22	0.95	0.89
SM 45:1; [M]+; SM(d19:0/26:1(17Z))	ME480263	1.10	1.54	1.13	0.76	1.09	0.57	0.76	1.19	0.76	1.10	0.97	1.03
DG 38:3; [M+NH4]+; DG(18:2/20:1/0:0)	ME479298	1.08	1.39	0.83	0.92	0.93	0.98	0.64	1.13	1.00	1.17	0.77	1.16
TG 51:3; [M+NH4]+; TG(16:0/17:1/18:2)	ME480344	0.93	1.39	0.76	0.87	1.09	0.82	0.87	1.35	0.78	1.10	0.92	1.12
PE 36:3; [M+H]+; GPEtn(18:0/18:3(6Z,9Z,12Z))	ME480087	0.74	1.12	0.99	1.33	1.23	0.97	0.51	0.71	1.30	1.43	0.95	0.72
PC 37:4; [M+H]+; GPCho(15:0/22:4(7Z,10Z,13Z,16Z))	ME479676	0.81	1.06	0.67	1.58	1.01	1.27	0.40	0.68	0.96	1.41	1.33	0.83
plasmenyl-PC 35:1; [M+Na]+; PC(P-18:0/17:1(9Z))	ME480177	0.80	1.01	0.91	1.67	0.79	1.29	0.52	0.76	1.08	1.30	0.90	0.97
PE 36:3; [M+H]+; GPEtn(16:0/20:3(5Z,8Z,11Z))	ME480086	0.69	1.43	0.89	1.38	0.65	0.95	0.84	0.39	1.23	1.35	1.21	0.98
plasmenyl-PE 36:3; [M+H]+; PE(P-16:0/20:3(5Z,8Z,11Z))	ME480200	0.91	1.57	0.96	1.49	0.65	1.03	0.44	0.61	0.86	1.72	0.75	1.00
PC 34:2; [M+Na]+; GPCho(16:0/18:2(6Z,9Z))	ME479584	0.89	1.53	0.76	1.50	0.69	1.21	0.39	0.68	0.90	1.35	1.09	1.02
PC 36:5; [M+H]+; GPCho(14:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME479636	0.86	1.53	0.63	1.55	0.65	1.19	0.48	0.71	0.94	1.39	1.03	1.04
PC 36:5; [M+H]+; GPCho(14:0/22:5(7Z,10Z,13Z,16Z,19Z))	ME479637	0.78	1.86	0.78	1.53	0.69	1.22	0.43	0.64	0.96	1.51	0.81	0.79
PC 36:5; [M+H]+; GPCho(22:4(7Z,10Z,13Z,16Z)/14:1(9Z))	ME479643	0.81	1.66	0.72	1.57	0.70	1.26	0.46	0.67	0.99	1.46	0.84	0.85
PC 34:3; [M+Na]+; GPCho(16:0/18:3(6Z,9Z,12Z))	ME479593	0.92	1.18	0.78	1.37	0.93	1.13	0.60	0.71	0.97	1.20	0.81	1.41
PE 39:0; [M+H]+; GPEtn(19:0/20:0)	ME480132	0.81	1.24	1.01	1.41	0.87	1.18	0.66	0.42	0.89	1.21	0.96	1.34
PE 24:0; [M+H]+; GPEtn(6:0/18:0)	ME479995	0.68	1.71	0.82	1.44	0.67	1.23	0.56	0.71	0.91	1.01	1.02	1.24
plasmenyl-PC 18:0; [M+Na]+; PC(P-16:0/2:0)	ME480175	1.01	1.38	0.88	1.33	0.64	1.34	0.65	0.75	0.94	1.03	0.88	1.16
PC 34:2; [M+Na]+; GPCho(17:1(9Z)/17:1(9Z))	ME479586	0.79	1.54	0.91	1.48	0.78	1.25	0.55	0.74	0.96	1.22	0.86	0.92
PC 34:2; [M+Na]+; GPCho(12:0/22:2(13Z,16Z))	ME479583	0.97	1.38	1.05	1.47	0.83	1.16	0.57	0.75	0.79	1.22	0.88	0.93
PC 36:5; [M+H]+; GPCho(14:1(9Z)/22:4(7Z,10Z,13Z,16Z))	ME479638	0.81	1.28	1.16	1.42	0.79	1.24	0.67	0.71	0.91	1.06	0.91	1.05
PC 36:5; [M+H]+; GPCho(22:5(4Z,7Z,10Z,13Z,16Z)/14:0)	ME479644	0.82	1.36	1.09	1.52	0.74	1.24	0.65	0.68	0.89	1.09	0.89	1.04
TG 44:1; [M+NH4]+; TG(12:0/16:1/16:0)	ME480267	0.20	4.37	0.36	0.45	0.47	4.01	0.35	0.26	0.30	0.48	0.18	0.57
TG 44:2; [M+NH4]+; TG(12:0/14:1/18:1)	ME480269	0.15	4.34	0.59	0.90	0.54	2.64	0.22	0.49	0.28	0.82	0.20	0.82
MG 23:0; [M+Li]+; MG(23:0/0:0/0:0)	ME479380	0.37	2.95	0.68	2.93	0.21	1.28	0.78	0.69	0.53	0.62	0.69	0.27
DG 38:5; [M+NH4]+; DG(16:0/22:5/0:0)	ME479303	0.39	5.72	1.48	0.36	0.50	0.32	0.84	0.51	0.93	0.29	0.38	0.28
PE 27:1; [M+H]+; GPEtn(10:0/17:1(9Z))	ME480009	0.53	5.54	0.33	0.58	0.28	0.56	0.42	0.79	0.95	0.52	0.34	1.15
plasmenyl-PE 32:1; [M+H]+; PE(P-16:0/16:1(7Z))	ME480191	0.50	5.84	0.44	0.38	0.83	0.23	0.71	1.21	0.48	0.37	0.37	0.65
DG 42:2; [M+NH4]+; DG(20:2/22:0/0:0)	ME479331	0.38	5.42	0.81	0.41	0.54	1.68	0.81	0.40	0.41	0.31	0.52	0.31
TG 51:2; [M+NH4]+; TG(16:1/17:0/18:1)	ME480335	0.29	5.44	0.67	1.31	0.32	1.82	0.21	0.49	0.17	0.64	0.32	0.33
DG 38:2; [M+NH4]+; DG(18:1/20:1/0:0)	ME479294	0.26	4.46	0.53	1.66	0.60	1.27	0.31	0.62	0.35	0.49	0.54	0.92
DG 38:2; [M+NH4]+; DG(18:2/20:0/0:0)	ME479295	0.31	4.94	0.60	1.42	0.49	0.78	0.49	0.78	0.28	0.58	0.64	0.68
DG 38:1; [M+NH4]+; DG(18:1/20:0/0:0)	ME479291	0.60	4.56	0.46	0.66	0.53	1.43	0.50	0.50	0.73	0.63	0.46	0.94
DG 42:3; [M+NH4]+; DG(18:3/24:0/0:0)	ME479333	0.51	4.26	1.12	0.74	0.64	1.31	0.85	0.47	0.63	0.28	0.69	0.51
CE(24:1); [M+NH4]+; 24:1 Cholesteryl ester	ME479242	0.31	2.61	0.33	1.04	1.80	1.54	1.31	0.70	0.29	0.47	0.63	0.97
PE 24:1; [M+H]+; GPEtn(4:0/20:1(11E))	ME479999	0.34	3.43	1.26	0.45	0.78	0.60	0.37	0.50	0.88	2.25	0.55	0.60
PC 42:3; [M+H]+; GPCho(20:1(11E)/22:2(13Z,16Z))	ME479871	0.28	3.24	0.43	1.60	0.38	1.45	0.09	0.50	0.26	2.54	0.27	0.95
PC 44:4; [M+H]+; GPCho(22:2(13Z,16Z)/22:2(13Z,16Z))	ME479934	0.35	2.55	0.48	1.54	0.46	1.55	0.15	0.63	0.40	2.42	0.49	0.98
plasmenyl-PC 43:0; [M+Na]+; PC(P-18:0/25:0)	ME480189	0.42	2.62	0.61	1.21	0.55	1.69	0.15	0.74	0.41	1.96	0.52	1.12
PC 40:0; [M+Na]+; GPCho(16:0/24:0)	ME479773	0.54	3.41	1.00	0.83	0.68	0.83	0.64	0.75	0.85	1.34	0.67	0.46
PE 36:1; [M+H]+; GPEtn(16:0/20:1(11E))	ME480078	0.61	3.19	1.16	0.89	0.55	0.91	0.49	0.56	0.82	1.58	0.59	0.65
PC 44:5; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/26:2(5E,9Z))	ME479935	0.61	3.16	0.83	0.80	0.63	1.09	0.73	0.64	0.41	1.63	0.77	0.70
TG 50:0; [M+Na]+; TG(16:0/16:0/18:0)	ME480299	0.56	3.43	0.87	1.04	0.42	1.33	0.43	0.71	0.32	1.74	0.63	0.52
CE(16:1); [M+NH4]+; 16:1 Cholesteryl ester	ME479232	0.96	3.27	0.38	1.45	0.04	0.92	0.39	0.63	0.28	2.07	0.50	1.11
lysoPC 24:0; [M+H]+; PC(24:0/0:0)	ME479368	0.57	3.74	0.44	1.08	0.35	0.92	0.26	0.44	0.44	2.42	0.31	1.04
PC 31:5; [M+Na]+; GPCho(9:0/22:5(7Z,10Z,13Z,16Z,19Z))	ME479551	0.56	3.85	0.32	0.74	0.40	0.72	0.51	0.40	0.59	2.43	0.52	0.96
TG 50:5; [M+NH4]+; TG(16:1/16:1/18:3)	ME480323	0.38	3.69	0.49	1.08	0.36	1.22	0.57	0.47	0.65	1.88	0.49	0.70
PC 33:2; [M+H]+; GPCho(15:1(9Z)/18:1(11E))	ME479570	0.75	4.30	0.41	0.78	0.38	0.90	0.40	0.42	0.59	1.81	0.57	0.70
PC 31:2; [M+H]+; GPCho(9:0/22:2(13Z,16Z))	ME479547	0.68	3.71	0.39	0.99	0.44	0.90	0.45	0.41	0.72	1.86	0.74	0.69
PE 38:6; [M+H]+; GPEtn(16:1(7Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME480126	0.84	3.71	0.31	1.00	0.51	0.87	0.41	0.41	0.58	1.98	0.50	0.86
PC 33:3; [M+H]+; GPCho(13:0/20:3(5Z,8Z,11Z))	ME479572	0.79	3.89	0.32	0.91	0.40	0.93	0.46	0.34	0.64	1.87	0.59	0.87
PE 38:3; [M+H]+; GPEtn(18:2(2E,4E)/20:1(11E))	ME480113	0.85	3.86	0.36	0.95	0.44	0.91	0.37	0.39	0.62	1.73	0.53	1.01
PE 37:3; [M+H]+; GPEtn(18:3(6Z,9Z,12Z)/19:0)	ME480105	0.64	4.08	0.34	0.94	0.41	0.99	0.36	0.44	0.56	2.06	0.38	0.78
TG 50:1; [M+NH4]+; TG(16:0/16:1/18:0)	ME480303	0.68	3.87	0.31	0.69	0.49	1.22	0.41	0.33	0.67	2.09	0.42	0.81
DG 34:1; [M+NH4]+; DG(16:0/18:1/0:0)	ME479255	0.67	3.27	0.35	1.00	0.72	0.90	0.46	0.56	0.59	2.08	0.41	0.98
PC 38:1; [M+H]+; GPCho(16:0/22:1(13Z))	ME479693	0.72	3.18	0.37	1.23	0.44	1.02	0.39	0.39	0.65	2.31	0.49	0.82
TG 52:3; [M+NH4]+; TG(16:0/18:0/18:3)	ME480380	0.55	3.25	0.29	1.23	0.46	1.19	0.30	0.42	0.57	2.32	0.48	0.95
TG 54:5; [M+NH4]+; TG(17:2/18:3/19:0)	ME480484	0.55	3.40	0.30	1.18	0.48	1.13	0.15	0.42	0.50	2.32	0.68	0.91
DG 35:1; [M+NH4]+; DG(17:1/18:0/0:0)	ME479262	0.74	2.99	0.31	1.45	0.38	1.08	0.53	0.39	0.81	1.62	0.68	1.02
plasmenyl-PE 36:1; [M+H]+; PE(P-18:0/18:1(11E))	ME480197	0.89	3.14	0.50	1.11	0.53	1.03	0.47	0.45	0.68	1.59	0.50	1.11
TG 54:9; [M+Li]+; TG(16:1/18:3/20:5)	ME480504	0.85	3.07	0.37	1.07	0.50	1.07	0.54	0.42	0.76	1.89	0.60	0.87
PE 39:5; [M+H]+; GPEtn(17:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME480136	0.77	3.10	0.48	1.19	0.43	0.79	0.41	0.44	0.79	1.98	0.59	1.04
plasmenyl-PE 40:4; [M+H]+; PE(P-18:0/22:4(7Z,10Z,13Z,16Z))	ME480208	0.78	2.98	0.49	1.19	0.45	0.80	0.33	0.53	0.83	1.97	0.61	1.03
PE 33:0; [M+H]+; GPEtn(13:0/20:0)	ME480034	0.83	3.06	0.53	1.03	0.61	1.27	0.60	0.51	0.69	1.61	0.49	0.76
TG 56:9; [M+NH4]+; TG(18:2/18:3/20:4)	ME480675	0.58	2.96	0.49	1.24	0.59	1.27	0.58	0.60	0.56	1.52	0.65	0.96
plasmenyl-PE 38:5; [M+H]+; PE(P-16:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME480206	0.72	3.32	0.60	0.94	0.53	0.86	0.53	0.51	0.85	1.43	0.80	0.92
TG 50:2; [M+Na]+; TG(16:1/17:0/17:1)	ME480307	0.88	3.41	0.34	0.96	0.57	1.18	0.50	0.34	0.68	1.62	0.71	0.83
PC 38:3; [M+H]+; GPCho(18:2(2E,4E)/20:1(11E))	ME479707	0.79	3.38	0.55	1.00	0.60	0.95	0.46	0.58	0.62	1.57	0.71	0.78
PC 37:5; [M+H]+; GPCho(17:2(9Z,12Z)/20:3(8Z,11Z,14Z))	ME479686	0.62	3.22	0.53	1.13	0.57	1.07	0.45	0.41	0.68	1.67	0.75	0.90
SM 41:5; [M]+; SM(d17:1(4E)/24:4(5Z,8Z,11Z,14Z))	ME480244	0.71	3.33	0.50	1.09	0.45	1.18	0.50	0.42	0.61	1.73	0.74	0.74
PC 38:3; [M+H]+; GPCho(18:3(6Z,9Z,12Z)/20:0)	ME479708	0.78	3.44	0.51	1.14	0.48	1.07	0.50	0.43	0.59	1.57	0.65	0.84
PC 38:3; [M+H]+; GPCho(22:2(13Z,16Z)/16:1(7Z))	ME479709	0.69	3.46	0.46	1.12	0.57	1.05	0.50	0.44	0.61	1.60	0.67	0.83
TG 54:5; [M+Na]+; TG(16:0/18:1/20:4)	ME480481	0.46	3.20	0.54	1.00	0.36	1.71	0.46	0.83	0.42	1.58	0.53	0.93
TG 54:6; [M+Li]+; TG(18:0/18:3/18:3)	ME480487	0.47	3.36	0.58	0.94	0.48	1.46	0.33	0.69	0.42	1.72	0.42	1.14
PE 38:4; [M+H]+; GPEtn(18:4(6Z,9Z,12Z,15Z)/20:0)	ME480119	0.52	3.70	0.43	1.29	0.55	0.77	0.38	0.28	0.48	1.92	0.50	1.18
TG 54:2; [M+NH4]+; TG(16:0/18:0/20:2)	ME480456	0.52	3.55	0.31	1.46	0.35	1.46	0.20	0.30	0.35	1.76	0.38	1.37
TG 54:5; [M+Na]+; TG(16:0/18:0/20:5)	ME480480	0.47	3.69	0.35	1.13	0.52	1.31	0.44	0.37	0.39	1.73	0.41	1.19
TG 55:4; [M+Li]+; TG(18:1/18:3/19:0)	ME480544	0.47	3.68	0.35	1.13	0.52	1.31	0.44	0.37	0.39	1.73	0.41	1.20
DG 38:1; [M+NH4]+; DG(18:0/20:1/0:0)	ME479290	0.62	3.60	0.40	0.75	0.53	1.79	0.49	0.68	0.68	1.02	0.42	1.03
PC 39:5; [M+H]+; GPCho(17:0/22:5(4Z,7Z,10Z,13Z,16Z))	ME479760	0.73	4.31	0.57	1.06	0.28	1.31	0.32	0.50	0.46	1.57	0.23	0.65
PE 42:7; [M+H]+; GPEtn(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))	ME480168	0.65	4.24	0.59	0.89	0.52	1.01	0.49	0.49	0.64	1.22	0.61	0.66
PE 26:2; [M+H]+; GPEtn(9:0/17:2(9Z,12Z))	ME480007	0.73	3.95	0.44	0.37	0.41	0.34	0.81	1.30	0.90	0.72	0.55	1.47
PE 27:2; [M+H]+; GPEtn(5:0/22:2(13Z,16Z))	ME480012	0.34	3.68	0.62	0.43	0.90	1.05	0.78	1.00	0.64	0.37	1.36	0.84
PC 27:1; [M+H]+; GPCho(11:0/16:1(9Z))	ME479476	0.45	3.47	0.54	0.54	0.71	0.90	0.82	0.96	1.28	0.57	0.89	0.87
PE 26:2; [M+H]+; GPEtn(4:0/22:2(13Z,16Z))	ME480004	0.53	3.10	0.59	0.51	1.13	1.10	0.69	0.96	0.97	0.54	1.02	0.86
PE 26:2; [M+H]+; GPEtn(8:0/18:2(2E,4E))	ME480006	0.42	3.14	0.44	0.41	0.93	1.13	0.65	1.20	1.07	0.76	0.90	0.96
PC 27:1; [M+H]+; GPCho(11:0/16:1(7Z))	ME479475	0.62	3.43	0.62	0.59	0.76	0.85	0.54	1.35	0.72	0.78	0.86	0.89
PE 29:2; [M+H]+; GPEtn(12:0/17:2(9Z,12Z))	ME480019	0.67	2.96	0.58	0.73	0.64	0.95	0.46	1.41	1.15	0.69	1.05	0.70
PE 28:1; [M+H]+; GPEtn(8:0/20:1(11E))	ME480017	0.44	4.50	0.80	0.53	0.65	0.46	1.02	0.57	0.62	0.81	1.06	0.55
SM 32:1; [M]+; SM(d14:1(4E)/18:0)	ME480222	0.60	3.69	0.60	0.94	0.54	0.51	1.01	0.97	0.61	0.50	1.02	1.02
PE 28:1; [M+H]+; GPEtn(10:0/18:1(11E))	ME480014	0.54	3.76	0.68	0.67	0.70	0.70	0.96	0.45	0.99	0.93	0.82	0.80
PE 28:1; [M+H]+; GPEtn(4:0/24:1(15Z))	ME480015	0.54	3.76	0.68	0.67	0.70	0.70	0.96	0.45	0.99	0.93	0.82	0.80
TG 51:3; [M+NH4]+; TG(16:0/17:2/18:1)	ME480345	0.39	3.49	1.21	1.23	0.64	1.47	0.67	0.59	0.64	0.62	0.57	0.48
TG 51:3; [M+NH4]+; TG(16:1/17:1/18:1)	ME480347	0.40	3.37	1.37	1.23	0.64	1.23	0.64	0.54	0.67	0.57	0.78	0.54
PC 41:0; [M+H]+; GPCho(20:0/21:0)	ME479835	0.44	2.87	0.79	0.81	0.77	1.57	0.51	1.49	0.49	1.16	0.58	0.51
TG 53:3; [M+NH4]+; TG(17:0/18:1/18:2)	ME480423	0.31	3.24	1.00	1.56	0.30	1.71	0.23	1.31	0.30	1.18	0.36	0.49

Factors:

F1	ZT_time:ZT0 \| Genotype:KO
F2	ZT_time:ZT0 \| Genotype:WT
F3	ZT_time:ZT12 \| Genotype:KO
F4	ZT_time:ZT12 \| Genotype:WT
F5	ZT_time:ZT16 \| Genotype:KO
F6	ZT_time:ZT16 \| Genotype:WT
F7	ZT_time:ZT20 \| Genotype:KO
F8	ZT_time:ZT20 \| Genotype:WT
F9	ZT_time:ZT4 \| Genotype:KO
F10	ZT_time:ZT4 \| Genotype:WT
F11	ZT_time:ZT8 \| Genotype:KO
F12	ZT_time:ZT8 \| Genotype:WT

Data matrix